,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1986585,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2982,GUCY1A1,https://ctdbase.org/detail.go?type=gene&acc=2982,,,2982.0,GUCY1A1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GUCY1A1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1,1986725,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2983,GUCY1B1,https://ctdbase.org/detail.go?type=gene&acc=2983,,,2983.0,GUCY1B1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in decreased expression of GUCY1B1 protein],,,PMID:11729227,https://www.ncbi.nlm.nih.gov/pubmed/11729227,11729227,,
2,1986726,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2983,GUCY1B1,https://ctdbase.org/detail.go?type=gene&acc=2983,,,2983.0,GUCY1B1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [lead results in decreased expression of GUCY1B1 protein],,,PMID:12761246,https://www.ncbi.nlm.nih.gov/pubmed/12761246,12761246,,
3,1986727,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10090,Mus musculus (house mouse),Ascorbic acid affects the reaction [GULO protein affects the expression of PCSK9 protein]|ascorbic acid affects the reaction [GULO protein affects the expression of LDLR protein],,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
4,1986728,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10090,Mus musculus (house mouse),Ascorbic acid deficiency affects the reaction [GULO affects the susceptibility to nickel subsulfide],,,PMID:21878346,https://www.ncbi.nlm.nih.gov/pubmed/21878346,21878346,,
5,1986729,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10090,Mus musculus (house mouse),[gulonolactone co-treated with GULO protein] results in increased abundance of ascorbic acid,,,PMID:16737683,https://www.ncbi.nlm.nih.gov/pubmed/16737683,16737683,,
6,1986730,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10090,Mus musculus (house mouse),GULO protein affects the chemical synthesis of ascorbic acid,,,PMID:22306178,https://www.ncbi.nlm.nih.gov/pubmed/22306178,22306178,,
7,1986731,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10116,Rattus norvegicus (Norway rat),GULO protein results in increased chemical synthesis of ascorbic acid,,,PMID:30606963,https://www.ncbi.nlm.nih.gov/pubmed/30606963,30606963,,
8,1986732,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2990,GUSB,https://ctdbase.org/detail.go?type=gene&acc=2990,,,2990.0,GUSB,10116,Rattus norvegicus (Norway rat),[ferulic acid co-treated with ascorbic acid] inhibits the reaction [isoproterenol results in increased activity of GUSB protein],,,PMID:17045618,https://www.ncbi.nlm.nih.gov/pubmed/17045618,17045618,,
9,1986733,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3002,GZMB,https://ctdbase.org/detail.go?type=gene&acc=3002,,,3002.0,GZMB,10090,Mus musculus (house mouse),Ascorbic acid deficiency results in decreased expression of GZMB mRNA,,,PMID:22306178,https://www.ncbi.nlm.nih.gov/pubmed/22306178,22306178,,
10,1986734,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of H2AX mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
11,1986861,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606,Homo sapiens (human),[ascorbic acid results in increased reduction of vitamin K 3] which results in increased phosphorylation of H2AX protein,,,PMID:19482829,https://www.ncbi.nlm.nih.gov/pubmed/19482829,19482829,,
12,1986862,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8342,H2BC14,https://ctdbase.org/detail.go?type=gene&acc=8342,,,8342.0,H2BC14,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of H2BC14 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
13,1986863,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3017,H2BC5,https://ctdbase.org/detail.go?type=gene&acc=3017,,,3017.0,H2BC5,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of H2BC5 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
14,1986864,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3030,HADHA,https://ctdbase.org/detail.go?type=gene&acc=3030,,,3030.0,HADHA,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of HADHA mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
15,1986865,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9464,HAND2,https://ctdbase.org/detail.go?type=gene&acc=9464,,,9464.0,HAND2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HAND2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
16,1986866,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9464,HAND2,https://ctdbase.org/detail.go?type=gene&acc=9464,,,9464.0,HAND2,10090,Mus musculus (house mouse),Cadmium sulfate inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of HAND2 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of HAND2 mRNA,,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
17,1986867,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309.0,HSPA5,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased expression of HSPA5 protein],,,PMID:17353921,https://www.ncbi.nlm.nih.gov/pubmed/17353921,17353921,,
18,1986868,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,26762,HAVCR1,https://ctdbase.org/detail.go?type=gene&acc=26762,,,26762.0,HAVCR1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HAVCR1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
19,1986869,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3054,HCFC1,https://ctdbase.org/detail.go?type=gene&acc=3054,,,3054.0,HCFC1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of HCFC1 mrna|[arsenic trioxide co-treated with ascorbic acid] results in increased expression of HCFC1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
20,1987017,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3070,HELLS,https://ctdbase.org/detail.go?type=gene&acc=3070,,,3070.0,HELLS,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of HELLS mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
21,1987018,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9843,HEPH,https://ctdbase.org/detail.go?type=gene&acc=9843,,,9843.0,HEPH,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of HEPH mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
22,1987019,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9709,HERPUD1,https://ctdbase.org/detail.go?type=gene&acc=9709,,,9709.0,HERPUD1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of HERPUD1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
23,1987020,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3280,HES1,https://ctdbase.org/detail.go?type=gene&acc=3280,,,3280.0,HES1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in decreased expression of HES1 protein],,,PMID:29663635,https://www.ncbi.nlm.nih.gov/pubmed/29663635,29663635,,
24,1987021,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,390992,HES3,https://ctdbase.org/detail.go?type=gene&acc=390992,,,390992.0,HES3,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of HES3 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
25,1987022,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,388585,HES5,https://ctdbase.org/detail.go?type=gene&acc=388585,,,388585.0,HES5,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of HES5 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
26,1987023,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3082,HGF,https://ctdbase.org/detail.go?type=gene&acc=3082,,,3082.0,HGF,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of KEAP1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPX2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGG mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of PLN mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HAVCR1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GATA6 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TF mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ZFAND2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ISL1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ESRG mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXB3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ASCL1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TFAP2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of CYP24A1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CEACAM6 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FLT1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SERPINA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of APOA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of RRAD mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of VCAM1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLM mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SRXN1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of H2BC14 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MPZL1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FOXG1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of UGT2A3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of POU5F1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TM4SF4 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTO1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX2 mrna|[[ascorbic acid co-treate,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
27,1987024,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in increased stability of HIF1A protein]|ascorbic acid inhibits the reaction [nickel sulfate results in increased stability of HIF1A protein]|ascorbic acid inhibits the reaction [potassium chromate(vi) results in increased stability of HIF1A protein],,,PMID:17382205,https://www.ncbi.nlm.nih.gov/pubmed/17382205,17382205,,
28,1987025,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),Ascorbic acid results in increased degradation of HIF1A protein|ascorbic acid inhibits the reaction [cupric chloride results in decreased hydroxylation of HIF1A protein]|ascorbic acid inhibits the reaction [sodium arsenite results in decreased hydroxylation of HIF1A protein]|ascorbic acid inhibits the reaction [vanadates results in increased stability of HIF1A protein]|ascorbic acid inhibits the reaction [manganese chloride results in decreased hydroxylation of HIF1A protein]|ascorbic acid inhibits the reaction [vanadates results in decreased hydroxylation of HIF1A protein]|ascorbic acid inhibits the reaction [cupric chloride results in increased stability of HIF1A protein]|ascorbic acid inhibits the reaction [manganese chloride results in increased stability of HIF1A protein]|ascorbic acid inhibits the reaction [nickel sulfate results in decreased hydroxylation of HIF1A protein],,,PMID:19074761,https://www.ncbi.nlm.nih.gov/pubmed/19074761,19074761,,
29,1987188,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nickel sulfate results in increased expression of HIF1A protein],,,PMID:16288478,https://www.ncbi.nlm.nih.gov/pubmed/16288478,16288478,,
30,1987189,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [quercetin results in increased expression of HIF1A protein],,,PMID:17364964,https://www.ncbi.nlm.nih.gov/pubmed/17364964,17364964,,
31,1987190,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [sodium arsenite results in increased expression of HIF1A protein],,,PMID:24188932,https://www.ncbi.nlm.nih.gov/pubmed/24188932,24188932,,
32,1987191,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [sodium arsenite results in increased stability of HIF1A protein],,,PMID:19074761|PMID:24188932,https://www.ncbi.nlm.nih.gov/pubmed/19074761|https://www.ncbi.nlm.nih.gov/pubmed/24188932,19074761|24188932,,
33,1987192,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309.0,HSPA5,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of HSPA5 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
34,1987193,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606,Homo sapiens (human),Manganese chloride inhibits the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with ketoglutaric acids co-treated with ascorbic acid co-treated with ferrous chloride] promotes the reaction [VHL protein binds to HIF1A protein]]|[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with ketoglutaric acids co-treated with ascorbic acid co-treated with ferrous chloride] promotes the reaction [VHL protein binds to HIF1A protein],,,PMID:19263519,https://www.ncbi.nlm.nih.gov/pubmed/19263519,19263519,,
35,1987194,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [AGT protein modified form results in decreased hydroxylation of HIF1A protein]|ascorbic acid inhibits the reaction [hydrogen peroxide results in decreased hydroxylation of HIF1A protein],,,PMID:20881940,https://www.ncbi.nlm.nih.gov/pubmed/20881940,20881940,,
36,1987195,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3098,HK1,https://ctdbase.org/detail.go?type=gene&acc=3098,,,3098.0,HK1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of HK1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
37,1987196,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3141,HLCS,https://ctdbase.org/detail.go?type=gene&acc=3141,,,3141.0,HLCS,9606,Homo sapiens (human),Ascorbic acid results in decreased activity of HLCS protein,,,PMID:26303405,https://www.ncbi.nlm.nih.gov/pubmed/26303405,26303405,,
38,1987197,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3146,HMGB1,https://ctdbase.org/detail.go?type=gene&acc=3146,,,3146.0,HMGB1,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of HMGB1 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
39,1987348,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3148,HMGB2,https://ctdbase.org/detail.go?type=gene&acc=3148,,,3148.0,HMGB2,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of HMGB2 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
40,1987349,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10140,Cavia (guinea pigs),[ascorbic acid co-treated with ammonium metavanadate] affects the activity of HMGCR protein,,,PMID:1669016,https://www.ncbi.nlm.nih.gov/pubmed/1669016,1669016,,
41,1987350,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of HMGCR mRNA,,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
42,1987351,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3157,HMGCS1,https://ctdbase.org/detail.go?type=gene&acc=3157,,,3157.0,HMGCS1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of HMGCS1 mRNA,,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
43,1987352,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3158,HMGCS2,https://ctdbase.org/detail.go?type=gene&acc=3158,,,3158.0,HMGCS2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HMGCS2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
44,1987353,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [benzo(a)pyrene-7,8-dione results in increased expression of HMOX1 protein]",,,PMID:22053912,https://www.ncbi.nlm.nih.gov/pubmed/22053912,22053912,,
45,1987354,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [HMOX1 protein results in increased expression of SOD2 mrna],,,PMID:10942521,https://www.ncbi.nlm.nih.gov/pubmed/10942521,10942521,,
46,1987355,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of HMOX1 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
47,1987356,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [resveratrol results in increased expression of HMOX1 mrna]|ascorbic acid inhibits the reaction [resveratrol results in increased expression of HMOX1 protein],,,PMID:21199573,https://www.ncbi.nlm.nih.gov/pubmed/21199573,21199573,,
48,1987357,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in increased expression of HMOX1 mrna],,,PMID:32525552,https://www.ncbi.nlm.nih.gov/pubmed/32525552,32525552,,
49,1987513,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [[lead acetate results in increased abundance of lead] which results in increased expression of HMOX1 mrna],,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
50,1987514,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of HMOX1 mRNA,,,PMID:33248029|PMID:8743975,https://www.ncbi.nlm.nih.gov/pubmed/33248029|https://www.ncbi.nlm.nih.gov/pubmed/8743975,33248029|8743975,,
51,1987515,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),[buthionine sulfoximine co-treated with ascorbic acid] promotes the reaction [copper sulfate results in increased expression of HMOX1 mrna],,,PMID:19683516,https://www.ncbi.nlm.nih.gov/pubmed/19683516,19683516,,
52,1987516,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090,Mus musculus (house mouse),Ascorbic acid promotes the reaction [sodium arsenite results in increased expression of HMOX1 mrna]|ascorbic acid inhibits the reaction [chromium hexavalent ion results in increased expression of HMOX1 mrna]|ascorbic acid inhibits the reaction [cadmium results in increased expression of HMOX1 mrna]|ascorbic acid inhibits the reaction [cadmium chloride results in increased expression of HMOX1 mrna],,,PMID:16517059,https://www.ncbi.nlm.nih.gov/pubmed/16517059,16517059,,
53,1987517,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [diquat results in decreased expression of HMOX1 protein],,,PMID:33475796,https://www.ncbi.nlm.nih.gov/pubmed/33475796,33475796,,
54,1987518,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [nelfinavir results in increased expression of HMOX1],,,PMID:15577407,https://www.ncbi.nlm.nih.gov/pubmed/15577407,15577407,,
55,1987519,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of HMOX1 protein,,,PMID:16171798,https://www.ncbi.nlm.nih.gov/pubmed/16171798,16171798,,
56,1987520,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in increased expression of HMOX1 protein],,,PMID:29663635|PMID:29940330,https://www.ncbi.nlm.nih.gov/pubmed/29663635|https://www.ncbi.nlm.nih.gov/pubmed/29940330,29663635|29940330,,
57,1987521,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased expression of HMOX1 mrna]|ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased expression of HMOX1 protein],,,PMID:31585129,https://www.ncbi.nlm.nih.gov/pubmed/31585129,31585129,,
58,1987679,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of HMOX1 mrna|methamphetamine promotes the reaction [ascorbic acid results in increased expression of HMOX1 protein]|sb 203580 inhibits the reaction [ascorbic acid results in increased expression of HMOX1 protein]|methamphetamine promotes the reaction [ascorbic acid results in increased expression of HMOX1 mrna],,,PMID:23022510,https://www.ncbi.nlm.nih.gov/pubmed/23022510,23022510,,
59,1987680,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of HMOX1 protein,,,PMID:22008531|PMID:23022510,https://www.ncbi.nlm.nih.gov/pubmed/22008531|https://www.ncbi.nlm.nih.gov/pubmed/23022510,22008531|23022510,,
60,1987681,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),Quercetin affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 protein]|hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 protein]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 mrna|hydrogen peroxide affects the reaction [quercetin affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 mrna]]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 protein|quercetin affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 mrna]|quercetin affects the reaction [hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 protein]]|hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 mrna]|hydrogen peroxide affects the reaction [quercetin affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of HMOX1 protein]],,,PMID:27028516,https://www.ncbi.nlm.nih.gov/pubmed/27028516,27028516,,
61,1987682,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,388275,HNRNPA1P7,https://ctdbase.org/detail.go?type=gene&acc=388275,,,388275.0,HNRNPA1P7,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of HNRNPA1P7 mrna|ascorbic acid results in decreased expression of HNRNPA1P7 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
62,1987683,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3199,HOXA2,https://ctdbase.org/detail.go?type=gene&acc=3199,,,3199.0,HOXA2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
63,1987684,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3199,HOXA2,https://ctdbase.org/detail.go?type=gene&acc=3199,,,3199.0,HOXA2,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [valproic acid results in decreased expression of HOXA2 mrna],,,PMID:19655241,https://www.ncbi.nlm.nih.gov/pubmed/19655241,19655241,,
64,1987685,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3211,HOXB1,https://ctdbase.org/detail.go?type=gene&acc=3211,,,3211.0,HOXB1,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of HOXB1 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
65,1987839,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3213,HOXB3,https://ctdbase.org/detail.go?type=gene&acc=3213,,,3213.0,HOXB3,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXB3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
66,1987840,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3233,HOXD4,https://ctdbase.org/detail.go?type=gene&acc=3233,,,3233.0,HOXD4,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXD4 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
67,1987841,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3234,HOXD8,https://ctdbase.org/detail.go?type=gene&acc=3234,,,3234.0,HOXD8,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXD8 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
68,1987842,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3240,HP,https://ctdbase.org/detail.go?type=gene&acc=3240,,,3240.0,HP,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [alpha-tocopherol affects the activity of HP protein polymorphism]|ascorbic acid affects the activity of HP protein polymorphism,,,PMID:19769483,https://www.ncbi.nlm.nih.gov/pubmed/19769483,19769483,,
69,1987843,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3240,HP,https://ctdbase.org/detail.go?type=gene&acc=3240,,,3240.0,HP,9606,Homo sapiens (human),HP gene polymorphism affects the susceptibility to ascorbic acid deficiency,,,PMID:20926521,https://www.ncbi.nlm.nih.gov/pubmed/20926521,20926521,,
70,1987844,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3251,HPRT1,https://ctdbase.org/detail.go?type=gene&acc=3251,,,3251.0,HPRT1,10029,Cricetulus griseus (Chinese hamster),"Ascorbic acid inhibits the reaction [3,5-dimethylaminophenol results in increased mutagenesis of HPRT1 gene]",,,PMID:25178734,https://www.ncbi.nlm.nih.gov/pubmed/25178734,25178734,,
71,1987845,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3251,HPRT1,https://ctdbase.org/detail.go?type=gene&acc=3251,,,3251.0,HPRT1,10029,Cricetulus griseus (Chinese hamster),[ascorbic acid results in increased susceptibility to chromium hexavalent ion] which results in increased mutagenesis of HPRT1 gene,,,PMID:17169990,https://www.ncbi.nlm.nih.gov/pubmed/17169990,17169990,,
72,1987846,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3251,HPRT1,https://ctdbase.org/detail.go?type=gene&acc=3251,,,3251.0,HPRT1,10116,Rattus norvegicus (Norway rat),"Ascorbic acid inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased mutagenesis of HPRT1 gene]",,,PMID:12467141,https://www.ncbi.nlm.nih.gov/pubmed/12467141,12467141,,
73,1987847,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3292,HSD17B1,https://ctdbase.org/detail.go?type=gene&acc=3292,,,3292.0,HSD17B1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of HSD17B1 mrna],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
74,1988016,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3294,HSD17B2,https://ctdbase.org/detail.go?type=gene&acc=3294,,,3294.0,HSD17B2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of HSD17B2 mrna],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
75,1988017,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3293,HSD17B3,https://ctdbase.org/detail.go?type=gene&acc=3293,,,3293.0,HSD17B3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of HSD17B3 mrna],,,PMID:17280759,https://www.ncbi.nlm.nih.gov/pubmed/17280759,17280759,,
76,1988018,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3283,HSD3B1,https://ctdbase.org/detail.go?type=gene&acc=3283,,,3283.0,HSD3B1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HSD3B1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
77,1988019,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3283,HSD3B1,https://ctdbase.org/detail.go?type=gene&acc=3283,,,3283.0,HSD3B1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of HSD3B1 mRNA,,,PMID:17901237,https://www.ncbi.nlm.nih.gov/pubmed/17901237,17901237,,
78,1988020,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3283,HSD3B1,https://ctdbase.org/detail.go?type=gene&acc=3283,,,3283.0,HSD3B1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of HSD3B1 mrna],,,PMID:17280759,https://www.ncbi.nlm.nih.gov/pubmed/17280759,17280759,,
79,1988021,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3326,HSP90AB1,https://ctdbase.org/detail.go?type=gene&acc=3326,,,3326.0,HSP90AB1,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of HSP90AB1 protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
80,1988022,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3303,HSPA1A,https://ctdbase.org/detail.go?type=gene&acc=3303,,,3303.0,HSPA1A,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of HSPA1A mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
81,1988023,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3313,HSPA9,https://ctdbase.org/detail.go?type=gene&acc=3313,,,3313.0,HSPA9,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of HSPA9 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
82,1988024,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3315,HSPB1,https://ctdbase.org/detail.go?type=gene&acc=3315,,,3315.0,HSPB1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of HSPB1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
83,1988025,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3315,HSPB1,https://ctdbase.org/detail.go?type=gene&acc=3315,,,3315.0,HSPB1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of HSPB1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
84,1988181,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3336,HSPE1,https://ctdbase.org/detail.go?type=gene&acc=3336,,,3336.0,HSPE1,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of HSPE1 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
85,1988182,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3347,HTN3,https://ctdbase.org/detail.go?type=gene&acc=3347,,,3347.0,HTN3,9606,Homo sapiens (human),[HTN3 protein modified form co-treated with copper co-treated with ascorbic acid] results in increased abundance of hydrogen peroxide,,,PMID:18975018,https://www.ncbi.nlm.nih.gov/pubmed/18975018,18975018,,
86,1988183,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3375,IAPP,https://ctdbase.org/detail.go?type=gene&acc=3375,,,3375.0,IAPP,10116,Rattus norvegicus (Norway rat),IAPP protein promotes the reaction [[copper co-treated with ascorbic acid] results in increased abundance of hydroxyl radical]|iapp protein promotes the reaction [[copper co-treated with ascorbic acid] results in increased abundance of hydrogen peroxide],,,PMID:23793354,https://www.ncbi.nlm.nih.gov/pubmed/23793354,23793354,,
87,1988184,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3376,IARS1,https://ctdbase.org/detail.go?type=gene&acc=3376,,,3376.0,IARS1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of IARS1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
88,1988185,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3381,IBSP,https://ctdbase.org/detail.go?type=gene&acc=3381,,,3381.0,IBSP,9606,Homo sapiens (human),Ascorbic acid results in increased expression of IBSP mRNA,,,PMID:28105418,https://www.ncbi.nlm.nih.gov/pubmed/28105418,28105418,,
89,1988186,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3381,IBSP,https://ctdbase.org/detail.go?type=gene&acc=3381,,,3381.0,IBSP,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of IBSP mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of IBSP mrna]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
90,1988187,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3381,IBSP,https://ctdbase.org/detail.go?type=gene&acc=3381,,,3381.0,IBSP,10116,Rattus norvegicus (Norway rat),Hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of IBSP mrna]|quercetin affects the reaction [hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of IBSP mrna]]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of IBSP mRNA,,,PMID:27028516,https://www.ncbi.nlm.nih.gov/pubmed/27028516,27028516,,
91,1988188,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3381,IBSP,https://ctdbase.org/detail.go?type=gene&acc=3381,,,3381.0,IBSP,9606,Homo sapiens (human),[ascorbic acid co-treated with IL11 protein] results in increased expression of IBSP mRNA,,,PMID:17956465,https://www.ncbi.nlm.nih.gov/pubmed/17956465,17956465,,
92,1988189,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of ICAM1 mrna],,,PMID:25551565,https://www.ncbi.nlm.nih.gov/pubmed/25551565,25551565,,
93,1988348,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of ICAM1 protein]",,,PMID:35349355,https://www.ncbi.nlm.nih.gov/pubmed/35349355,35349355,,
94,1988349,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of ICAM1 mrna]|ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of ICAM1 protein],,,PMID:25305479,https://www.ncbi.nlm.nih.gov/pubmed/25305479,25305479,,
95,1988350,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [norepinephrine results in increased expression of ICAM1 mrna],,,PMID:23114885,https://www.ncbi.nlm.nih.gov/pubmed/23114885,23114885,,
96,1988351,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNF protein results in increased expression of ICAM1 protein],,,PMID:12723939,https://www.ncbi.nlm.nih.gov/pubmed/12723939,12723939,,
97,1988352,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8870,IER3,https://ctdbase.org/detail.go?type=gene&acc=8870,,,8870.0,IER3,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of IER3 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
98,1988353,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3429,IFI27,https://ctdbase.org/detail.go?type=gene&acc=3429,,,3429.0,IFI27,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of IFI27 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
99,1988354,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of IFNG protein,,,PMID:14624943,https://www.ncbi.nlm.nih.gov/pubmed/14624943,14624943,,
100,1988355,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10090,Mus musculus (house mouse),IFNG protein promotes the reaction [ascorbic acid promotes the reaction [quartz results in increased secretion of TNF protein]],,,PMID:19298665,https://www.ncbi.nlm.nih.gov/pubmed/19298665,19298665,,
101,1988356,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [formaldehyde results in increased expression of IFNG mrna],,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
102,1988357,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,13489,Dicentrarchus labrax (European seabass),Ascorbic acid affects the expression of IGF1 mRNA,,,PMID:21281732,https://www.ncbi.nlm.nih.gov/pubmed/21281732,21281732,,
103,1988513,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,9823,Sus scrofa (pig),Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of IGF1 mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of IGF1 mRNA,,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
104,1988514,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3480,IGF1R,https://ctdbase.org/detail.go?type=gene&acc=3480,,,3480.0,IGF1R,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of IGF1R protein,,,PMID:20530736,https://www.ncbi.nlm.nih.gov/pubmed/20530736,20530736,,
105,1988515,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3480,IGF1R,https://ctdbase.org/detail.go?type=gene&acc=3480,,,3480.0,IGF1R,9823,Sus scrofa (pig),Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of IGF1R mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of IGF1R mRNA,,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
106,1988516,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3488,IGFBP5,https://ctdbase.org/detail.go?type=gene&acc=3488,,,3488.0,IGFBP5,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of IGFBP5 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
107,1988517,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3488,IGFBP5,https://ctdbase.org/detail.go?type=gene&acc=3488,,,3488.0,IGFBP5,10116,Rattus norvegicus (Norway rat),[alpha-tocopherol co-treated with beta carotene co-treated with ascorbic acid co-treated with zinc co-treated with sodium selenite] results in decreased expression of IGFBP5 mRNA,,,PMID:23859036,https://www.ncbi.nlm.nih.gov/pubmed/23859036,23859036,,
108,1988518,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3490,IGFBP7,https://ctdbase.org/detail.go?type=gene&acc=3490,,,3490.0,IGFBP7,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IGFBP7 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
109,1988519,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,714473,IGHV3,https://ctdbase.org/detail.go?type=gene&acc=714473,,,714473.0,,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IGHV3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
110,1988520,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3549,IHH,https://ctdbase.org/detail.go?type=gene&acc=3549,,,3549.0,IHH,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of IHH mRNA,,,PMID:20530736,https://www.ncbi.nlm.nih.gov/pubmed/20530736,20530736,,
111,1988521,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551.0,IKBKB,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased activity of IKBKB protein],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
112,1988712,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10320,IKZF1,https://ctdbase.org/detail.go?type=gene&acc=10320,,,10320.0,IKZF1,9606,Homo sapiens (human),"5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole-3',5'-monophosphorothioate inhibits the reaction [ascorbic acid results in decreased activity of IKZF1 protein]|ascorbic acid results in decreased activity of IKZF1 protein|2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole inhibits the reaction [ascorbic acid results in decreased activity of IKZF1 protein]",,,PMID:17664058,https://www.ncbi.nlm.nih.gov/pubmed/17664058,17664058,,
113,1988713,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein],,,PMID:25551565,https://www.ncbi.nlm.nih.gov/pubmed/25551565,25551565,,
114,1988714,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [formaldehyde promotes the reaction [lipopolysaccharides results in increased expression of IL10 mrna]],,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
115,1988715,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3589,IL11,https://ctdbase.org/detail.go?type=gene&acc=3589,,,3589.0,IL11,9606,Homo sapiens (human),[ascorbic acid co-treated with IL11 protein] results in increased expression of RUNX2 mrna|[ascorbic acid co-treated with IL11 protein] results in increased expression of BGLAP mrna|[ascorbic acid co-treated with IL11 protein] results in increased expression of IBSP mRNA,,,PMID:17956465,https://www.ncbi.nlm.nih.gov/pubmed/17956465,17956465,,
116,1988716,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL1B protein]",,,PMID:35349355,https://www.ncbi.nlm.nih.gov/pubmed/35349355,35349355,,
117,1988717,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [aspirin inhibits the reaction [IL1B results in increased chemical synthesis of dinoprostone]]|ascorbic acid inhibits the reaction [IL1B results in increased chemical synthesis of dinoprostone]|ascorbic acid promotes the reaction [aspirin inhibits the reaction [IL1B results in increased chemical synthesis of 8-epi-prostaglandin f2alpha]]|ascorbic acid inhibits the reaction [IL1B results in increased chemical synthesis of 8-epi-prostaglandin f2alpha],,,PMID:16529823,https://www.ncbi.nlm.nih.gov/pubmed/16529823,16529823,,
118,1988718,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606,Homo sapiens (human),Resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL2A1 mrna]]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SOX9 mrna]|resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ACAN mrna]]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL2A1 mrna]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in decreased expression of MMP13 mrna]|resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SOX9 mrna]]|il1b protein results in decreased susceptibility to [TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ACAN mrna],,,PMID:26526931,https://www.ncbi.nlm.nih.gov/pubmed/26526931,26526931,,
119,1988883,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,182,JAG1,https://ctdbase.org/detail.go?type=gene&acc=182,,,182.0,JAG1,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of JAG1 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
120,1988884,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3745,KCNB1,https://ctdbase.org/detail.go?type=gene&acc=3745,,,3745.0,KCNB1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of KCNB1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
121,1988885,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,55818,KDM3A,https://ctdbase.org/detail.go?type=gene&acc=55818,,,55818.0,KDM3A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nickel chloride results in increased expression of KDM3A mrna]|ascorbic acid inhibits the reaction [nickel chloride results in increased expression of KDM3A protein],,,PMID:22318714,https://www.ncbi.nlm.nih.gov/pubmed/22318714,22318714,,
122,1988886,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090,Mus musculus (house mouse),"CAT protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of IL1B mrna]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of IL1B mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of IL1B protein]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of IL1B protein|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of IL1B mrna|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of IL1B protein]",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
123,1988887,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [silicon dioxide analog promotes the reaction [lipopolysaccharides results in increased expression of IL1B protein]],,,PMID:24685903,https://www.ncbi.nlm.nih.gov/pubmed/24685903,24685903,,
124,1988888,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [streptozocin results in increased expression of IL1B protein],,,PMID:28259689,https://www.ncbi.nlm.nih.gov/pubmed/28259689,28259689,,
125,1988889,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),"Ascorbic acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL1B protein]|ascorbic acid deficiency promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL1B protein]",,,PMID:30606963,https://www.ncbi.nlm.nih.gov/pubmed/30606963,30606963,,
126,1988890,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in increased expression of IL1B protein],,,PMID:22728154,https://www.ncbi.nlm.nih.gov/pubmed/22728154,22728154,,
127,1988891,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lipopolysaccharides results in increased expression of IL1B mrna],,,PMID:15612528,https://www.ncbi.nlm.nih.gov/pubmed/15612528,15612528,,
128,1989064,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium fluoride results in increased expression of IL1B protein],,,PMID:34089294,https://www.ncbi.nlm.nih.gov/pubmed/34089294,34089294,,
129,1989065,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3554,IL1R1,https://ctdbase.org/detail.go?type=gene&acc=3554,,,3554.0,IL1R1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IL1R1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
130,1989066,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of IL4 protein,,,PMID:14624943,https://www.ncbi.nlm.nih.gov/pubmed/14624943,14624943,,
131,1989067,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of IL6 protein],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
132,1989068,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),[acetylcysteine co-treated with ascorbic acid] inhibits the reaction [vehicle emissions results in increased expression of IL6 mrna],,,PMID:32810504,https://www.ncbi.nlm.nih.gov/pubmed/32810504,32810504,,
133,1989069,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL6 protein]",,,PMID:35349355,https://www.ncbi.nlm.nih.gov/pubmed/35349355,35349355,,
134,1989070,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [formaldehyde inhibits the reaction [lipopolysaccharides results in increased expression of IL6 mrna]],,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
135,1989071,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in increased expression of IL6 protein],,,PMID:22728154,https://www.ncbi.nlm.nih.gov/pubmed/22728154,22728154,,
136,1989072,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium fluoride results in increased expression of IL6 protein],,,PMID:34089294,https://www.ncbi.nlm.nih.gov/pubmed/34089294,34089294,,
137,1989073,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),[ascorbic acid co-treated with vitamin E] results in decreased expression of IL6,,,PMID:22207723,https://www.ncbi.nlm.nih.gov/pubmed/22207723,22207723,,
138,1989241,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3624,INHBA,https://ctdbase.org/detail.go?type=gene&acc=3624,,,3624.0,INHBA,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of KEAP1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPX2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGG mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of PLN mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HAVCR1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GATA6 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TF mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ZFAND2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ISL1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ESRG mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXB3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ASCL1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TFAP2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of CYP24A1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CEACAM6 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FLT1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SERPINA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of APOA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of RRAD mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of VCAM1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLM mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SRXN1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of H2BC14 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MPZL1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FOXG1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of UGT2A3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of POU5F1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TM4SF4 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTO1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX2 mrna|[[ascorbic acid co-treate,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
139,1989242,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,83729,INHBE,https://ctdbase.org/detail.go?type=gene&acc=83729,,,83729.0,INHBE,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of INHBE mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
140,1989243,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [INS1 protein results in increased secretion of LEP protein]|[ins1 protein co-treated with ascorbic acid] results in increased expression of CDKN1A mrna|[ascorbic acid co-treated with INS1 protein] results in increased expression of CASP8 mrna|[ascorbic acid co-treated with INS1 protein] results in increased expression of NAMPT mrna|[ascorbic acid co-treated with INS1 protein] results in decreased expression of GPD1 mRNA,,,PMID:20400526,https://www.ncbi.nlm.nih.gov/pubmed/20400526,20400526,,
141,1989244,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in decreased expression of INS1 protein],,,PMID:21911000,https://www.ncbi.nlm.nih.gov/pubmed/21911000,21911000,,
142,1989245,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116,Rattus norvegicus (Norway rat),[lutein co-treated with ascorbic acid] results in decreased expression of INS1 protein,,,PMID:12949374,https://www.ncbi.nlm.nih.gov/pubmed/12949374,12949374,,
143,1989246,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3643,INSR,https://ctdbase.org/detail.go?type=gene&acc=3643,,,3643.0,INSR,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in increased expression of INSR mrna],,,PMID:21911000,https://www.ncbi.nlm.nih.gov/pubmed/21911000,21911000,,
144,1989247,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3658,IREB2,https://ctdbase.org/detail.go?type=gene&acc=3658,,,3658.0,IREB2,10090,Mus musculus (house mouse),[ascorbic acid co-treated with CAT protein] inhibits the reaction [zinc deficiency results in increased expression of IREB2 protein],,,PMID:18073202,https://www.ncbi.nlm.nih.gov/pubmed/18073202,18073202,,
145,1989248,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10892,MALT1,https://ctdbase.org/detail.go?type=gene&acc=10892,,,10892.0,MALT1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of MALT1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
146,1989249,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3667,IRS1,https://ctdbase.org/detail.go?type=gene&acc=3667,,,3667.0,IRS1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in decreased phosphorylation of IRS1 protein]|[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in decreased expression of IRS1 protein],,,PMID:21911000,https://www.ncbi.nlm.nih.gov/pubmed/21911000,21911000,,
147,1989418,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3670,ISL1,https://ctdbase.org/detail.go?type=gene&acc=3670,,,3670.0,ISL1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ISL1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
148,1989419,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3670,ISL1,https://ctdbase.org/detail.go?type=gene&acc=3670,,,3670.0,ISL1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of ISL1 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
149,1989420,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817.0,KEAP1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of KEAP1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
150,1989421,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817.0,KEAP1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in decreased expression of KEAP1 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
151,1989422,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817.0,KEAP1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of KEAP1 protein|ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in increased expression of KEAP1 protein],,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
152,1989423,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,57498,KIDINS220,https://ctdbase.org/detail.go?type=gene&acc=57498,,,57498.0,KIDINS220,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of KIDINS220 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
153,1989424,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,23095,KIF1B,https://ctdbase.org/detail.go?type=gene&acc=23095,,,23095.0,KIF1B,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of KIF1B mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
154,1989425,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10749,KIF1C,https://ctdbase.org/detail.go?type=gene&acc=10749,,,10749.0,KIF1C,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of KIF1C mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
155,1989426,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9493,KIF23,https://ctdbase.org/detail.go?type=gene&acc=9493,,,9493.0,KIF23,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of KIF23 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
156,1989427,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22914,KLRK1,https://ctdbase.org/detail.go?type=gene&acc=22914,,,22914.0,KLRK1,10090,Mus musculus (house mouse),Ascorbic acid deficiency results in decreased expression of KLRK1 protein,,,PMID:22306178,https://www.ncbi.nlm.nih.gov/pubmed/22306178,22306178,,
157,1989584,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3853,KRT6A,https://ctdbase.org/detail.go?type=gene&acc=3853,,,3853.0,KRT6A,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of KRT6A mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
158,1989585,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3929,LBP,https://ctdbase.org/detail.go?type=gene&acc=3929,,,3929.0,LBP,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of LBP mrna],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
159,1989586,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3932,LCK,https://ctdbase.org/detail.go?type=gene&acc=3932,,,3932.0,LCK,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of LCK mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
160,1989587,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3932,LCK,https://ctdbase.org/detail.go?type=gene&acc=3932,,,3932.0,LCK,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [potassium dichromate results in increased phosphorylation of LCK protein]|ascorbic acid inhibits the reaction [bis(2-hydroxy-2-ethylbutanoato)oxochromate(v) results in increased phosphorylation of LCK protein],,,PMID:14572611,https://www.ncbi.nlm.nih.gov/pubmed/14572611,14572611,,
161,1989588,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3939,LDHA,https://ctdbase.org/detail.go?type=gene&acc=3939,,,3939.0,LDHA,9606,Homo sapiens (human),[ascorbic acid co-treated with alpha-tocopherol co-treated with ferulic acid] inhibits the reaction [[ozone co-treated with oxygen] results in increased secretion of LDHA protein],,,PMID:26270818,https://www.ncbi.nlm.nih.gov/pubmed/26270818,26270818,,
162,1989589,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [MPO results in increased chemical synthesis of troglitazone analog],,,PMID:15039298,https://www.ncbi.nlm.nih.gov/pubmed/15039298,15039298,,
163,1989590,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of CEBPA mrna|bexarotene inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna|[tributyltin co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 protein|bexarotene promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mrna]|tributyltin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of DMP1 mrna]|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mrna|[lg 100268 co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|tributyltin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|[rosiglitazone co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 protein|[diazepinylbenzoic acid co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in decreased expression of ABCA1 mrna|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of DMP1 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of ABCA1 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna|diazepinylbenzoic acid inhibits the reaction [[tributyltin co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna]|tributyltin promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mrna]|[t0901317 co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna|tributyltin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|diazepinylbenzoic acid inhibits the reaction [[LG 100268 co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mrna|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of DMP1 mrna|[bexarotene co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 protein|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna|bexarotene inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|bexarotene inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of DMP1 mrna]|bexarotene promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna]|[tributyltin co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna|tributyltin promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna]|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna],,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
164,1989727,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9606,Homo sapiens (human),[copper co-treated with ascorbic acid] results in increased oxidation of and affects the folding of INS protein|trientine inhibits the reaction [[copper co-treated with ascorbic acid] results in increased oxidation of and affects the folding of INS protein],,,PMID:23403016,https://www.ncbi.nlm.nih.gov/pubmed/23403016,23403016,,
165,1989728,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3791,KDR,https://ctdbase.org/detail.go?type=gene&acc=3791,,,3791.0,KDR,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of KDR mRNA,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
166,1989729,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,10090,Mus musculus (house mouse),"Rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|tretinoin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mrna|pioglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|triphenyltin hydroxide inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|pioglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|pioglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|triphenyltin hydroxide promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|d,d-T80-prallethrin promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|quinoxyfen inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mrna]|tretinoin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mrna]|allethrins inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|pioglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|tretinoin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|tetrabromobisphenol A inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|triphenyltin hydroxide inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|tetrabromobisphenol A promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of RUNX2 mrna]|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|tetrabromobisphenol A promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|tretinoin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|d,d-T80-prallethrin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|allethrins inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|d,d-T80-prallethrin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna|triphenyltin hydroxide promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|quinoxyfen inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of RUNX2 mRNA",,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
167,1989818,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in decreased expression of SP7 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS1 protein co-treated with firemaster 550] results in decreased expression of SP7 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS1 protein co-treated with firemaster 550] results in increased expression of FABP4 mRNA,,,PMID:25062436,https://www.ncbi.nlm.nih.gov/pubmed/25062436,25062436,,
168,1989819,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,9606,Homo sapiens (human),SREBF2 protein affects the reaction [ascorbic acid results in increased expression of LDLR mrna]|ascorbic acid results in increased expression of LDLR mrna|srebf2 protein affects the reaction [ascorbic acid results in increased expression of LDLR protein]|ascorbic acid results in increased expression of LDLR protein|foxo3 protein affects the reaction [ascorbic acid results in increased expression of LDLR protein]|ascorbic acid inhibits the reaction [dactinomycin results in decreased expression of LDLR mrna]|ascorbic acid affects the reaction [GULO protein affects the expression of LDLR protein],,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
169,1989820,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,51176,LEF1,https://ctdbase.org/detail.go?type=gene&acc=51176,,,51176.0,LEF1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of LEF1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
170,1989821,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,51176,LEF1,https://ctdbase.org/detail.go?type=gene&acc=51176,,,51176.0,LEF1,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of LEF1 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
171,1989822,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952.0,LEP,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased secretion of LEP protein|ascorbic acid inhibits the reaction [INS1 protein results in increased secretion of LEP protein],,,PMID:20400526,https://www.ncbi.nlm.nih.gov/pubmed/20400526,20400526,,
172,1989823,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3956,LGALS1,https://ctdbase.org/detail.go?type=gene&acc=3956,,,3956.0,LGALS1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of LGALS1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
173,1989824,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3958,LGALS3,https://ctdbase.org/detail.go?type=gene&acc=3958,,,3958.0,LGALS3,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of LGALS3 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
174,1989825,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3972,LHB,https://ctdbase.org/detail.go?type=gene&acc=3972,,,3972.0,LHB,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of LHB protein],,,PMID:16248992|PMID:16298753|PMID:17280759,https://www.ncbi.nlm.nih.gov/pubmed/16248992|https://www.ncbi.nlm.nih.gov/pubmed/16298753|https://www.ncbi.nlm.nih.gov/pubmed/17280759,16248992|16298753|17280759,,
175,1989973,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3973,LHCGR,https://ctdbase.org/detail.go?type=gene&acc=3973,,,3973.0,LHCGR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of LHCGR mrna],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
176,1989974,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4017,LOXL2,https://ctdbase.org/detail.go?type=gene&acc=4017,,,4017.0,LOXL2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of LOXL2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
177,1989975,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9170,LPAR2,https://ctdbase.org/detail.go?type=gene&acc=9170,,,9170.0,LPAR2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [benzo(a)pyrene results in decreased methylation of LPAR2 promoter]|ascorbic acid inhibits the reaction [benzo(a)pyrene results in increased expression of LPAR2 mrna],,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
178,1989976,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4060,LUM,https://ctdbase.org/detail.go?type=gene&acc=4060,,,4060.0,LUM,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of LUM mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
179,1989977,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,56925,LXN,https://ctdbase.org/detail.go?type=gene&acc=56925,,,56925.0,LXN,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of LXN protein|ascorbic acid results in increased expression of LXN mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
180,1989978,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4067,LYN,https://ctdbase.org/detail.go?type=gene&acc=4067,,,4067.0,LYN,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [potassium dichromate results in increased phosphorylation of LYN protein]|ascorbic acid inhibits the reaction [bis(2-hydroxy-2-ethylbutanoato)oxochromate(v) results in increased phosphorylation of LYN protein],,,PMID:14572611,https://www.ncbi.nlm.nih.gov/pubmed/14572611,14572611,,
181,1989979,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,23764,MAFF,https://ctdbase.org/detail.go?type=gene&acc=23764,,,23764.0,MAFF,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of MAFF mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
182,1989980,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4097,MAFG,https://ctdbase.org/detail.go?type=gene&acc=4097,,,4097.0,MAFG,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of MAFG mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
183,1989981,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9863,MAGI2,https://ctdbase.org/detail.go?type=gene&acc=9863,,,9863.0,MAGI2,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of MAGI2 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
184,1989982,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4133,MAP2,https://ctdbase.org/detail.go?type=gene&acc=4133,,,4133.0,MAP2,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of MAP2 protein,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
185,1990136,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4133,MAP2,https://ctdbase.org/detail.go?type=gene&acc=4133,,,4133.0,MAP2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of MAP2 protein,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
186,1990137,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5606,MAP2K3,https://ctdbase.org/detail.go?type=gene&acc=5606,,,5606.0,MAP2K3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased phosphorylation of MAP2K3 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,
187,1990138,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5608,MAP2K6,https://ctdbase.org/detail.go?type=gene&acc=5608,,,5608.0,MAP2K6,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased phosphorylation of MAP2K6 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,
188,1990139,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4217,MAP3K5,https://ctdbase.org/detail.go?type=gene&acc=4217,,,4217.0,MAP3K5,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [plant extracts results in increased phosphorylation of MAP3K5 protein],,,PMID:20206247,https://www.ncbi.nlm.nih.gov/pubmed/20206247,20206247,,
189,1990140,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased phosphorylation of MAPK1 protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
190,1990141,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10090,Mus musculus (house mouse),U 0126 inhibits the reaction [ascorbic acid results in increased phosphorylation of MAPK1 protein]|ascorbic acid results in increased phosphorylation of MAPK1 protein,,,PMID:20530736,https://www.ncbi.nlm.nih.gov/pubmed/20530736,20530736,,
191,1990142,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9669,Mustela putorius furo (domestic ferret),[beta carotene co-treated with alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein],,,PMID:16401635,https://www.ncbi.nlm.nih.gov/pubmed/16401635,16401635,,
192,1990143,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased phosphorylation of MAPK1 protein],,,PMID:31585129,https://www.ncbi.nlm.nih.gov/pubmed/31585129,31585129,,
193,1990144,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in increased phosphorylation of MAPK1 protein],,,PMID:22728154,https://www.ncbi.nlm.nih.gov/pubmed/22728154,22728154,,
194,1990145,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate affects the localization of MAPK1 protein modified form],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
195,1990304,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased phosphorylation of MAPK14 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,
196,1990305,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased phosphorylation of MAPK3 protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
197,1990306,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090,Mus musculus (house mouse),Ascorbic acid results in increased phosphorylation of MAPK3 protein|u 0126 inhibits the reaction [ascorbic acid results in increased phosphorylation of MAPK3 protein],,,PMID:20530736,https://www.ncbi.nlm.nih.gov/pubmed/20530736,20530736,,
198,1990307,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9669,Mustela putorius furo (domestic ferret),[beta carotene co-treated with alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK3 protein],,,PMID:16401635,https://www.ncbi.nlm.nih.gov/pubmed/16401635,16401635,,
199,1990308,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased phosphorylation of MAPK3 protein],,,PMID:31585129,https://www.ncbi.nlm.nih.gov/pubmed/31585129,31585129,,
200,1990309,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in increased phosphorylation of MAPK3 protein],,,PMID:22728154,https://www.ncbi.nlm.nih.gov/pubmed/22728154,22728154,,
201,1990310,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate affects the localization of MAPK3 protein modified form],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
202,1990311,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606,Homo sapiens (human),CAT protein inhibits the reaction [[ascorbic acid co-treated with eosine I bluish] results in increased phosphorylation of MAPK8 protein]|[ascorbic acid co-treated with eosine I bluish] results in increased phosphorylation of MAPK8 protein,,,PMID:24488945,https://www.ncbi.nlm.nih.gov/pubmed/24488945,24488945,,
203,1990312,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [plant extracts results in increased phosphorylation of MAPK8 protein],,,PMID:20206247,https://www.ncbi.nlm.nih.gov/pubmed/20206247,20206247,,
204,1990313,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9669,Mustela putorius furo (domestic ferret),[beta carotene co-treated with alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK8 protein],,,PMID:16401635,https://www.ncbi.nlm.nih.gov/pubmed/16401635,16401635,,
205,1990421,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,9606,Homo sapiens (human),CAT protein inhibits the reaction [[ascorbic acid co-treated with eosine I bluish] results in increased phosphorylation of MAPK9 protein]|[ascorbic acid co-treated with eosine I bluish] results in increased phosphorylation of MAPK9 protein,,,PMID:24488945,https://www.ncbi.nlm.nih.gov/pubmed/24488945,24488945,,
206,1990422,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [plant extracts results in increased phosphorylation of MAPK9 protein],,,PMID:20206247,https://www.ncbi.nlm.nih.gov/pubmed/20206247,20206247,,
207,1990423,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4137,MAPT,https://ctdbase.org/detail.go?type=gene&acc=4137,,,4137.0,MAPT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cyanoginosin LR results in increased phosphorylation of MAPT protein],,,PMID:24142891,https://www.ncbi.nlm.nih.gov/pubmed/24142891,24142891,,
208,1990424,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4173,MCM4,https://ctdbase.org/detail.go?type=gene&acc=4173,,,4173.0,MCM4,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of MCM4 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
209,1990425,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4192,MDK,https://ctdbase.org/detail.go?type=gene&acc=4192,,,4192.0,MDK,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of MDK mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
210,1990426,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193.0,MDM2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of MDM2 protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
211,1990427,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4224,MEP1A,https://ctdbase.org/detail.go?type=gene&acc=4224,,,4224.0,MEP1A,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of MEP1A mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
212,1990428,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4233,MET,https://ctdbase.org/detail.go?type=gene&acc=4233,,,4233.0,MET,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of MET mRNA,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
213,1990429,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[kojic acid co-treated with diethylnitrosamine] results in increased expression of MGMT mrna],,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
214,1990430,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4257,MGST1,https://ctdbase.org/detail.go?type=gene&acc=4257,,,4257.0,MGST1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of MGST1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
215,1990552,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,407050,MIR93,https://ctdbase.org/detail.go?type=gene&acc=407050,,,407050.0,MIR93,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [estradiol results in increased expression of MIR93 mrna],,,PMID:23492819,https://www.ncbi.nlm.nih.gov/pubmed/23492819,23492819,,
216,1990553,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of MKI67 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
217,1990554,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,8022,Oncorhynchus mykiss (rainbow trout),[vitamin A co-treated with cholecalciferol co-treated with vitamin E co-treated with ascorbic acid] inhibits the reaction [[cyhalothrin co-treated with chlorantranilipole] results in increased expression of MKI67 protein],,,PMID:36813254,https://www.ncbi.nlm.nih.gov/pubmed/36813254,36813254,,
218,1990555,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,10116,Rattus norvegicus (Norway rat),[alpha-tocopherol co-treated with beta carotene co-treated with ascorbic acid co-treated with zinc co-treated with sodium selenite] results in decreased expression of MKI67 mRNA,,,PMID:23859036,https://www.ncbi.nlm.nih.gov/pubmed/23859036,23859036,,
219,1990556,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4292,MLH1,https://ctdbase.org/detail.go?type=gene&acc=4292,,,4292.0,MLH1,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [MLH1 gene mutant form results in decreased susceptibility to chromium hexavalent ion],,,PMID:15831465,https://www.ncbi.nlm.nih.gov/pubmed/15831465,15831465,,
220,1990557,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4292,MLH1,https://ctdbase.org/detail.go?type=gene&acc=4292,,,4292.0,MLH1,9606,Homo sapiens (human),MLH1 protein promotes the reaction [ascorbic acid results in increased susceptibility to chromium hexavalent ion],,,PMID:17301063,https://www.ncbi.nlm.nih.gov/pubmed/17301063,17301063,,
221,1990558,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4292,MLH1,https://ctdbase.org/detail.go?type=gene&acc=4292,,,4292.0,MLH1,9606,Homo sapiens (human),MLH1 protein results in increased susceptibility to [chromium hexavalent ion co-treated with ascorbic acid],,,PMID:17169990,https://www.ncbi.nlm.nih.gov/pubmed/17169990,17169990,,
222,1990559,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,90523,MLIP,https://ctdbase.org/detail.go?type=gene&acc=90523,,,90523.0,MLIP,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MLIP mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
223,1990560,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4312,MMP1,https://ctdbase.org/detail.go?type=gene&acc=4312,,,4312.0,MMP1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MMP1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
224,1990666,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4312,MMP1,https://ctdbase.org/detail.go?type=gene&acc=4312,,,4312.0,MMP1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [tobacco smoke pollution results in increased expression of MMP1 mrna],,,PMID:10836612,https://www.ncbi.nlm.nih.gov/pubmed/10836612,10836612,,
225,1990667,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,9606,Homo sapiens (human),[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in decreased expression of MMP13 mrna|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in decreased expression of MMP13 mrna],,,PMID:26526931,https://www.ncbi.nlm.nih.gov/pubmed/26526931,26526931,,
226,1990668,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4322,MMP13,https://ctdbase.org/detail.go?type=gene&acc=4322,,,4322.0,MMP13,10090,Mus musculus (house mouse),"Mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of MMP13 protein]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of MMP13 mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of MMP13 mrna]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of MMP13 mrna|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of MMP13 protein]",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
227,1990669,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] affects the expression of MMP2 mRNA,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
228,1990670,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cyclosporine results in increased expression of MMP2 protein],,,PMID:19391111,https://www.ncbi.nlm.nih.gov/pubmed/19391111,19391111,,
229,1990671,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4316,MMP7,https://ctdbase.org/detail.go?type=gene&acc=4316,,,4316.0,MMP7,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of MMP7 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
230,1990672,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased expression of MMP9 mRNA,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
231,1990673,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[MPO protein co-treated with hydrogen peroxide] results in increased oxidation of fenoterol]|ascorbic acid inhibits the reaction [[MPO protein co-treated with hydrogen peroxide] results in increased oxidation of albuterol],,,PMID:19462961,https://www.ncbi.nlm.nih.gov/pubmed/19462961,19462961,,
232,1990674,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with beta carotene co-treated with alpha-tocopherol co-treated with sodium selenite] inhibits the reaction [galactosamine results in increased activity of MPO protein],,,PMID:31022331,https://www.ncbi.nlm.nih.gov/pubmed/31022331,31022331,,
233,1990814,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [fluorouracil results in increased activity of MPO protein],,,PMID:26921358,https://www.ncbi.nlm.nih.gov/pubmed/26921358,26921358,,
234,1990815,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [formaldehyde inhibits the reaction [lipopolysaccharides results in increased expression of MPO protein]],,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
235,1990816,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [indomethacin results in increased activity of MPO protein],,,PMID:18726076,https://www.ncbi.nlm.nih.gov/pubmed/18726076,18726076,,
236,1990817,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9019,MPZL1,https://ctdbase.org/detail.go?type=gene&acc=9019,,,9019.0,MPZL1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MPZL1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
237,1990818,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4436,MSH2,https://ctdbase.org/detail.go?type=gene&acc=4436,,,4436.0,MSH2,9606,Homo sapiens (human),MSH2 protein promotes the reaction [ascorbic acid results in increased susceptibility to chromium hexavalent ion],,,PMID:17301063,https://www.ncbi.nlm.nih.gov/pubmed/17301063,17301063,,
238,1990819,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4436,MSH2,https://ctdbase.org/detail.go?type=gene&acc=4436,,,4436.0,MSH2,9606,Homo sapiens (human),MSH2 protein results in increased susceptibility to [chromium hexavalent ion co-treated with ascorbic acid],,,PMID:17169990,https://www.ncbi.nlm.nih.gov/pubmed/17169990,17169990,,
239,1990820,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4485,MST1,https://ctdbase.org/detail.go?type=gene&acc=4485,,,4485.0,MST1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of MST1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
240,1990821,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11223,MST1L,https://ctdbase.org/detail.go?type=gene&acc=11223,,,11223.0,MST1L,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of MST1L mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
241,1990822,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4488,MSX2,https://ctdbase.org/detail.go?type=gene&acc=4488,,,4488.0,MSX2,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of MSX2 mrna|cadmium sulfate inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of MSX2 mrna],,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
242,1990823,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4489,MT1A,https://ctdbase.org/detail.go?type=gene&acc=4489,,,4489.0,MT1A,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of MT1A mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
243,1990939,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4504,MT3,https://ctdbase.org/detail.go?type=gene&acc=4504,,,4504.0,MT3,9606,Homo sapiens (human),[[MT3 protein binds to zinc] which co-treated with ascorbic acid] inhibits the reaction [copper results in increased chemical synthesis of hydroxyl radical],,,PMID:17389590,https://www.ncbi.nlm.nih.gov/pubmed/17389590,17389590,,
244,1990940,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4504,MT3,https://ctdbase.org/detail.go?type=gene&acc=4504,,,4504.0,MT3,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of MT3 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
245,1990941,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10797,MTHFD2,https://ctdbase.org/detail.go?type=gene&acc=10797,,,10797.0,MTHFD2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of MTHFD2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
246,1990942,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4602,MYB,https://ctdbase.org/detail.go?type=gene&acc=4602,,,4602.0,MYB,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with ferrous sulfate] results in increased expression of MYB protein,,,PMID:7593635,https://www.ncbi.nlm.nih.gov/pubmed/7593635,7593635,,
247,1990943,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4605,MYBL2,https://ctdbase.org/detail.go?type=gene&acc=4605,,,4605.0,MYBL2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of MYBL2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
248,1990944,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [phenylhydrazine results in decreased expression of MYC mrna],,,PMID:30140404,https://www.ncbi.nlm.nih.gov/pubmed/30140404,30140404,,
249,1990945,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4629,MYH11,https://ctdbase.org/detail.go?type=gene&acc=4629,,,4629.0,MYH11,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of MYH11 protein,,,PMID:14639096,https://www.ncbi.nlm.nih.gov/pubmed/14639096,14639096,,
250,1990946,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4624,MYH6,https://ctdbase.org/detail.go?type=gene&acc=4624,,,4624.0,MYH6,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of MYH6 mRNA,,,PMID:12668514,https://www.ncbi.nlm.nih.gov/pubmed/12668514,12668514,,
251,1990947,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4625,MYH7,https://ctdbase.org/detail.go?type=gene&acc=4625,,,4625.0,MYH7,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of MYH7 mRNA,,,PMID:12668514|PMID:21570463,https://www.ncbi.nlm.nih.gov/pubmed/12668514|https://www.ncbi.nlm.nih.gov/pubmed/21570463,12668514|21570463,,
252,1990948,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4633,MYL2,https://ctdbase.org/detail.go?type=gene&acc=4633,,,4633.0,MYL2,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of MYL2 mRNA,,,PMID:21570463,https://www.ncbi.nlm.nih.gov/pubmed/21570463,21570463,,
253,1991146,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4635,MYL4,https://ctdbase.org/detail.go?type=gene&acc=4635,,,4635.0,MYL4,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MYL4 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
254,1991147,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4640,MYO1A,https://ctdbase.org/detail.go?type=gene&acc=4640,,,4640.0,MYO1A,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of MYO1A mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
255,1991148,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4643,MYO1E,https://ctdbase.org/detail.go?type=gene&acc=4643,,,4643.0,MYO1E,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of MYO1E mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
256,1991149,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10135,NAMPT,https://ctdbase.org/detail.go?type=gene&acc=10135,,,10135.0,NAMPT,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with INS1 protein] results in increased expression of NAMPT mRNA,,,PMID:20400526,https://www.ncbi.nlm.nih.gov/pubmed/20400526,20400526,,
257,1991150,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4677,NARS1,https://ctdbase.org/detail.go?type=gene&acc=4677,,,4677.0,NARS1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of NARS1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
258,1991151,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,83988,NCALD,https://ctdbase.org/detail.go?type=gene&acc=83988,,,83988.0,NCALD,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NCALD mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
259,1991152,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10397,NDRG1,https://ctdbase.org/detail.go?type=gene&acc=10397,,,10397.0,NDRG1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nickel sulfate results in increased expression of NDRG1 protein],,,PMID:16288478,https://www.ncbi.nlm.nih.gov/pubmed/16288478,16288478,,
260,1991153,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,57447,NDRG2,https://ctdbase.org/detail.go?type=gene&acc=57447,,,57447.0,NDRG2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of NDRG2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
261,1991154,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10763,NES,https://ctdbase.org/detail.go?type=gene&acc=10763,,,10763.0,NES,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of NES protein,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
262,1991155,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4779,NFE2L1,https://ctdbase.org/detail.go?type=gene&acc=4779,,,4779.0,NFE2L1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of NFE2L1 protein|ascorbic acid results in increased expression of NFE2L1 mRNA,,,PMID:25130429,https://www.ncbi.nlm.nih.gov/pubmed/25130429,25130429,,
263,1991307,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),[ascorbic acid co-treated with alpha-tocopherol co-treated with ferulic acid] promotes the reaction [[ozone co-treated with oxygen] results in increased localization of NFE2L2 protein],,,PMID:26270818,https://www.ncbi.nlm.nih.gov/pubmed/26270818,26270818,,
264,1991308,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [estradiol results in decreased expression of NFE2L2 mrna]|ascorbic acid inhibits the reaction [estradiol results in decreased expression of NFE2L2 protein],,,PMID:23492819|PMID:25130429,https://www.ncbi.nlm.nih.gov/pubmed/23492819|https://www.ncbi.nlm.nih.gov/pubmed/25130429,23492819|25130429,,
265,1991309,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased phosphorylation of NFE2L2 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
266,1991310,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [resveratrol results in increased activity of NFE2L2 promoter],,,PMID:21199573,https://www.ncbi.nlm.nih.gov/pubmed/21199573,21199573,,
267,1991311,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [[lead acetate results in increased abundance of lead] which results in increased expression of NFE2L2 mrna]|[lead acetate results in increased abundance of lead] inhibits the reaction [ascorbic acid results in increased expression of NFE2L2 protein]|ascorbic acid results in increased expression of NFE2L2 mrna|ascorbic acid results in increased expression of NFE2L2 protein,,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
268,1991312,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [diquat results in decreased expression of NFE2L2 protein],,,PMID:33475796,https://www.ncbi.nlm.nih.gov/pubmed/33475796,33475796,,
269,1991313,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Ascorbic acid affects the localization of NFE2L2 protein,,,PMID:23027624|PMID:26921358,https://www.ncbi.nlm.nih.gov/pubmed/23027624|https://www.ncbi.nlm.nih.gov/pubmed/26921358,23027624|26921358,,
270,1991314,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in increased expression of NFE2L2 protein],,,PMID:29663635|PMID:29940330,https://www.ncbi.nlm.nih.gov/pubmed/29663635|https://www.ncbi.nlm.nih.gov/pubmed/29940330,29663635|29940330,,
271,1991315,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [arsenic trioxide results in decreased expression of NFE2L2 mrna],,,PMID:29297235,https://www.ncbi.nlm.nih.gov/pubmed/29297235,29297235,,
272,1991459,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [estradiol affects the localization of NFE2L2 protein]|ascorbic acid inhibits the reaction [estradiol inhibits the reaction [NFE2L2 protein binds to SOD3 promoter]],,,PMID:23027624,https://www.ncbi.nlm.nih.gov/pubmed/23027624,23027624,,
273,1991460,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [estradiol results in decreased expression of NFE2L2 mrna]|ascorbic acid inhibits the reaction [estradiol results in decreased expression of NFE2L2 protein],,,PMID:23492819,https://www.ncbi.nlm.nih.gov/pubmed/23492819,23492819,,
274,1991461,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased expression of NFE2L2 protein]|ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased expression of NFE2L2 mrna],,,PMID:31585129,https://www.ncbi.nlm.nih.gov/pubmed/31585129,31585129,,
275,1991462,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Ascorbic acid promotes the reaction [cadmium results in increased expression of NFE2L2 protein],,,PMID:22008531,https://www.ncbi.nlm.nih.gov/pubmed/22008531,22008531,,
276,1991463,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Ascorbic acid promotes the reaction [fluorouracil affects the localization of NFE2L2 protein],,,PMID:26921358,https://www.ncbi.nlm.nih.gov/pubmed/26921358,26921358,,
277,1991464,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of NFE2L2 protein,,,PMID:22008531|PMID:23027624,https://www.ncbi.nlm.nih.gov/pubmed/22008531|https://www.ncbi.nlm.nih.gov/pubmed/23027624,22008531|23027624,,
278,1991465,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9603,NFE2L3,https://ctdbase.org/detail.go?type=gene&acc=9603,,,9603.0,NFE2L3,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of NFE2L3 protein|ascorbic acid results in decreased expression of NFE2L3 mRNA,,,PMID:25130429,https://www.ncbi.nlm.nih.gov/pubmed/25130429,25130429,,
279,1991466,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4781,NFIB,https://ctdbase.org/detail.go?type=gene&acc=4781,,,4781.0,NFIB,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NFIB mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
280,1991467,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606,Homo sapiens (human),[ascorbic acid co-treated with ferrous sulfate] results in increased activity of NFKB1 protein|[hyaluronic acid co-treated with chondroitin sulfates] inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of NFKB1 protein],,,PMID:17879260,https://www.ncbi.nlm.nih.gov/pubmed/17879260,17879260,,
281,1991639,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [norepinephrine affects the localization of NFKB1 protein],,,PMID:23114885,https://www.ncbi.nlm.nih.gov/pubmed/23114885,23114885,,
282,1991640,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with ferrous sulfate] results in increased activity of [NFKB1 protein binds to RELA protein]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of [NFKB1 protein binds to RELA protein]]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of [NFKB1 protein binds to RELA protein]]",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
283,1991641,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [fluorouracil affects the localization of NFKB1 protein],,,PMID:26921358,https://www.ncbi.nlm.nih.gov/pubmed/26921358,26921358,,
284,1991642,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of NFKBIA protein modified form],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
285,1991643,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606,Homo sapiens (human),[ascorbic acid co-treated with ferrous sulfate] results in decreased expression of NFKBIA protein|[hyaluronic acid co-treated with chondroitin sulfates] inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in decreased expression of NFKBIA protein],,,PMID:17879260,https://www.ncbi.nlm.nih.gov/pubmed/17879260,17879260,,
286,1991644,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNF protein results in increased expression of NFKBIA mrna]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of NFKBIA mrna],,,PMID:25551565,https://www.ncbi.nlm.nih.gov/pubmed/25551565,25551565,,
287,1991645,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased degradation of NFKBIA protein],,,PMID:25305479,https://www.ncbi.nlm.nih.gov/pubmed/25305479,25305479,,
288,1991646,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4800,NFYA,https://ctdbase.org/detail.go?type=gene&acc=4800,,,4800.0,NFYA,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of NFYA mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
289,1991647,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4814,NINJ1,https://ctdbase.org/detail.go?type=gene&acc=4814,,,4814.0,NINJ1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of NINJ1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
290,1991815,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7080,NKX2-1,https://ctdbase.org/detail.go?type=gene&acc=7080,,,7080.0,NKX2-1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nitrofen results in decreased expression of NKX2-1 protein]|ascorbic acid inhibits the reaction [nitrofen results in decreased expression of NKX2-1 mrna],,,PMID:15083329,https://www.ncbi.nlm.nih.gov/pubmed/15083329,15083329,,
291,1991816,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7080,NKX2-1,https://ctdbase.org/detail.go?type=gene&acc=7080,,,7080.0,NKX2-1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [nitrofen results in decreased expression of NKX2-1 protein],,,PMID:16863852,https://www.ncbi.nlm.nih.gov/pubmed/16863852,16863852,,
292,1991817,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1482,NKX2-5,https://ctdbase.org/detail.go?type=gene&acc=1482,,,1482.0,NKX2-5,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NKX2-5 mRNA,,,PMID:12668514,https://www.ncbi.nlm.nih.gov/pubmed/12668514,12668514,,
293,1991818,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4830,NME1,https://ctdbase.org/detail.go?type=gene&acc=4830,,,4830.0,NME1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of NME1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
294,1991819,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4826,NNAT,https://ctdbase.org/detail.go?type=gene&acc=4826,,,4826.0,NNAT,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NNAT mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
295,1991820,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9241,NOG,https://ctdbase.org/detail.go?type=gene&acc=9241,,,9241.0,NOG,10116,Rattus norvegicus (Norway rat),NOG protein inhibits the reaction [ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein]]]|nog protein inhibits the reaction [ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein]]]|nog protein inhibits the reaction [ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMPR1A protein]]],,,PMID:27387537,https://www.ncbi.nlm.nih.gov/pubmed/27387537,27387537,,
296,1991821,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [aspirin results in increased expression of NOS2 protein],,,PMID:17218764,https://www.ncbi.nlm.nih.gov/pubmed/17218764,17218764,,
297,1991822,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606,Homo sapiens (human),Ascorbic acid results in increased activity of NOS2 protein,,,PMID:20179380,https://www.ncbi.nlm.nih.gov/pubmed/20179380,20179380,,
298,1991823,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5721,PSME2,https://ctdbase.org/detail.go?type=gene&acc=5721,,,5721.0,PSME2,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of PSME2 mrna|ascorbic acid results in increased expression of PSME2 protein,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
299,1991971,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5742,PTGS1,https://ctdbase.org/detail.go?type=gene&acc=5742,,,5742.0,PTGS1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [formaldehyde results in increased expression of PTGS1 mrna],,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
300,1991972,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),"Mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of NOS2 protein]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of NOS2 mrna|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of NOS2 protein]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of NOS2 protein|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of NOS2 mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of NOS2 mrna]",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
301,1991973,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9986,Oryctolagus cuniculus (rabbit),[trimetazidine co-treated with acetylcysteine co-treated with ascorbic acid co-treated with insulin] inhibits the reaction [aluminum phosphide results in increased expression of NOS2 protein],,,PMID:34665895,https://www.ncbi.nlm.nih.gov/pubmed/34665895,34665895,,
302,1991974,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with formaldehyde] results in decreased expression of NOS2 mRNA,,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
303,1991975,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E co-treated with beta carotene co-treated with copper] inhibits the reaction [streptozocin results in increased expression of NOS2 mrna],,,PMID:18779489,https://www.ncbi.nlm.nih.gov/pubmed/18779489,18779489,,
304,1991976,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cyclosporine results in increased expression of NOS2 protein],,,PMID:19391111,https://www.ncbi.nlm.nih.gov/pubmed/19391111,19391111,,
305,1991977,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),"Ascorbic acid inhibits the reaction [endotoxin, escherichia coli results in increased expression of NOS2 protein]|ascorbic acid inhibits the reaction [lipopolysaccharides results in increased expression of NOS2 protein]",,,PMID:17637181,https://www.ncbi.nlm.nih.gov/pubmed/17637181,17637181,,
306,1991978,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [isoproterenol results in increased expression of NOS2 protein],,,PMID:19466570,https://www.ncbi.nlm.nih.gov/pubmed/19466570,19466570,,
307,1991979,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lipopolysaccharides results in increased expression of NOS2 mrna],,,PMID:15612528,https://www.ncbi.nlm.nih.gov/pubmed/15612528,15612528,,
308,1992133,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [nickel sulfate results in increased activity of NOS2 protein],,,PMID:23463385,https://www.ncbi.nlm.nih.gov/pubmed/23463385,23463385,,
309,1992134,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of NOS2,,,PMID:19494560,https://www.ncbi.nlm.nih.gov/pubmed/19494560,19494560,,
310,1992135,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,9606,Homo sapiens (human),Ascorbic acid results in increased activity of NOS3 protein,,,PMID:11243424,https://www.ncbi.nlm.nih.gov/pubmed/11243424,11243424,,
311,1992136,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,9606,Homo sapiens (human),[isosorbide dinitrate co-treated with ascorbic acid] affects the expression of NOS3 mRNA,,,PMID:15719745,https://www.ncbi.nlm.nih.gov/pubmed/15719745,15719745,,
312,1992137,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10090,Mus musculus (house mouse),Ascorbic acid results in increased phosphorylation of NOS3 protein,,,PMID:21570463,https://www.ncbi.nlm.nih.gov/pubmed/21570463,21570463,,
313,1992138,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [formaldehyde results in decreased expression of NOS3 mrna],,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
314,1992139,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in increased expression of NOS3 protein],,,PMID:11729227,https://www.ncbi.nlm.nih.gov/pubmed/11729227,11729227,,
315,1992140,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10116,Rattus norvegicus (Norway rat),[vitamin E co-treated with ascorbic acid] inhibits the reaction [dexamethasone results in decreased expression of NOS3 protein],,,PMID:20068362,https://www.ncbi.nlm.nih.gov/pubmed/20068362,20068362,,
316,1992141,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,27035,NOX1,https://ctdbase.org/detail.go?type=gene&acc=27035,,,27035.0,NOX1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NOX1 protein,,,PMID:21570463,https://www.ncbi.nlm.nih.gov/pubmed/21570463,21570463,,
317,1992142,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,50507,NOX4,https://ctdbase.org/detail.go?type=gene&acc=50507,,,50507.0,NOX4,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of NOX4 protein]|ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of NOX4 mrna],,,PMID:25305479,https://www.ncbi.nlm.nih.gov/pubmed/25305479,25305479,,
318,1992289,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,50507,NOX4,https://ctdbase.org/detail.go?type=gene&acc=50507,,,50507.0,NOX4,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NOX4 protein|ascorbic acid results in increased expression of NOX4 mRNA,,,PMID:21570463,https://www.ncbi.nlm.nih.gov/pubmed/21570463,21570463,,
319,1992290,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4869,NPM1,https://ctdbase.org/detail.go?type=gene&acc=4869,,,4869.0,NPM1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NPM1 mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
320,1992291,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of NQO1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
321,1992292,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [estradiol results in decreased expression of NQO1 mrna]|ascorbic acid inhibits the reaction [estradiol results in decreased expression of NQO1 protein],,,PMID:25130429,https://www.ncbi.nlm.nih.gov/pubmed/25130429,25130429,,
322,1992293,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of NQO1 mrna],,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
323,1992294,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in increased expression of NQO1 mrna],,,PMID:32525552,https://www.ncbi.nlm.nih.gov/pubmed/32525552,32525552,,
324,1992295,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [diquat results in decreased expression of NQO1 protein],,,PMID:33475796,https://www.ncbi.nlm.nih.gov/pubmed/33475796,33475796,,
325,1992296,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090,Mus musculus (house mouse),Ascorbic acid promotes the reaction [sodium arsenite results in increased expression of NQO1 mrna],,,PMID:16517059,https://www.ncbi.nlm.nih.gov/pubmed/16517059,16517059,,
326,1992297,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in increased expression of NQO1 protein],,,PMID:29663635,https://www.ncbi.nlm.nih.gov/pubmed/29663635,29663635,,
327,1992298,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of NQO1 protein|ascorbic acid promotes the reaction [cadmium results in increased expression of NQO1 protein],,,PMID:22008531,https://www.ncbi.nlm.nih.gov/pubmed/22008531,22008531,,
328,1992402,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,9606,Homo sapiens (human),Bexarotene promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna|tributyltin promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna]|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna],,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
329,1992403,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7025,NR2F1,https://ctdbase.org/detail.go?type=gene&acc=7025,,,7025.0,NR2F1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of NR2F1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
330,1992404,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7026,NR2F2,https://ctdbase.org/detail.go?type=gene&acc=7026,,,7026.0,NR2F2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of NR2F2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
331,1992405,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of NR3C1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
332,1992406,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8013,NR4A3,https://ctdbase.org/detail.go?type=gene&acc=8013,,,8013.0,NR4A3,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of NR4A3 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
333,1992407,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2516,NR5A1,https://ctdbase.org/detail.go?type=gene&acc=2516,,,2516.0,NR5A1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of NR5A1 mrna],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
334,1992408,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9315,NREP,https://ctdbase.org/detail.go?type=gene&acc=9315,,,9315.0,NREP,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NREP mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
335,1992409,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9378,NRXN1,https://ctdbase.org/detail.go?type=gene&acc=9378,,,9378.0,NRXN1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of NRXN1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
336,1992410,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7468,NSD2,https://ctdbase.org/detail.go?type=gene&acc=7468,,,7468.0,NSD2,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of NSD2 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
337,1992562,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4915,NTRK2,https://ctdbase.org/detail.go?type=gene&acc=4915,,,4915.0,NTRK2,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of NTRK2 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
338,1992563,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,100506658,OCLN,https://ctdbase.org/detail.go?type=gene&acc=100506658,,,100506658.0,OCLN,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in decreased expression of OCLN mrna],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
339,1992564,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,100506658,OCLN,https://ctdbase.org/detail.go?type=gene&acc=100506658,,,100506658.0,OCLN,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of OCLN protein],,,PMID:29940330,https://www.ncbi.nlm.nih.gov/pubmed/29940330,29940330,,
340,1992565,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4967,OGDH,https://ctdbase.org/detail.go?type=gene&acc=4967,,,4967.0,OGDH,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [arsenic results in decreased activity of OGDH protein],,,PMID:24295472,https://www.ncbi.nlm.nih.gov/pubmed/24295472,24295472,,
341,1992566,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4967,OGDH,https://ctdbase.org/detail.go?type=gene&acc=4967,,,4967.0,OGDH,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased activity of OGDH protein],,,PMID:12915223,https://www.ncbi.nlm.nih.gov/pubmed/12915223,12915223,,
342,1992567,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,55239,OGFOD1,https://ctdbase.org/detail.go?type=gene&acc=55239,,,55239.0,OGFOD1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of OGFOD1 mrna|[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of OGFOD1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
343,1992568,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4968,OGG1,https://ctdbase.org/detail.go?type=gene&acc=4968,,,4968.0,OGG1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [sodium arsenite results in increased methylation of OGG1 promoter]|ascorbic acid inhibits the reaction [sodium arsenite results in decreased expression of OGG1 protein],,,PMID:33388378,https://www.ncbi.nlm.nih.gov/pubmed/33388378,33388378,,
344,1992569,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10215,OLIG2,https://ctdbase.org/detail.go?type=gene&acc=10215,,,10215.0,OLIG2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OLIG2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
345,1992570,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4973,OLR1,https://ctdbase.org/detail.go?type=gene&acc=4973,,,4973.0,OLR1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of OLR1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
346,1992571,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10956,OS9,https://ctdbase.org/detail.go?type=gene&acc=10956,,,10956.0,OS9,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of OS9 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
347,1992712,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5015,OTX2,https://ctdbase.org/detail.go?type=gene&acc=5015,,,5015.0,OTX2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
348,1992713,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8974,P4HA2,https://ctdbase.org/detail.go?type=gene&acc=8974,,,8974.0,P4HA2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of P4HA2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
349,1992714,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54681,P4HTM,https://ctdbase.org/detail.go?type=gene&acc=54681,,,54681.0,P4HTM,9606,Homo sapiens (human),[ketoglutaric acids co-treated with ascorbic acid co-treated with ferrous chloride] results in increased activity of P4HTM protein,,,PMID:19263519,https://www.ncbi.nlm.nih.gov/pubmed/19263519,19263519,,
350,1992715,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5066,PAM,https://ctdbase.org/detail.go?type=gene&acc=5066,,,5066.0,PAM,10029,Cricetulus griseus (Chinese hamster),Ascorbic acid results in decreased activity of PAM protein,,,PMID:16704972,https://www.ncbi.nlm.nih.gov/pubmed/16704972,16704972,,
351,1992716,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9061,PAPSS1,https://ctdbase.org/detail.go?type=gene&acc=9061,,,9061.0,PAPSS1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of PAPSS1 mrna|[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of PAPSS1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
352,1992717,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased cleavage of PARP1 protein],,,PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16407847,16407847,,
353,1992718,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [oleanolic acid results in increased cleavage of PARP1 protein],,,PMID:22678527,https://www.ncbi.nlm.nih.gov/pubmed/22678527,22678527,,
354,1992719,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [chromium hexavalent ion results in increased cleavage of PARP1 protein],,,PMID:17301063,https://www.ncbi.nlm.nih.gov/pubmed/17301063,17301063,,
355,1992720,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in increased degradation of PARP1 protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
356,1992721,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of PARP1 mrna]|[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of PARP1 mRNA",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
357,1992904,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cadmium results in increased cleavage of PARP1 protein],,,PMID:19433269,https://www.ncbi.nlm.nih.gov/pubmed/19433269,19433269,,
358,1992905,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in increased cleavage of PARP1 protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
359,1992906,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,67307,PBLD2,https://ctdbase.org/detail.go?type=gene&acc=67307,,,67307.0,Pbld2,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of PBLD2 protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
360,1992907,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,26025,PCDHGA12,https://ctdbase.org/detail.go?type=gene&acc=26025,,,26025.0,PCDHGA12,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of PCDHGA12 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
361,1992908,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5106,PCK2,https://ctdbase.org/detail.go?type=gene&acc=5106,,,5106.0,PCK2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of PCK2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
362,1992909,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of PCNA protein,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
363,1992910,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,9669,Mustela putorius furo (domestic ferret),[beta carotene co-treated with alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of PCNA protein],,,PMID:16401635,https://www.ncbi.nlm.nih.gov/pubmed/16401635,16401635,,
364,1992911,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with kojic acid co-treated with diethylnitrosamine] results in increased expression of PCNA protein,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
365,1992912,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of PCNA protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
366,1992913,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5121,PCP4,https://ctdbase.org/detail.go?type=gene&acc=5121,,,5121.0,PCP4,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of PCP4 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
367,1993056,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,255738,PCSK9,https://ctdbase.org/detail.go?type=gene&acc=255738,,,255738.0,PCSK9,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of PCSK9 mrna|ascorbic acid affects the reaction [GULO protein affects the expression of PCSK9 protein]|ascorbic acid results in decreased expression of PCSK9 protein|foxo3 protein affects the reaction [ascorbic acid results in decreased expression of PCSK9 protein]|ascorbic acid results in decreased expression of and results in decreased secretion of PCSK9 protein,,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
368,1993057,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5136,PDE1A,https://ctdbase.org/detail.go?type=gene&acc=5136,,,5136.0,PDE1A,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of PDE1A mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
369,1993058,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5159,PDGFRB,https://ctdbase.org/detail.go?type=gene&acc=5159,,,5159.0,PDGFRB,10116,Rattus norvegicus (Norway rat),[alpha-tocopherol co-treated with beta carotene co-treated with ascorbic acid co-treated with zinc co-treated with sodium selenite] results in decreased expression of PDGFRB mrna|[alpha-tocopherol co-treated with beta carotene co-treated with ascorbic acid co-treated with zinc co-treated with sodium selenite] results in decreased expression of PDGFRB protein,,,PMID:23859036,https://www.ncbi.nlm.nih.gov/pubmed/23859036,23859036,,
370,1993059,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,64714,PDIA2,https://ctdbase.org/detail.go?type=gene&acc=64714,,,64714.0,PDIA2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of PDIA2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
371,1993060,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2923,PDIA3,https://ctdbase.org/detail.go?type=gene&acc=2923,,,2923.0,PDIA3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased expression of PDIA3 mrna]|ascorbic acid inhibits the reaction [fenretinide results in increased expression of PDIA3 protein],,,PMID:17353921,https://www.ncbi.nlm.nih.gov/pubmed/17353921,17353921,,
372,1993061,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5037,PEBP1,https://ctdbase.org/detail.go?type=gene&acc=5037,,,5037.0,PEBP1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of PEBP1 mrna|ascorbic acid results in increased expression of PEBP1 protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
373,1993062,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5184,PEPD,https://ctdbase.org/detail.go?type=gene&acc=5184,,,5184.0,PEPD,9606,Homo sapiens (human),Ascorbic acid results in increased activity of PEPD protein,,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
374,1993063,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5198,PFAS,https://ctdbase.org/detail.go?type=gene&acc=5198,,,5198.0,PFAS,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in increased expression of PFAS mrna|ascorbic acid results in increased expression of PFAS mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
375,1993064,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5207,PFKFB1,https://ctdbase.org/detail.go?type=gene&acc=5207,,,5207.0,PFKFB1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [iodoacetamide affects the activity of PFKFB1 protein],,,PMID:6092364,https://www.ncbi.nlm.nih.gov/pubmed/6092364,6092364,,
376,1993194,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5253,PHF2,https://ctdbase.org/detail.go?type=gene&acc=5253,,,5253.0,PHF2,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of PHF2 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
377,1993195,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,26227,PHGDH,https://ctdbase.org/detail.go?type=gene&acc=26227,,,26227.0,PHGDH,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of PHGDH mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
378,1993196,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22822,PHLDA1,https://ctdbase.org/detail.go?type=gene&acc=22822,,,22822.0,PHLDA1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of PHLDA1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
379,1993197,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7262,PHLDA2,https://ctdbase.org/detail.go?type=gene&acc=7262,,,7262.0,PHLDA2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of PHLDA2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
380,1993198,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5295,PIK3R1,https://ctdbase.org/detail.go?type=gene&acc=5295,,,5295.0,PIK3R1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of PIK3R1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
381,1993199,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5315,PKM,https://ctdbase.org/detail.go?type=gene&acc=5315,,,5315.0,PKM,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of PKM mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
382,1993200,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11145,PLAAT3,https://ctdbase.org/detail.go?type=gene&acc=11145,,,11145.0,PLAAT3,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of PLAAT3 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
383,1993201,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5327,PLAT,https://ctdbase.org/detail.go?type=gene&acc=5327,,,5327.0,PLAT,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [endosulfan results in increased activity of PLAT protein]|ascorbic acid promotes the reaction [vitamin E results in increased activity of PLAT protein],,,PMID:21804306,https://www.ncbi.nlm.nih.gov/pubmed/21804306,21804306,,
384,1993202,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5340,PLG,https://ctdbase.org/detail.go?type=gene&acc=5340,,,5340.0,PLG,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [humic substances results in decreased activity of PLG protein]|ascorbic acid inhibits the reaction [arsenic promotes the reaction [humic substances results in decreased activity of PLG protein]],,,PMID:11419606,https://www.ncbi.nlm.nih.gov/pubmed/11419606,11419606,,
385,1993203,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5346,PLIN1,https://ctdbase.org/detail.go?type=gene&acc=5346,,,5346.0,PLIN1,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mRNA,,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
386,1993338,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5346,PLIN1,https://ctdbase.org/detail.go?type=gene&acc=5346,,,5346.0,PLIN1,10090,Mus musculus (house mouse),Tretinoin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|tetrabromobisphenol A promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna|triphenyltin hydroxide promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna]|pioglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN1 mrna],,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
387,1993339,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5347,PLK1,https://ctdbase.org/detail.go?type=gene&acc=5347,,,5347.0,PLK1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of PLK1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
388,1993340,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10769,PLK2,https://ctdbase.org/detail.go?type=gene&acc=10769,,,10769.0,PLK2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of PLK2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
389,1993341,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5350,PLN,https://ctdbase.org/detail.go?type=gene&acc=5350,,,5350.0,PLN,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of PLN mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
390,1993342,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5358,PLS3,https://ctdbase.org/detail.go?type=gene&acc=5358,,,5358.0,PLS3,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of PLS3 mrna|ascorbic acid results in increased expression of PLS3 protein,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
391,1993343,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5366,PMAIP1,https://ctdbase.org/detail.go?type=gene&acc=5366,,,5366.0,PMAIP1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased expression of PMAIP1 mrna],,,PMID:17216584,https://www.ncbi.nlm.nih.gov/pubmed/17216584,17216584,,
392,1993344,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5376,PMP22,https://ctdbase.org/detail.go?type=gene&acc=5376,,,5376.0,PMP22,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of PMP22 mRNA,,,PMID:15034573|PMID:17303424,https://www.ncbi.nlm.nih.gov/pubmed/15034573|https://www.ncbi.nlm.nih.gov/pubmed/17303424,15034573|17303424,,
393,1993345,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5376,PMP22,https://ctdbase.org/detail.go?type=gene&acc=5376,,,5376.0,PMP22,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [bucladesine results in increased activity of PMP22 promoter],,,PMID:15034573,https://www.ncbi.nlm.nih.gov/pubmed/15034573,15034573,,
394,1993346,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4860,PNP,https://ctdbase.org/detail.go?type=gene&acc=4860,,,4860.0,PNP,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of PNP protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
395,1993473,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),"1,2-dioleoyl-sn-glycero-3-phosphoglycerol inhibits the reaction [[ascorbic acid co-treated with copper sulfate] results in decreased activity of PON1 protein]|palmitoleic acid inhibits the reaction [[ascorbic acid co-treated with copper sulfate] results in decreased activity of PON1 protein]|erucic acid inhibits the reaction [[ascorbic acid co-treated with copper sulfate] results in decreased activity of PON1 protein]|oleic acid inhibits the reaction [[ascorbic acid co-treated with copper sulfate] results in decreased activity of PON1 protein]|1,2-oleoylphosphatidylcholine inhibits the reaction [[ascorbic acid co-treated with copper sulfate] results in decreased activity of PON1 protein]",,,PMID:12871208,https://www.ncbi.nlm.nih.gov/pubmed/12871208,12871208,,
396,1993474,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),"CAT protein inhibits the reaction [copper promotes the reaction [ascorbic acid results in decreased activity of PON1 protein]]|oleic acid inhibits the reaction [copper promotes the reaction [ascorbic acid results in decreased activity of PON1 protein]]|1,2-dipalmitoylphosphatidylglycerol inhibits the reaction [copper promotes the reaction [ascorbic acid results in decreased activity of PON1 protein]]|ascorbic acid results in decreased activity of PON1 protein|1,2-dioleoyl-sn-glycero-3-phosphoglycerol inhibits the reaction [copper promotes the reaction [ascorbic acid results in decreased activity of PON1 protein]]|sulfhydryl compounds inhibits the reaction [copper promotes the reaction [ascorbic acid results in decreased activity of PON1 protein]]|hypochlorous acid promotes the reaction [copper promotes the reaction [ascorbic acid results in decreased activity of PON1 protein]]|copper promotes the reaction [ascorbic acid results in decreased activity of PON1 protein]",,,PMID:15104111,https://www.ncbi.nlm.nih.gov/pubmed/15104111,15104111,,
397,1993475,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),[ascorbic acid co-treated with copper sulfate] inhibits the reaction [PON1 protein results in increased hydrolysis of paraoxon]|[ascorbic acid co-treated with ferrous sulfate] inhibits the reaction [PON1 protein results in increased hydrolysis of paraoxon]|[ascorbic acid co-treated with copper sulfate] inhibits the reaction [PON1 protein results in increased hydrolysis of phenylacetic acid]|[ascorbic acid co-treated with ferrous sulfate] inhibits the reaction [PON1 protein results in increased hydrolysis of phenylacetic acid],,,PMID:15375178,https://www.ncbi.nlm.nih.gov/pubmed/15375178,15375178,,
398,1993476,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),[ascorbic acid co-treated with copper sulfate] results in decreased activity of PON1 protein|[ascorbic acid co-treated with ferrous sulfate] results in decreased activity of PON1 protein,,,PMID:12871208|PMID:15375178,https://www.ncbi.nlm.nih.gov/pubmed/12871208|https://www.ncbi.nlm.nih.gov/pubmed/15375178,12871208|15375178,,
399,1993477,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),[iron co-treated with ascorbic acid] results in decreased expression of PON1 protein|butylated hydroxytoluene inhibits the reaction [[iron co-treated with ascorbic acid] results in decreased expression of PON1 protein]|[iron co-treated with ascorbic acid] results in decreased activity of PON1 protein,,,PMID:16052486,https://www.ncbi.nlm.nih.gov/pubmed/16052486,16052486,,
400,1993478,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),"[PON1 protein results in increased metabolism of [acrolein binds to ascorbic acid]] which results in increased chemical synthesis of 5,6,7,8-tetrahydroxy-4-oxooctanal|pon1 protein results in increased metabolism of [acrolein binds to ascorbic acid]",,,PMID:20353174,https://www.ncbi.nlm.nih.gov/pubmed/20353174,20353174,,
401,1993479,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [aspirin results in increased expression of PTGS2 mrna],,,PMID:17218764,https://www.ncbi.nlm.nih.gov/pubmed/17218764,17218764,,
402,1993644,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in increased expression of PTGS2 mrna],,,PMID:32525552,https://www.ncbi.nlm.nih.gov/pubmed/32525552,32525552,,
403,1993645,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased expression of PTGS2 mRNA,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
404,1993646,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [JP8 aviation fuel results in increased expression of PTGS2 mrna],,,PMID:19095747,https://www.ncbi.nlm.nih.gov/pubmed/19095747,19095747,,
405,1993647,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5744,PTHLH,https://ctdbase.org/detail.go?type=gene&acc=5744,,,5744.0,PTHLH,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of PTHLH mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
406,1993648,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5747,PTK2,https://ctdbase.org/detail.go?type=gene&acc=5747,,,5747.0,PTK2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of PTK2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
407,1993649,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),"Linoleic acid inhibits the reaction [9,11-linoleic acid inhibits the reaction [[ascorbic acid co-treated with copper analog co-treated with calcium analog] results in decreased activity of pon1]]|linoleic acid inhibits the reaction [trans-10,cis-12-conjugated linoleic acid inhibits the reaction [[ascorbic acid co-treated with copper analog co-treated with calcium analog] results in decreased activity of PON1]]|9,11-linoleic acid inhibits the reaction [[ascorbic acid co-treated with copper analog co-treated with calcium analog] results in decreased activity of pon1]|trans-10,cis-12-conjugated linoleic acid inhibits the reaction [[ascorbic acid co-treated with copper analog co-treated with calcium analog] results in decreased activity of pon1]|oleic acid inhibits the reaction [[ascorbic acid co-treated with copper analog co-treated with calcium analog] results in decreased activity of pon1]|[ascorbic acid co-treated with copper analog co-treated with calcium analog] results in decreased activity of PON1",,,PMID:12934671,https://www.ncbi.nlm.nih.gov/pubmed/12934671,12934671,,
408,1993650,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5445,PON2,https://ctdbase.org/detail.go?type=gene&acc=5445,,,5445.0,PON2,9606,Homo sapiens (human),"PON2 protein results in increased metabolism of [acrolein binds to ascorbic acid]|[pon2 protein results in increased metabolism of [acrolein binds to ascorbic acid]] which results in increased chemical synthesis of 5,6,7,8-tetrahydroxy-4-oxooctanal",,,PMID:20353174,https://www.ncbi.nlm.nih.gov/pubmed/20353174,20353174,,
409,1993651,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5460,POU5F1,https://ctdbase.org/detail.go?type=gene&acc=5460,,,5460.0,POU5F1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of POU5F1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
410,1993652,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5460,POU5F1,https://ctdbase.org/detail.go?type=gene&acc=5460,,,5460.0,POU5F1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [cobalt results in increased expression of POU5F1 protein],,,PMID:24497960,https://www.ncbi.nlm.nih.gov/pubmed/24497960,24497960,,
411,1993819,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5460,POU5F1,https://ctdbase.org/detail.go?type=gene&acc=5460,,,5460.0,POU5F1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of POU5F1 mRNA,,,PMID:21166886,https://www.ncbi.nlm.nih.gov/pubmed/21166886,21166886,,
412,1993820,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5460,POU5F1,https://ctdbase.org/detail.go?type=gene&acc=5460,,,5460.0,POU5F1,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of POU5F1 mRNA,,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
413,1993821,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,13489,Dicentrarchus labrax (European seabass),Ascorbic acid affects the expression of PPARG mRNA,,,PMID:21281732,https://www.ncbi.nlm.nih.gov/pubmed/21281732,21281732,,
414,1993822,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA,,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
415,1993823,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mrna|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mrna]|tretinoin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mrna],,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
416,1993824,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mrna|src protein promotes the reaction [tetrachlorodibenzodioxin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mrna]]|tetrachlorodibenzodioxin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mrna],,,PMID:14505802,https://www.ncbi.nlm.nih.gov/pubmed/14505802,14505802,,
417,1993825,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9823,Sus scrofa (pig),"[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of PPARG mrna|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of PPARG mrna]|troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of PPARG mrna]",,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
418,1993826,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,9606,Homo sapiens (human),Ascorbic acid results in increased expression of PPARGC1A mRNA,,,PMID:23056435,https://www.ncbi.nlm.nih.gov/pubmed/23056435,23056435,,
419,1993827,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,23082,PPRC1,https://ctdbase.org/detail.go?type=gene&acc=23082,,,23082.0,PPRC1,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in increased expression of PPRC1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
420,1994002,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,400736,PRAMEF13,https://ctdbase.org/detail.go?type=gene&acc=400736,,,400736.0,PRAMEF13,9606,Homo sapiens (human),Ascorbic acid results in increased expression of PRAMEF13 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
421,1994003,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5052,PRDX1,https://ctdbase.org/detail.go?type=gene&acc=5052,,,5052.0,PRDX1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with kojic acid co-treated with diethylnitrosamine] results in decreased expression of PRDX1 mRNA,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
422,1994004,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10935,PRDX3,https://ctdbase.org/detail.go?type=gene&acc=10935,,,10935.0,PRDX3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of PRDX3 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
423,1994005,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5551,PRF1,https://ctdbase.org/detail.go?type=gene&acc=5551,,,5551.0,PRF1,10090,Mus musculus (house mouse),Ascorbic acid deficiency results in decreased expression of PRF1 mRNA,,,PMID:22306178,https://www.ncbi.nlm.nih.gov/pubmed/22306178,22306178,,
424,1994006,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5579,PRKCB,https://ctdbase.org/detail.go?type=gene&acc=5579,,,5579.0,PRKCB,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of PRKCB mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
425,1994007,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5588,PRKCQ,https://ctdbase.org/detail.go?type=gene&acc=5588,,,5588.0,PRKCQ,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of PRKCQ mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
426,1994008,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5617,PRL,https://ctdbase.org/detail.go?type=gene&acc=5617,,,5617.0,PRL,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of PRL protein],,,PMID:16298753,https://www.ncbi.nlm.nih.gov/pubmed/16298753,16298753,,
427,1994009,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5617,PRL,https://ctdbase.org/detail.go?type=gene&acc=5617,,,5617.0,PRL,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of PRL protein],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
428,1994010,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5627,PROS1,https://ctdbase.org/detail.go?type=gene&acc=5627,,,5627.0,PROS1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of PROS1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
429,1994011,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,38175,PSA,https://ctdbase.org/detail.go?type=gene&acc=38175,,,38175.0,Psa,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of PSA mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
430,1994282,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5694,PSMB6,https://ctdbase.org/detail.go?type=gene&acc=5694,,,5694.0,PSMB6,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [rotenone results in increased expression of PSMB6 mrna]|ascorbic acid inhibits the reaction [epoxomicin results in increased expression of PSMB6 mrna],,,PMID:27345029,https://www.ncbi.nlm.nih.gov/pubmed/27345029,27345029,,
431,1994283,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5702,PSMC3,https://ctdbase.org/detail.go?type=gene&acc=5702,,,5702.0,PSMC3,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of PSMC3 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
432,1994284,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090,Mus musculus (house mouse),[quartz co-treated with ascorbic acid] results in increased expression of PTGS2 mrna|[quartz co-treated with ascorbic acid] results in increased expression of PTGS2 protein,,,PMID:17222177,https://www.ncbi.nlm.nih.gov/pubmed/17222177,17222177,,
433,1994285,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116,Rattus norvegicus (Norway rat),"Ascorbic acid inhibits the reaction [lipopolysaccharides results in increased expression of PTGS2 protein]|ascorbic acid inhibits the reaction [endotoxin, escherichia coli results in increased expression of PTGS2 protein]",,,PMID:17637181,https://www.ncbi.nlm.nih.gov/pubmed/17637181,17637181,,
434,1994286,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [fluorouracil results in increased expression of PTGS2 protein],,,PMID:26921358,https://www.ncbi.nlm.nih.gov/pubmed/26921358,26921358,,
435,1994287,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [formaldehyde results in increased expression of PTGS2 mrna],,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
436,1994288,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in increased expression of PTGS2 protein],,,PMID:22728154,https://www.ncbi.nlm.nih.gov/pubmed/22728154,22728154,,
437,1994289,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein],,,PMID:21873648,https://www.ncbi.nlm.nih.gov/pubmed/21873648,21873648,,
438,1994290,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [lead results in increased expression of PTGS2 protein],,,PMID:12761246,https://www.ncbi.nlm.nih.gov/pubmed/12761246,12761246,,
439,1994291,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5745,PTH1R,https://ctdbase.org/detail.go?type=gene&acc=5745,,,5745.0,PTH1R,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of PTH1R mrna|cadmium sulfate inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of PTH1R mrna],,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
440,1994465,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5764,PTN,https://ctdbase.org/detail.go?type=gene&acc=5764,,,5764.0,PTN,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of PTN mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
441,1994466,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5816,PVALB,https://ctdbase.org/detail.go?type=gene&acc=5816,,,5816.0,PVALB,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of PVALB protein],,,PMID:31708536,https://www.ncbi.nlm.nih.gov/pubmed/31708536,31708536,,
442,1994467,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5865,RAB3B,https://ctdbase.org/detail.go?type=gene&acc=5865,,,5865.0,RAB3B,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of RAB3B mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
443,1994468,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5865,RAB3B,https://ctdbase.org/detail.go?type=gene&acc=5865,,,5865.0,RAB3B,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of RAB3B mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
444,1994469,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5870,RAB6A,https://ctdbase.org/detail.go?type=gene&acc=5870,,,5870.0,RAB6A,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of RAB6A mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
445,1994470,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5879,RAC1,https://ctdbase.org/detail.go?type=gene&acc=5879,,,5879.0,RAC1,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [arsenic trioxide results in increased activity of RAC1 protein],,,PMID:12239215,https://www.ncbi.nlm.nih.gov/pubmed/12239215,12239215,,
446,1994471,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10111,RAD50,https://ctdbase.org/detail.go?type=gene&acc=10111,,,10111.0,RAD50,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of RAD50 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
447,1994472,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5889,RAD51C,https://ctdbase.org/detail.go?type=gene&acc=5889,,,5889.0,RAD51C,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of RAD51C mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
448,1994473,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,25788,RAD54B,https://ctdbase.org/detail.go?type=gene&acc=25788,,,25788.0,RAD54B,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of RAD54B mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
449,1994474,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5901,RAN,https://ctdbase.org/detail.go?type=gene&acc=5901,,,5901.0,RAN,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of RAN protein|ascorbic acid results in increased expression of RAN mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
450,1994680,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5916,RARG,https://ctdbase.org/detail.go?type=gene&acc=5916,,,5916.0,RARG,13489,Dicentrarchus labrax (European seabass),Ascorbic acid results in decreased expression of RARG mRNA,,,PMID:21281732,https://www.ncbi.nlm.nih.gov/pubmed/21281732,21281732,,
451,1994681,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,146713,RBFOX3,https://ctdbase.org/detail.go?type=gene&acc=146713,,,146713.0,RBFOX3,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of RBFOX3 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of RBFOX3 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
452,1994682,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,282996,RBM20,https://ctdbase.org/detail.go?type=gene&acc=282996,,,282996.0,RBM20,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of RBM20 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
453,1994683,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1827,RCAN1,https://ctdbase.org/detail.go?type=gene&acc=1827,,,1827.0,RCAN1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of RCAN1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
454,1994684,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5966,REL,https://ctdbase.org/detail.go?type=gene&acc=5966,,,5966.0,REL,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [norepinephrine affects the localization of REL protein],,,PMID:23114885,https://www.ncbi.nlm.nih.gov/pubmed/23114885,23114885,,
455,1994685,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in decreased expression of RELA protein],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
456,1994686,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606,Homo sapiens (human),[ascorbic acid co-treated with alpha-tocopherol co-treated with ferulic acid] inhibits the reaction [[ozone co-treated with oxygen] results in increased localization of RELA protein],,,PMID:26270818,https://www.ncbi.nlm.nih.gov/pubmed/26270818,26270818,,
457,1994687,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606,Homo sapiens (human),[ascorbic acid co-treated with ferrous sulfate] results in increased activity of RELA protein|[hyaluronic acid co-treated with chondroitin sulfates] inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of RELA protein],,,PMID:17879260,https://www.ncbi.nlm.nih.gov/pubmed/17879260,17879260,,
458,1994688,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased phosphorylation of RELA protein]",,,PMID:35349355,https://www.ncbi.nlm.nih.gov/pubmed/35349355,35349355,,
459,1994830,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased phosphorylation of and affects the localization of RELA protein],,,PMID:25305479,https://www.ncbi.nlm.nih.gov/pubmed/25305479,25305479,,
460,1994831,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [norepinephrine affects the localization of RELA protein],,,PMID:23114885,https://www.ncbi.nlm.nih.gov/pubmed/23114885,23114885,,
461,1994832,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with ferrous sulfate] results in increased activity of [NFKB1 protein binds to RELA protein]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of [NFKB1 protein binds to RELA protein]]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of [NFKB1 protein binds to RELA protein]]",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
462,1994833,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cyclosporine results in increased expression of RELA protein],,,PMID:19391111,https://www.ncbi.nlm.nih.gov/pubmed/19391111,19391111,,
463,1994834,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate affects the localization of RELA protein],,,PMID:22728154,https://www.ncbi.nlm.nih.gov/pubmed/22728154,22728154,,
464,1994835,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,85397,RGS8,https://ctdbase.org/detail.go?type=gene&acc=85397,,,85397.0,RGS8,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of RGS8 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
465,1994836,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22895,RPH3A,https://ctdbase.org/detail.go?type=gene&acc=22895,,,22895.0,RPH3A,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of RPH3A mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
466,1994837,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6235,RPS29,https://ctdbase.org/detail.go?type=gene&acc=6235,,,6235.0,RPS29,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of RPS29 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
467,1994838,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3921,RPSA,https://ctdbase.org/detail.go?type=gene&acc=3921,,,3921.0,RPSA,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of RPSA protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
468,1994839,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6236,RRAD,https://ctdbase.org/detail.go?type=gene&acc=6236,,,6236.0,RRAD,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of RRAD mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
469,1995016,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9606,Homo sapiens (human),EZH2 protein inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of RUNX2 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of RUNX2 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
470,1995017,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9606,Homo sapiens (human),Ascorbic acid results in increased expression of RUNX2 mRNA,,,PMID:28105418,https://www.ncbi.nlm.nih.gov/pubmed/28105418,28105418,,
471,1995018,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9606,Homo sapiens (human),[cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] results in increased expression of RUNX2 mRNA,,,PMID:17692823,https://www.ncbi.nlm.nih.gov/pubmed/17692823,17692823,,
472,1995019,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9606,Homo sapiens (human),"[SAG compound co-treated with 2,4-di-tert-butylphenol co-treated with fibroblast growth factor 2 co-treated with ascorbic acid co-treated with alpha-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of RUNX2 mRNA",,,PMID:36682590,https://www.ncbi.nlm.nih.gov/pubmed/36682590,36682590,,
473,1995020,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10090,Mus musculus (house mouse),4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of RUNX2 protein]|[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of RUNX2 protein|[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of RUNX2 mrna|4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of RUNX2 mrna],,,PMID:31935364,https://www.ncbi.nlm.nih.gov/pubmed/31935364,31935364,,
474,1995021,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10090,Mus musculus (house mouse),Rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of RUNX2 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of RUNX2 mRNA,,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
475,1995022,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 mrna]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
476,1995023,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10090,Mus musculus (house mouse),U 0126 inhibits the reaction [ascorbic acid results in increased expression of RUNX2 mrna]|ascorbic acid results in increased expression of RUNX2 mRNA,,,PMID:20530736,https://www.ncbi.nlm.nih.gov/pubmed/20530736,20530736,,
477,1995180,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10090,Mus musculus (house mouse),[folic acid co-treated with ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein,,,PMID:32324263,https://www.ncbi.nlm.nih.gov/pubmed/32324263,32324263,,
478,1995181,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10116,Rattus norvegicus (Norway rat),NOG protein inhibits the reaction [ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein]]]|[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein|ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein]]|dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 protein],,,PMID:27387537,https://www.ncbi.nlm.nih.gov/pubmed/27387537,27387537,,
479,1995182,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with phosphates] results in increased expression of RUNX2 mRNA,,,PMID:21613385,https://www.ncbi.nlm.nih.gov/pubmed/21613385,21613385,,
480,1995183,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10116,Rattus norvegicus (Norway rat),Quercetin affects the reaction [hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of RUNX2 mrna]]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of RUNX2 mrna|hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of RUNX2 mrna],,,PMID:27028516,https://www.ncbi.nlm.nih.gov/pubmed/27028516,27028516,,
481,1995184,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9823,Sus scrofa (pig),"2,2-bis(4-glycidyloxyphenyl)propane promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of RUNX2 mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of RUNX2 mRNA",,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
482,1995185,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9606,Homo sapiens (human),[ascorbic acid co-treated with IL11 protein] results in increased expression of RUNX2 mRNA,,,PMID:17956465,https://www.ncbi.nlm.nih.gov/pubmed/17956465,17956465,,
483,1995186,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,9606,Homo sapiens (human),Ascorbic acid results in increased expression of RUNX2 mRNA,,,PMID:17274723,https://www.ncbi.nlm.nih.gov/pubmed/17274723,17274723,,
484,1995187,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6281,S100A10,https://ctdbase.org/detail.go?type=gene&acc=6281,,,6281.0,S100A10,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of S100A10 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
485,1995188,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6273,S100A2,https://ctdbase.org/detail.go?type=gene&acc=6273,,,6273.0,S100A2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [copper promotes the reaction [S100A2 protein binds to S100A2 protein]],,,PMID:21924240,https://www.ncbi.nlm.nih.gov/pubmed/21924240,21924240,,
486,1995341,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6275,S100A4,https://ctdbase.org/detail.go?type=gene&acc=6275,,,6275.0,S100A4,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [copper promotes the reaction [S100A4 protein binds to S100A4 protein]],,,PMID:21924240,https://www.ncbi.nlm.nih.gov/pubmed/21924240,21924240,,
487,1995342,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6277,S100A6,https://ctdbase.org/detail.go?type=gene&acc=6277,,,6277.0,S100A6,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of S100A6 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
488,1995343,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6285,S100B,https://ctdbase.org/detail.go?type=gene&acc=6285,,,6285.0,S100B,9913,Bos taurus (cattle),Ascorbic acid inhibits the reaction [cupric chloride promotes the reaction [S100B protein binds to S100B protein]],,,PMID:10666291,https://www.ncbi.nlm.nih.gov/pubmed/10666291,10666291,,
489,1995344,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6285,S100B,https://ctdbase.org/detail.go?type=gene&acc=6285,,,6285.0,S100B,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of S100B mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of S100B protein,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
490,1995345,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6285,S100B,https://ctdbase.org/detail.go?type=gene&acc=6285,,,6285.0,S100B,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of S100B mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
491,1995346,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,795,S100G,https://ctdbase.org/detail.go?type=gene&acc=795,,,795.0,S100G,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of S100G mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
492,1995347,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,23314,SATB2,https://ctdbase.org/detail.go?type=gene&acc=23314,,,23314.0,SATB2,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of SATB2 mrna|ezh2 protein inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of SATB2 mrna],,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
493,1995348,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SCARB1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
494,1995349,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,20249,SCD1,https://ctdbase.org/detail.go?type=gene&acc=20249,,,20249.0,Scd1,10090,Mus musculus (house mouse),SRC protein promotes the reaction [tetrachlorodibenzodioxin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of SCD1 mrna]]|[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of SCD1 mrna|tetrachlorodibenzodioxin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of SCD1 mrna],,,PMID:14505802,https://www.ncbi.nlm.nih.gov/pubmed/14505802,14505802,,
495,1995476,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6326,SCN2A,https://ctdbase.org/detail.go?type=gene&acc=6326,,,6326.0,SCN2A,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SCN2A mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
496,1995477,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6326,SCN2A,https://ctdbase.org/detail.go?type=gene&acc=6326,,,6326.0,SCN2A,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SCN2A mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
497,1995478,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6383,SDC2,https://ctdbase.org/detail.go?type=gene&acc=6383,,,6383.0,SDC2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of SDC2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
498,1995479,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6389,SDHA,https://ctdbase.org/detail.go?type=gene&acc=6389,,,6389.0,SDHA,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [arsenic trioxide results in decreased expression of SDHA protein],,,PMID:19422848,https://www.ncbi.nlm.nih.gov/pubmed/19422848,19422848,,
499,1995480,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,174482,SDHB-1,https://ctdbase.org/detail.go?type=gene&acc=174482,,,174482.0,sdhb-1,6239,Caenorhabditis elegans,Ascorbic acid inhibits the reaction [SDHB-1 gene mutant form results in increased susceptibility to oxygen],,,PMID:19233206,https://www.ncbi.nlm.nih.gov/pubmed/19233206,19233206,,
500,1995481,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,23480,SEC61G,https://ctdbase.org/detail.go?type=gene&acc=23480,,,23480.0,SEC61G,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of SEC61G mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
501,1995482,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6401,SELE,https://ctdbase.org/detail.go?type=gene&acc=6401,,,6401.0,SELE,9606,Homo sapiens (human),[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of SELE mrna]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of SELE mrna],,,PMID:25551565,https://www.ncbi.nlm.nih.gov/pubmed/25551565,25551565,,
502,1995483,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10512,SEMA3C,https://ctdbase.org/detail.go?type=gene&acc=10512,,,10512.0,SEMA3C,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SEMA3C mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
503,1995484,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5265,SERPINA1,https://ctdbase.org/detail.go?type=gene&acc=5265,,,5265.0,SERPINA1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SERPINA1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
504,1995643,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5055,SERPINB2,https://ctdbase.org/detail.go?type=gene&acc=5055,,,5055.0,SERPINB2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SERPINB2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
505,1995644,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,10116,Rattus norvegicus (Norway rat),Ascorbic acid promotes the reaction [vitamin E inhibits the reaction [endosulfan results in increased activity of SERPINE1 protein]],,,PMID:21804306,https://www.ncbi.nlm.nih.gov/pubmed/21804306,21804306,,
506,1995645,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,83667,SESN2,https://ctdbase.org/detail.go?type=gene&acc=83667,,,83667.0,SESN2,9606,Homo sapiens (human),[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of SESN2 mrna|nutlin 3 inhibits the reaction [[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of SESN2 mrna],,,PMID:20530418,https://www.ncbi.nlm.nih.gov/pubmed/20530418,20530418,,
507,1995646,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6423,SFRP2,https://ctdbase.org/detail.go?type=gene&acc=6423,,,6423.0,SFRP2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SFRP2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
508,1995647,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6439,SFTPB,https://ctdbase.org/detail.go?type=gene&acc=6439,,,6439.0,SFTPB,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nitrofen results in decreased expression of SFTPB mrna],,,PMID:16490937,https://www.ncbi.nlm.nih.gov/pubmed/16490937,16490937,,
509,1995648,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6439,SFTPB,https://ctdbase.org/detail.go?type=gene&acc=6439,,,6439.0,SFTPB,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nitrofen results in decreased expression of SFTPB protein],,,PMID:15083329,https://www.ncbi.nlm.nih.gov/pubmed/15083329,15083329,,
510,1995649,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6439,SFTPB,https://ctdbase.org/detail.go?type=gene&acc=6439,,,6439.0,SFTPB,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [nitrofen results in decreased expression of SFTPB protein],,,PMID:16863852,https://www.ncbi.nlm.nih.gov/pubmed/16863852,16863852,,
511,1995650,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6440,SFTPC,https://ctdbase.org/detail.go?type=gene&acc=6440,,,6440.0,SFTPC,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of SFTPC mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
512,1995651,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9467,SH3BP5,https://ctdbase.org/detail.go?type=gene&acc=9467,,,9467.0,SH3BP5,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SH3BP5 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
513,1995652,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6472,SHMT2,https://ctdbase.org/detail.go?type=gene&acc=6472,,,6472.0,SHMT2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SHMT2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
514,1995789,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6476,SI,https://ctdbase.org/detail.go?type=gene&acc=6476,,,6476.0,SI,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of SI mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
515,1995790,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4891,SLC11A2,https://ctdbase.org/detail.go?type=gene&acc=4891,,,4891.0,SLC11A2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SLC11A2 protein|ascorbic acid results in increased expression of SLC11A2 protein,,,PMID:18815723,https://www.ncbi.nlm.nih.gov/pubmed/18815723,18815723,,
516,1995791,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,57084,SLC17A6,https://ctdbase.org/detail.go?type=gene&acc=57084,,,57084.0,SLC17A6,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SLC17A6 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
517,1995792,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,57030,SLC17A7,https://ctdbase.org/detail.go?type=gene&acc=57030,,,57030.0,SLC17A7,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SLC17A7 protein,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
518,1995793,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10864,SLC22A7,https://ctdbase.org/detail.go?type=gene&acc=10864,,,10864.0,SLC22A7,9606,Homo sapiens (human),SLC22A7 protein results in increased transport of ascorbic acid,,,PMID:15901346,https://www.ncbi.nlm.nih.gov/pubmed/15901346,15901346,,
519,1995794,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963.0,SLC23A1,13489,Dicentrarchus labrax (European seabass),Ascorbic acid results in increased expression of SLC23A1 mRNA,,,PMID:21281732,https://www.ncbi.nlm.nih.gov/pubmed/21281732,21281732,,
520,1995795,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963.0,SLC23A1,9031,Gallus gallus (chicken),SLC23A1 protein results in increased transport of ascorbic acid,,,PMID:17258485,https://www.ncbi.nlm.nih.gov/pubmed/17258485,17258485,,
521,1995796,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963.0,SLC23A1,9606,Homo sapiens (human),Ascorbic acid deficiency results in increased expression of SLC23A1 protein|ascorbic acid results in decreased expression of SLC23A1 mrna|ascorbic acid deficiency results in increased expression of SLC23A1 mrna|ascorbic acid results in decreased expression of SLC23A1 protein,,,PMID:20471816,https://www.ncbi.nlm.nih.gov/pubmed/20471816,20471816,,
522,1995797,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963.0,SLC23A1,9606,Homo sapiens (human),Quercetin inhibits the reaction [SLC23A1 protein results in increased transport of ascorbic acid]|slc23a1 protein results in increased transport of ascorbic acid,,,PMID:11834736,https://www.ncbi.nlm.nih.gov/pubmed/11834736,11834736,,
523,1995798,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963.0,SLC23A1,9606,Homo sapiens (human),SLC23A1 gene polymorphism affects the abundance of ascorbic acid,,,PMID:20519558,https://www.ncbi.nlm.nih.gov/pubmed/20519558,20519558,,
524,1995939,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963.0,SLC23A1,9606,Homo sapiens (human),SLC23A1 protein affects the transport of ascorbic acid,,,PMID:12381735,https://www.ncbi.nlm.nih.gov/pubmed/12381735,12381735,,
525,1995940,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963.0,SLC23A1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SLC23A1 mRNA,,,PMID:20122894,https://www.ncbi.nlm.nih.gov/pubmed/20122894,20122894,,
526,1995941,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9963,SLC23A1,https://ctdbase.org/detail.go?type=gene&acc=9963,,,9963.0,SLC23A1,10090,Mus musculus (house mouse),SLC23A1 protein affects the uptake of ascorbic acid,,,PMID:11984597,https://www.ncbi.nlm.nih.gov/pubmed/11984597,11984597,,
527,1995942,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9962,SLC23A2,https://ctdbase.org/detail.go?type=gene&acc=9962,,,9962.0,SLC23A2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nickel sulfate results in decreased expression of SLC23A2 mrna],,,PMID:16288478,https://www.ncbi.nlm.nih.gov/pubmed/16288478,16288478,,
528,1995943,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9962,SLC23A2,https://ctdbase.org/detail.go?type=gene&acc=9962,,,9962.0,SLC23A2,9606,Homo sapiens (human),Quercetin inhibits the reaction [SLC23A2 protein results in increased uptake of ascorbic acid]|hydrocortisone inhibits the reaction [SLC23A2 protein results in increased uptake of ascorbic acid]|indomethacin inhibits the reaction [SLC23A2 protein results in increased uptake of ascorbic acid]|genistein inhibits the reaction [SLC23A2 protein results in increased uptake of ascorbic acid]|diclofenac inhibits the reaction [SLC23A2 protein results in increased uptake of ascorbic acid]|progesterone inhibits the reaction [SLC23A2 protein results in increased uptake of ascorbic acid]|estradiol inhibits the reaction [SLC23A2 protein results in increased uptake of ascorbic acid],,,PMID:17092984,https://www.ncbi.nlm.nih.gov/pubmed/17092984,17092984,,
529,1995944,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9962,SLC23A2,https://ctdbase.org/detail.go?type=gene&acc=9962,,,9962.0,SLC23A2,10090,Mus musculus (house mouse),Ascorbic acid deficiency results in increased expression of SLC23A2 protein,,,PMID:22001929,https://www.ncbi.nlm.nih.gov/pubmed/22001929,22001929,,
530,1995945,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9962,SLC23A2,https://ctdbase.org/detail.go?type=gene&acc=9962,,,9962.0,SLC23A2,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SLC23A2 mRNA,,,PMID:20122894,https://www.ncbi.nlm.nih.gov/pubmed/20122894,20122894,,
531,1995946,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9962,SLC23A2,https://ctdbase.org/detail.go?type=gene&acc=9962,,,9962.0,SLC23A2,10090,Mus musculus (house mouse),SLC23A2 mRNA results in increased abundance of ascorbic acid,,,PMID:22558179,https://www.ncbi.nlm.nih.gov/pubmed/22558179,22558179,,
532,1995947,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9962,SLC23A2,https://ctdbase.org/detail.go?type=gene&acc=9962,,,9962.0,SLC23A2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of SLC23A2 mrna|slc23a2 protein results in increased transport of ascorbic acid,,,PMID:19418264,https://www.ncbi.nlm.nih.gov/pubmed/19418264,19418264,,
533,1995948,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of SLC2A1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
534,1996065,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6517,SLC2A4,https://ctdbase.org/detail.go?type=gene&acc=6517,,,6517.0,SLC2A4,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SLC2A4 mRNA,,,PMID:20122894,https://www.ncbi.nlm.nih.gov/pubmed/20122894,20122894,,
535,1996066,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6517,SLC2A4,https://ctdbase.org/detail.go?type=gene&acc=6517,,,6517.0,SLC2A4,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate affects the localization of SLC2A4 protein],,,PMID:21911000,https://www.ncbi.nlm.nih.gov/pubmed/21911000,21911000,,
536,1996067,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6529,SLC6A1,https://ctdbase.org/detail.go?type=gene&acc=6529,,,6529.0,SLC6A1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of SLC6A1 protein],,,PMID:31708536,https://www.ncbi.nlm.nih.gov/pubmed/31708536,31708536,,
537,1996068,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,23657,SLC7A11,https://ctdbase.org/detail.go?type=gene&acc=23657,,,23657.0,SLC7A11,9606,Homo sapiens (human),Ascorbic acid results in increased expression of SLC7A11 mRNA,,,PMID:26198647,https://www.ncbi.nlm.nih.gov/pubmed/26198647,26198647,,
538,1996069,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11309,SLCO2B1,https://ctdbase.org/detail.go?type=gene&acc=11309,,,11309.0,SLCO2B1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SLCO2B1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
539,1996070,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead results in decreased expression of SOD1 protein],,,PMID:22056337,https://www.ncbi.nlm.nih.gov/pubmed/22056337,22056337,,
540,1996071,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4086,SMAD1,https://ctdbase.org/detail.go?type=gene&acc=4086,,,4086.0,SMAD1,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SMAD1 mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SMAD1 mrna]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
541,1996072,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4089,SMAD4,https://ctdbase.org/detail.go?type=gene&acc=4089,,,4089.0,SMAD4,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SMAD4 mrna]|[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SMAD4 mRNA",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
542,1996073,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4090,SMAD5,https://ctdbase.org/detail.go?type=gene&acc=4090,,,4090.0,SMAD5,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SMAD5 mrna]|[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SMAD5 mRNA",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
543,1996197,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4093,SMAD9,https://ctdbase.org/detail.go?type=gene&acc=4093,,,4093.0,SMAD9,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SMAD9 mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SMAD9 mrna]",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
544,1996198,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,79677,SMC6,https://ctdbase.org/detail.go?type=gene&acc=79677,,,79677.0,SMC6,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SMC6 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
545,1996199,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6622,SNCA,https://ctdbase.org/detail.go?type=gene&acc=6622,,,6622.0,SNCA,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SNCA mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
546,1996200,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606,Homo sapiens (human),[ascorbic acid co-treated with vitamin E] results in increased expression of SOD1 mRNA,,,PMID:22207723,https://www.ncbi.nlm.nih.gov/pubmed/22207723,22207723,,
547,1996201,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in decreased activity of SOD1 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
548,1996202,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of SOD1 mrna],,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
549,1996203,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of SOD1 mRNA,,,PMID:31576639|PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/31576639|https://www.ncbi.nlm.nih.gov/pubmed/32913121,31576639|32913121,,
550,1996204,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of SOD1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
551,1996205,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SOD1 mRNA,,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
552,1996206,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090,Mus musculus (house mouse),SOD1 protein affects the abundance of ascorbic acid,,,PMID:16377630,https://www.ncbi.nlm.nih.gov/pubmed/16377630,16377630,,
553,1996380,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116,Rattus norvegicus (Norway rat),[alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [arsenite results in increased expression of SOD1 protein],,,PMID:21344382,https://www.ncbi.nlm.nih.gov/pubmed/21344382,21344382,,
554,1996381,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in increased expression of SOD1 protein],,,PMID:29663635,https://www.ncbi.nlm.nih.gov/pubmed/29663635,29663635,,
555,1996382,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [carbon tetrachloride results in decreased activity of SOD1 protein],,,PMID:30676168,https://www.ncbi.nlm.nih.gov/pubmed/30676168,30676168,,
556,1996383,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased activity of SOD1 protein]|ascorbic acid inhibits the reaction [potassium dichromate results in decreased activity of SOD1 protein],,,PMID:17822687,https://www.ncbi.nlm.nih.gov/pubmed/17822687,17822687,,
557,1996384,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of SOD1 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
558,1996385,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),Ascorbic acid results in increased expression of SOD2 mrna|ascorbic acid deficiency results in increased expression of SOD2 mRNA,,,PMID:19932582,https://www.ncbi.nlm.nih.gov/pubmed/19932582,19932582,,
559,1996386,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [HMOX1 protein results in increased expression of SOD2 mrna],,,PMID:10942521,https://www.ncbi.nlm.nih.gov/pubmed/10942521,10942521,,
560,1996387,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of SOD2 mrna],,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
561,1996388,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [norepinephrine results in increased expression of SOD2 mrna],,,PMID:23114885,https://www.ncbi.nlm.nih.gov/pubmed/23114885,23114885,,
562,1996389,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),SOD2 protein results in increased susceptibility to ascorbic acid,,,PMID:15130278,https://www.ncbi.nlm.nih.gov/pubmed/15130278,15130278,,
563,1996536,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),[alpha-tocopherol co-treated with beta carotene co-treated with ascorbic acid co-treated with zinc co-treated with sodium selenite] results in decreased expression of SOD2 mRNA,,,PMID:23859036,https://www.ncbi.nlm.nih.gov/pubmed/23859036,23859036,,
564,1996537,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E co-treated with beta carotene co-treated with copper] inhibits the reaction [streptozocin results in decreased expression of SOD2 mrna]|[ascorbic acid co-treated with vitamin E co-treated with beta carotene co-treated with copper] inhibits the reaction [streptozocin results in decreased expression of SOD2 protein],,,PMID:18779489,https://www.ncbi.nlm.nih.gov/pubmed/18779489,18779489,,
565,1996538,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [formaldehyde results in decreased expression of SOD2 mrna],,,PMID:27020608,https://www.ncbi.nlm.nih.gov/pubmed/27020608,27020608,,
566,1996539,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead results in decreased expression of SOD2 protein],,,PMID:22056337,https://www.ncbi.nlm.nih.gov/pubmed/22056337,22056337,,
567,1996540,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lipopolysaccharides results in increased expression of SOD2 mrna],,,PMID:15612528,https://www.ncbi.nlm.nih.gov/pubmed/15612528,15612528,,
568,1996541,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of SOD2 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
569,1996542,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased expression of SOD2 mrna],,,PMID:20122981|PMID:20876158|PMID:21554548,https://www.ncbi.nlm.nih.gov/pubmed/20122981|https://www.ncbi.nlm.nih.gov/pubmed/20876158|https://www.ncbi.nlm.nih.gov/pubmed/21554548,20122981|20876158|21554548,,
570,1996543,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6649,SOD3,https://ctdbase.org/detail.go?type=gene&acc=6649,,,6649.0,SOD3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [estradiol results in decreased expression of SOD3 protein]|ascorbic acid inhibits the reaction [estradiol results in decreased expression of SOD3 mrna],,,PMID:25130429,https://www.ncbi.nlm.nih.gov/pubmed/25130429,25130429,,
571,1996544,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6649,SOD3,https://ctdbase.org/detail.go?type=gene&acc=6649,,,6649.0,SOD3,10116,Rattus norvegicus (Norway rat),Ascorbic acid affects the localization of SOD3 protein|ascorbic acid inhibits the reaction [estradiol results in decreased expression of SOD3 protein]|ascorbic acid inhibits the reaction [estradiol results in decreased expression of SOD3 mrna]|ascorbic acid inhibits the reaction [estradiol results in decreased activity of SOD3 protein]|ascorbic acid results in increased activity of SOD3 protein|ascorbic acid inhibits the reaction [estradiol inhibits the reaction [NFE2L2 protein binds to SOD3 promoter]]|ascorbic acid results in increased expression of SOD3 protein,,,PMID:23027624,https://www.ncbi.nlm.nih.gov/pubmed/23027624,23027624,,
572,1996714,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6272,SORT1,https://ctdbase.org/detail.go?type=gene&acc=6272,,,6272.0,SORT1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SORT1 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
573,1996715,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6656,SOX1,https://ctdbase.org/detail.go?type=gene&acc=6656,,,6656.0,SOX1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
574,1996716,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6663,SOX10,https://ctdbase.org/detail.go?type=gene&acc=6663,,,6663.0,SOX10,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SOX10 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
575,1996717,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6664,SOX11,https://ctdbase.org/detail.go?type=gene&acc=6664,,,6664.0,SOX11,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of SOX11 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
576,1996718,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9580,SOX13,https://ctdbase.org/detail.go?type=gene&acc=9580,,,9580.0,SOX13,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in increased expression of SOX13 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
577,1996719,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6657,SOX2,https://ctdbase.org/detail.go?type=gene&acc=6657,,,6657.0,SOX2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
578,1996720,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6657,SOX2,https://ctdbase.org/detail.go?type=gene&acc=6657,,,6657.0,SOX2,9606,Homo sapiens (human),Ascorbic acid results in increased expression of SOX2 mRNA,,,PMID:21166886,https://www.ncbi.nlm.nih.gov/pubmed/21166886,21166886,,
579,1996721,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6657,SOX2,https://ctdbase.org/detail.go?type=gene&acc=6657,,,6657.0,SOX2,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of SOX2 mRNA,,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
580,1996722,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6662,SOX9,https://ctdbase.org/detail.go?type=gene&acc=6662,,,6662.0,SOX9,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of SOX9 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
581,1996723,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6662,SOX9,https://ctdbase.org/detail.go?type=gene&acc=6662,,,6662.0,SOX9,9606,Homo sapiens (human),[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SOX9 mrna|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SOX9 mrna]|resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SOX9 mrna]],,,PMID:26526931,https://www.ncbi.nlm.nih.gov/pubmed/26526931,26526931,,
582,1996880,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6667,SP1,https://ctdbase.org/detail.go?type=gene&acc=6667,,,6667.0,SP1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SP1 protein,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
583,1996881,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6670,SP3,https://ctdbase.org/detail.go?type=gene&acc=6670,,,6670.0,SP3,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SP3 protein,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
584,1996882,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6671,SP4,https://ctdbase.org/detail.go?type=gene&acc=6671,,,6671.0,SP4,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SP4 protein,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
585,1996883,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,9606,Homo sapiens (human),Bexarotene inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|tributyltin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna],,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
586,1996884,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,9606,Homo sapiens (human),"[SAG compound co-treated with 2,4-di-tert-butylphenol co-treated with fibroblast growth factor 2 co-treated with ascorbic acid co-treated with alpha-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of SP7 mRNA",,,PMID:36682590,https://www.ncbi.nlm.nih.gov/pubmed/36682590,36682590,,
587,1996885,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of TIMP1 protein,,,PMID:12510807,https://www.ncbi.nlm.nih.gov/pubmed/12510807,12510807,,
588,1996886,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] affects the expression of TIMP1 mRNA,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
589,1996887,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [AGT protein modified form results in increased expression of TIMP1 protein]|ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of TIMP1 protein],,,PMID:20881940,https://www.ncbi.nlm.nih.gov/pubmed/20881940,20881940,,
590,1996888,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of TIMP1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
591,1997028,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7082,TJP1,https://ctdbase.org/detail.go?type=gene&acc=7082,,,7082.0,TJP1,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in decreased expression of TJP1 mrna],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
592,1997029,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7082,TJP1,https://ctdbase.org/detail.go?type=gene&acc=7082,,,7082.0,TJP1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein],,,PMID:29940330,https://www.ncbi.nlm.nih.gov/pubmed/29940330,29940330,,
593,1997030,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,10090,Mus musculus (house mouse),"Tetrabromobisphenol A inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|d,d-T80-prallethrin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna|quinoxyfen inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|tretinoin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|pioglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|triphenyltin hydroxide inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]|allethrins inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SP7 mrna]",,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
594,1997031,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS1 protein co-treated with firemaster 550] results in decreased expression of SP7 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in decreased expression of SP7 mRNA,,,PMID:25062436,https://www.ncbi.nlm.nih.gov/pubmed/25062436,25062436,,
595,1997032,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SP7 mrna|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SP7 mrna]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SP7 protein]|[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SP7 protein",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
596,1997033,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,10090,Mus musculus (house mouse),Carbobenzoxy-leucyl-leucyl-norvalinal inhibits the reaction [ascorbic acid results in increased expression of SP7 mrna]|ascorbic acid results in increased expression of SP7 protein|ascorbic acid results in increased expression of SP7 mrna|egln1 mRNA affects the reaction [ascorbic acid results in increased expression of SP7 protein]|ethyl protocatechuate inhibits the reaction [ascorbic acid results in increased expression of SP7 mrna]|ethyl protocatechuate inhibits the reaction [ascorbic acid results in increased expression of SP7 protein]|deferoxamine inhibits the reaction [ascorbic acid results in increased expression of SP7 mrna],,,PMID:21467157,https://www.ncbi.nlm.nih.gov/pubmed/21467157,21467157,,
597,1997163,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,10090,Mus musculus (house mouse),[folic acid co-treated with ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of SP7 mrna|[folic acid co-treated with ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of SP7 protein,,,PMID:32324263,https://www.ncbi.nlm.nih.gov/pubmed/32324263,32324263,,
598,1997164,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6678,SPARC,https://ctdbase.org/detail.go?type=gene&acc=6678,,,6678.0,SPARC,9606,Homo sapiens (human),[cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] results in increased expression of SPARC protein,,,PMID:17692823,https://www.ncbi.nlm.nih.gov/pubmed/17692823,17692823,,
599,1997165,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8404,SPARCL1,https://ctdbase.org/detail.go?type=gene&acc=8404,,,8404.0,SPARCL1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SPARCL1 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
600,1997166,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,9606,Homo sapiens (human),[cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] results in increased expression of SPP1 protein,,,PMID:17692823,https://www.ncbi.nlm.nih.gov/pubmed/17692823,17692823,,
601,1997167,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,9606,Homo sapiens (human),"[SAG compound co-treated with 2,4-di-tert-butylphenol co-treated with fibroblast growth factor 2 co-treated with ascorbic acid co-treated with alpha-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of SPP1 mRNA",,,PMID:36682590,https://www.ncbi.nlm.nih.gov/pubmed/36682590,36682590,,
602,1997168,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SPP1 mrna]|[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of SPP1 mRNA",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
603,1997169,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,9823,Sus scrofa (pig),"Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SPP1 mrna]|2,2-bis(4-glycidyloxyphenyl)propane promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SPP1 mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SPP1 mRNA",,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
604,1997170,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,165679,SPTSSB,https://ctdbase.org/detail.go?type=gene&acc=165679,,,165679.0,SPTSSB,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SPTSSB mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
605,1997171,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SQSTM1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
606,1997329,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in increased expression of SQSTM1 mrna],,,PMID:32525552,https://www.ncbi.nlm.nih.gov/pubmed/32525552,32525552,,
607,1997330,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,10090,Mus musculus (house mouse),SRC protein promotes the reaction [tetrachlorodibenzodioxin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mrna]]|src protein promotes the reaction [tetrachlorodibenzodioxin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of SCD1 mrna]],,,PMID:14505802,https://www.ncbi.nlm.nih.gov/pubmed/14505802,14505802,,
608,1997331,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6720,SREBF1,https://ctdbase.org/detail.go?type=gene&acc=6720,,,6720.0,SREBF1,9606,Homo sapiens (human),Tributyltin promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mrna|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mrna]|bexarotene promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of SREBF1 mrna],,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
609,1997332,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6721,SREBF2,https://ctdbase.org/detail.go?type=gene&acc=6721,,,6721.0,SREBF2,9606,Homo sapiens (human),SREBF2 protein affects the reaction [ascorbic acid results in increased expression of LDLR protein]|ascorbic acid results in increased expression of SREBF2 mrna|srebf2 protein affects the reaction [ascorbic acid results in increased expression of LDLR mrna]|ascorbic acid results in decreased metabolism of SREBF2 protein,,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
610,1997333,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,140809,SRXN1,https://ctdbase.org/detail.go?type=gene&acc=140809,,,140809.0,SRXN1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SRXN1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
611,1997334,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6750,SST,https://ctdbase.org/detail.go?type=gene&acc=6750,,,6750.0,SST,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of SST mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
612,1997335,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cadmium results in decreased expression of STAR mrna],,,PMID:15055539,https://www.ncbi.nlm.nih.gov/pubmed/15055539,15055539,,
613,1997336,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of STAR mrna],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
614,1997499,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [mercuric chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT1 protein]],,,PMID:16896058,https://www.ncbi.nlm.nih.gov/pubmed/16896058,16896058,,
615,1997500,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of STAT1 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
616,1997501,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606,Homo sapiens (human),Ascorbic acid affects the expression of STAT3 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
617,1997502,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [mercuric chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT3 protein]],,,PMID:16896058,https://www.ncbi.nlm.nih.gov/pubmed/16896058,16896058,,
618,1997503,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6778,STAT6,https://ctdbase.org/detail.go?type=gene&acc=6778,,,6778.0,STAT6,9606,Homo sapiens (human),Ascorbic acid affects the expression of STAT6 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
619,1997504,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9262,STK17B,https://ctdbase.org/detail.go?type=gene&acc=9262,,,9262.0,STK17B,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of STK17B mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
620,1997505,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11075,STMN2,https://ctdbase.org/detail.go?type=gene&acc=11075,,,11075.0,STMN2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of STMN2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
621,1997506,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8801,SUCLG2,https://ctdbase.org/detail.go?type=gene&acc=8801,,,8801.0,SUCLG2,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of SUCLG2 protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
622,1997507,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SULT1A1 mRNA,,,PMID:21144891,https://www.ncbi.nlm.nih.gov/pubmed/21144891,21144891,,
623,1997508,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6818,SULT1A3,https://ctdbase.org/detail.go?type=gene&acc=6818,,,6818.0,SULT1A3,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of SULT1A3 mRNA,,,PMID:21144891,https://www.ncbi.nlm.nih.gov/pubmed/21144891,21144891,,
624,1997671,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,20888,SULT1C1,https://ctdbase.org/detail.go?type=gene&acc=20888,,,20888.0,Sult1c1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of SULT1C1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
625,1997672,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6822,SULT2A1,https://ctdbase.org/detail.go?type=gene&acc=6822,,,6822.0,SULT2A1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of SULT2A1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
626,1997673,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6839,SUV39H1,https://ctdbase.org/detail.go?type=gene&acc=6839,,,6839.0,SUV39H1,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of SUV39H1 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
627,1997674,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,79723,SUV39H2,https://ctdbase.org/detail.go?type=gene&acc=79723,,,79723.0,SUV39H2,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of SUV39H2 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
628,1997675,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,41247,SYN,https://ctdbase.org/detail.go?type=gene&acc=41247,,,41247.0,Syn,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SYN protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SYN mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
629,1997676,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6853,SYN1,https://ctdbase.org/detail.go?type=gene&acc=6853,,,6853.0,SYN1,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [corticosterone results in decreased expression of SYN1 protein],,,PMID:33872575,https://www.ncbi.nlm.nih.gov/pubmed/33872575,33872575,,
630,1997677,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9066,SYT7,https://ctdbase.org/detail.go?type=gene&acc=9066,,,9066.0,SYT7,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of SYT7 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
631,1997678,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6901,TAFAZZIN,https://ctdbase.org/detail.go?type=gene&acc=6901,,,6901.0,TAFAZZIN,9606,Homo sapiens (human),[cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] results in increased expression of TAFAZZIN mRNA,,,PMID:17692823,https://www.ncbi.nlm.nih.gov/pubmed/17692823,17692823,,
632,1997679,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6876,TAGLN,https://ctdbase.org/detail.go?type=gene&acc=6876,,,6876.0,TAGLN,9606,Homo sapiens (human),[ascorbic acid co-treated with TGFB1 protein] results in increased expression of TAGLN mrna|ascorbic acid results in increased expression of TAGLN mRNA,,,PMID:18607632,https://www.ncbi.nlm.nih.gov/pubmed/18607632,18607632,,
633,1997680,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6897,TARS1,https://ctdbase.org/detail.go?type=gene&acc=6897,,,6897.0,TARS1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of TARS1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
634,1997849,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9882,TBC1D4,https://ctdbase.org/detail.go?type=gene&acc=9882,,,9882.0,TBC1D4,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in increased expression of TBC1D4 protein],,,PMID:21911000,https://www.ncbi.nlm.nih.gov/pubmed/21911000,21911000,,
635,1997850,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6909,TBX2,https://ctdbase.org/detail.go?type=gene&acc=6909,,,6909.0,TBX2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TBX2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
636,1997851,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6941,TCF19,https://ctdbase.org/detail.go?type=gene&acc=6941,,,6941.0,TCF19,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of TCF19 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
637,1997852,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6942,TCF20,https://ctdbase.org/detail.go?type=gene&acc=6942,,,6942.0,TCF20,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of TCF20 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
638,1997853,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6996,TDG,https://ctdbase.org/detail.go?type=gene&acc=6996,,,6996.0,TDG,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased expression of TDG protein],,,PMID:33388378,https://www.ncbi.nlm.nih.gov/pubmed/33388378,33388378,,
639,1997854,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7015,TERT,https://ctdbase.org/detail.go?type=gene&acc=7015,,,7015.0,TERT,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of TERT mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
640,1997855,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,80312,TET1,https://ctdbase.org/detail.go?type=gene&acc=80312,,,80312.0,TET1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased expression of TET1 protein],,,PMID:33388378,https://www.ncbi.nlm.nih.gov/pubmed/33388378,33388378,,
641,1997856,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,80312,TET1,https://ctdbase.org/detail.go?type=gene&acc=80312,,,80312.0,TET1,9606,Homo sapiens (human),Ascorbic acid affects the activity of TET1 protein,,,PMID:24162740,https://www.ncbi.nlm.nih.gov/pubmed/24162740,24162740,,
642,1997857,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54790,TET2,https://ctdbase.org/detail.go?type=gene&acc=54790,,,54790.0,TET2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased expression of TET2 protein],,,PMID:33388378,https://www.ncbi.nlm.nih.gov/pubmed/33388378,33388378,,
643,1997858,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7018,TF,https://ctdbase.org/detail.go?type=gene&acc=7018,,,7018.0,TF,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TF mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
644,1997997,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7018,TF,https://ctdbase.org/detail.go?type=gene&acc=7018,,,7018.0,TF,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of TF mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
645,1997998,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7018,TF,https://ctdbase.org/detail.go?type=gene&acc=7018,,,7018.0,TF,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of TF mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
646,1997999,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7020,TFAP2A,https://ctdbase.org/detail.go?type=gene&acc=7020,,,7020.0,TFAP2A,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TFAP2A mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
647,1998000,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7032,TFF2,https://ctdbase.org/detail.go?type=gene&acc=7032,,,7032.0,TFF2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of TFF2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
648,1998001,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7037,TFRC,https://ctdbase.org/detail.go?type=gene&acc=7037,,,7037.0,TFRC,10090,Mus musculus (house mouse),[ascorbic acid co-treated with CAT protein] inhibits the reaction [zinc deficiency results in increased expression of TFRC protein],,,PMID:18073202,https://www.ncbi.nlm.nih.gov/pubmed/18073202,18073202,,
649,1998002,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10140,Cavia (guinea pigs),[ascorbic acid co-treated with ethanol] results in decreased expression of TGFB1 mRNA,,,PMID:22149461,https://www.ncbi.nlm.nih.gov/pubmed/22149461,22149461,,
650,1998003,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of TGFB1 protein],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
651,1998004,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,9606,Homo sapiens (human),[ascorbic acid co-treated with TGFB1 protein] results in increased expression of CNN1 protein|[ascorbic acid co-treated with TGFB1 protein] results in increased expression of CNN1 mrna|[ascorbic acid co-treated with TGFB1 protein] results in increased expression of TAGLN mrna|[ascorbic acid co-treated with TGFB1 protein] results in increased expression of ACTA2 protein|[ascorbic acid co-treated with TGFB1 protein] results in increased expression of ACTA2 mRNA,,,PMID:18607632,https://www.ncbi.nlm.nih.gov/pubmed/18607632,18607632,,
652,1998005,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of TGFB1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
653,1998006,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of TGFB1 mRNA,,,PMID:14566779,https://www.ncbi.nlm.nih.gov/pubmed/14566779,14566779,,
654,1998170,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with kojic acid co-treated with diethylnitrosamine] results in decreased expression of TGFB1 mRNA,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
655,1998171,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7042,TGFB2,https://ctdbase.org/detail.go?type=gene&acc=7042,,,7042.0,TGFB2,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of TGFB2 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
656,1998172,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7097,TLR2,https://ctdbase.org/detail.go?type=gene&acc=7097,,,7097.0,TLR2,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR2 protein|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR2 mrna]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR2 protein]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR2 mrna|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR2 mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR2 protein]",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
657,1998173,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099.0,TLR4,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of TLR4 mrna],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
658,1998174,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099.0,TLR4,10090,Mus musculus (house mouse),"CAT protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR4 mrna]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR4 mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR4 protein]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR4 protein]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR4 protein|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR4 mRNA",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
659,1998175,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4071,TM4SF1,https://ctdbase.org/detail.go?type=gene&acc=4071,,,4071.0,TM4SF1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of TM4SF1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
660,1998176,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with alpha-tocopherol co-treated with acetylcysteine] results in decreased expression of TH protein|ascorbic acid results in decreased expression of TH protein,,,PMID:25891525,https://www.ncbi.nlm.nih.gov/pubmed/25891525,25891525,,
661,1998177,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of TH mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
662,1998295,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076.0,TIMP1,9606,Homo sapiens (human),[ascorbic acid co-treated with quartz] results in increased expression of TIMP1 mRNA,,,PMID:27381660,https://www.ncbi.nlm.nih.gov/pubmed/27381660,27381660,,
663,1998296,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7104,TM4SF4,https://ctdbase.org/detail.go?type=gene&acc=7104,,,7104.0,TM4SF4,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TM4SF4 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
664,1998297,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,28959,TMEM176B,https://ctdbase.org/detail.go?type=gene&acc=28959,,,28959.0,TMEM176B,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of TMEM176B mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
665,1998298,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,164656,TMPRSS6,https://ctdbase.org/detail.go?type=gene&acc=164656,,,164656.0,TMPRSS6,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of TMPRSS6 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
666,1998299,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10140,Cavia (guinea pigs),[ascorbic acid co-treated with ethanol] results in decreased expression of TNF mRNA,,,PMID:22149461,https://www.ncbi.nlm.nih.gov/pubmed/22149461,22149461,,
667,1998300,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of TNF protein],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
668,1998301,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7043,TGFB3,https://ctdbase.org/detail.go?type=gene&acc=7043,,,7043.0,TGFB3,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of S100B mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SYN mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of FZD10 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of S100B protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of DLG4 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of E2F2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SYN protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of RBFOX3 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of MAP2 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of TUBB3 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GABRA2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN2B mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of CNTN1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIA2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SCN2A mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN2A mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of TERT mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of FOXM1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GFAP mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SLC17A7 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of RBFOX3 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SLC17A6 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of GLI1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of HOXB1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of HES3 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of INHBE mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of LEF1 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
669,1998399,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7043,TGFB3,https://ctdbase.org/detail.go?type=gene&acc=7043,,,7043.0,TGFB3,9606,Homo sapiens (human),[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL2A1 mrna|[tgfb3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in decreased expression of MMP13 mrna|resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL2A1 mrna]]|[tgfb3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ACAN mrna|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SOX9 mrna]|[tgfb3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SOX9 mrna|resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ACAN mrna]]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL2A1 mrna]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in decreased expression of MMP13 mrna]|resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of SOX9 mrna]]|il1b protein results in decreased susceptibility to [TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ACAN mrna],,,PMID:26526931,https://www.ncbi.nlm.nih.gov/pubmed/26526931,26526931,,
670,1998400,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of TH protein,,,PMID:22285708,https://www.ncbi.nlm.nih.gov/pubmed/22285708,22285708,,
671,1998401,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of CXCL8 mrna]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of NFKBIA mrna]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of TNF protein]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of CXCL8 mrna]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of SELE mrna]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of ICAM1 mrna]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of TNF protein]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of NFKBIA mrna]|ascorbic acid promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of SELE mrna],,,PMID:25551565,https://www.ncbi.nlm.nih.gov/pubmed/25551565,25551565,,
672,1998402,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of TNF mrna]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of TNF mrna],,,PMID:25551565,https://www.ncbi.nlm.nih.gov/pubmed/25551565,25551565|25551565,,
673,1998403,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of TNF protein]",,,PMID:35349355,https://www.ncbi.nlm.nih.gov/pubmed/35349355,35349355,,
674,1998518,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of TNF protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
675,1998519,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNF protein results in increased abundance of hydrogen peroxide]|ascorbic acid inhibits the reaction [TNF protein results in increased abundance of nitric oxide]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of ICAM1 protein],,,PMID:12723939,https://www.ncbi.nlm.nih.gov/pubmed/12723939,12723939,,
676,1998520,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TNF mrna|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TNF mrna]|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TNF protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TNF protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TNF mrna]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TNF protein",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
677,1998521,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [streptozocin results in increased expression of TNF protein],,,PMID:28259689,https://www.ncbi.nlm.nih.gov/pubmed/28259689,28259689,,
678,1998522,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),Ascorbic acid promotes the reaction [quartz results in increased expression of TNF mrna]|butylated hydroxytoluene inhibits the reaction [dextran sulfate promotes the reaction [ascorbic acid promotes the reaction [quartz results in increased secretion of TNF protein]]]|mannitol inhibits the reaction [ascorbic acid promotes the reaction [quartz results in increased secretion of TNF protein]]|ifng protein promotes the reaction [ascorbic acid promotes the reaction [quartz results in increased secretion of TNF protein]]|cat protein inhibits the reaction [ascorbic acid promotes the reaction [quartz results in increased secretion of TNF protein]]|ascorbic acid promotes the reaction [quartz results in increased secretion of TNF protein]|dextran sulfate promotes the reaction [ascorbic acid promotes the reaction [quartz results in increased secretion of TNF protein]],,,PMID:19298665,https://www.ncbi.nlm.nih.gov/pubmed/19298665,19298665,,
679,1998523,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [abamectin results in increased expression of TNF protein]|[ascorbic acid co-treated with sesame oil] inhibits the reaction [abamectin results in increased expression of TNF protein],,,PMID:31739238,https://www.ncbi.nlm.nih.gov/pubmed/31739238,31739238,,
680,1998524,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),"Ascorbic acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]|ascorbic acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF mrna]|ascorbic acid deficiency promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]",,,PMID:30606963,https://www.ncbi.nlm.nih.gov/pubmed/30606963,30606963,,
681,1998655,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in increased expression of TNF protein],,,PMID:22728154,https://www.ncbi.nlm.nih.gov/pubmed/22728154,22728154,,
682,1998656,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [norepinephrine results in increased secretion of TNF protein],,,PMID:15158148,https://www.ncbi.nlm.nih.gov/pubmed/15158148,15158148,,
683,1998657,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium arsenite results in increased expression of TNF protein],,,PMID:19429265,https://www.ncbi.nlm.nih.gov/pubmed/19429265,19429265,,
684,1998658,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium benzoate results in increased expression of TNF protein],,,PMID:35187746,https://www.ncbi.nlm.nih.gov/pubmed/35187746,35187746,,
685,1998659,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium fluoride results in increased expression of TNF protein],,,PMID:34089294,https://www.ncbi.nlm.nih.gov/pubmed/34089294,34089294,,
686,1998660,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8792,TNFRSF11A,https://ctdbase.org/detail.go?type=gene&acc=8792,,,8792.0,TNFRSF11A,9606,Homo sapiens (human),[ascorbic acid co-treated with TNFSF11 protein] results in decreased expression of TNFRSF11A mRNA,,,PMID:15730627,https://www.ncbi.nlm.nih.gov/pubmed/15730627,15730627,,
687,1998661,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4982,TNFRSF11B,https://ctdbase.org/detail.go?type=gene&acc=4982,,,4982.0,TNFRSF11B,9606,Homo sapiens (human),EZH2 protein inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of TNFRSF11B mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of TNFRSF11B mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
688,1998662,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4982,TNFRSF11B,https://ctdbase.org/detail.go?type=gene&acc=4982,,,4982.0,TNFRSF11B,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of TNFRSF11B mRNA,,,PMID:17664058,https://www.ncbi.nlm.nih.gov/pubmed/17664058,17664058,,
689,1998663,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8743,TNFSF10,https://ctdbase.org/detail.go?type=gene&acc=8743,,,8743.0,TNFSF10,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNFSF10 protein affects the localization of CYCS protein]|ascorbic acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP3 protein]|ascorbic acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein]|ascorbic acid inhibits the reaction [TNFSF10 protein results in increased chemical synthesis of reactive oxygen species]|ascorbic acid results in decreased susceptibility to TNFSF10 protein|ascorbic acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP9 protein],,,PMID:23711929,https://www.ncbi.nlm.nih.gov/pubmed/23711929,23711929,,
690,1998786,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8743,TNFSF10,https://ctdbase.org/detail.go?type=gene&acc=8743,,,8743.0,TNFSF10,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of TNFSF10 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
691,1998787,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8600,TNFSF11,https://ctdbase.org/detail.go?type=gene&acc=8600,,,8600.0,TNFSF11,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of and results in increased secretion of TNFSF11 protein,,,PMID:32156525,https://www.ncbi.nlm.nih.gov/pubmed/32156525,32156525,,
692,1998788,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8600,TNFSF11,https://ctdbase.org/detail.go?type=gene&acc=8600,,,8600.0,TNFSF11,9606,Homo sapiens (human),[ascorbic acid co-treated with TNFSF11 protein] results in decreased expression of TNFRSF11A mrna|[ascorbic acid co-treated with TNFSF11 protein] results in decreased expression of CAR2 mRNA,,,PMID:15730627,https://www.ncbi.nlm.nih.gov/pubmed/15730627,15730627,,
693,1998789,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8600,TNFSF11,https://ctdbase.org/detail.go?type=gene&acc=8600,,,8600.0,TNFSF11,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 mrna]|ascorbic acid inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 protein],,,PMID:15952411,https://www.ncbi.nlm.nih.gov/pubmed/15952411,15952411,,
694,1998790,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54543,TOMM7,https://ctdbase.org/detail.go?type=gene&acc=54543,,,54543.0,TOMM7,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of TOMM7 mrna|ascorbic acid results in decreased expression of TOMM7 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
695,1998791,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7153,TOP2A,https://ctdbase.org/detail.go?type=gene&acc=7153,,,7153.0,TOP2A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [wedelolactone results in decreased activity of TOP2A protein],,,PMID:22733624,https://www.ncbi.nlm.nih.gov/pubmed/22733624,22733624,,
696,1998792,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Nutlin 3 inhibits the reaction [[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein]|acetylcysteine inhibits the reaction [[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein]|[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein|benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of TP53 protein],,,PMID:20530418,https://www.ncbi.nlm.nih.gov/pubmed/20530418,20530418,,
697,1998793,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of TP53 protein],,,PMID:31388677,https://www.ncbi.nlm.nih.gov/pubmed/31388677,31388677,,
698,1998794,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [potassium bromate results in increased phosphorylation of TP53 protein],,,PMID:20067818,https://www.ncbi.nlm.nih.gov/pubmed/20067818,20067818,,
699,1998939,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [potassium chromate(vi) results in increased expression of TP53 protein]|ascorbic acid inhibits the reaction [potassium chromate(vi) results in increased expression of TP53 protein modified form],,,PMID:25977998,https://www.ncbi.nlm.nih.gov/pubmed/25977998,25977998,,
700,1998940,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [silicon dioxide results in increased expression of TP53 mrna]|ascorbic acid inhibits the reaction [silicon dioxide results in increased expression of TP53 protein],,,PMID:22245848,https://www.ncbi.nlm.nih.gov/pubmed/22245848,22245848,,
701,1998941,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [cisplatin results in increased expression of TP53 protein],,,PMID:21429301,https://www.ncbi.nlm.nih.gov/pubmed/21429301,21429301,,
702,1998942,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in increased phosphorylation of TP53 protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
703,1998943,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9669,Mustela putorius furo (domestic ferret),[beta carotene co-treated with alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of TP53 protein]|[beta carotene co-treated with alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TP53 protein],,,PMID:16401635,https://www.ncbi.nlm.nih.gov/pubmed/16401635,16401635,,
704,1998944,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,8022,Oncorhynchus mykiss (rainbow trout),[vitamin A co-treated with cholecalciferol co-treated with vitamin E co-treated with ascorbic acid] inhibits the reaction [[cyhalothrin co-treated with chlorantranilipole] results in increased expression of TP53 protein],,,PMID:36813254,https://www.ncbi.nlm.nih.gov/pubmed/36813254,36813254,,
705,1998945,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in increased expression of TP53 mrna]|ascorbic acid inhibits the reaction [potassium dichromate results in increased localization of TP53 protein modified form]|ascorbic acid inhibits the reaction [potassium dichromate results in increased expression of and results in increased phosphorylation of TP53 protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
706,1998946,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11257,TP53TG1,https://ctdbase.org/detail.go?type=gene&acc=11257,,,11257.0,TP53TG1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of TP53TG1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
707,1998947,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7178,TPT1,https://ctdbase.org/detail.go?type=gene&acc=7178,,,7178.0,TPT1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of TPT1 mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
708,1999128,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7200,TRH,https://ctdbase.org/detail.go?type=gene&acc=7200,,,7200.0,TRH,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of TRH mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
709,1999129,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,57761,TRIB3,https://ctdbase.org/detail.go?type=gene&acc=57761,,,57761.0,TRIB3,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of TRIB3 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
710,1999130,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,57761,TRIB3,https://ctdbase.org/detail.go?type=gene&acc=57761,,,57761.0,TRIB3,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of TRIB3 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
711,1999131,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10155,TRIM28,https://ctdbase.org/detail.go?type=gene&acc=10155,,,10155.0,TRIM28,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of TRIM28 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
712,1999132,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10155,TRIM28,https://ctdbase.org/detail.go?type=gene&acc=10155,,,10155.0,TRIM28,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [potassium chromate(vi) results in increased expression of TRIM28 protein modified form],,,PMID:25977998,https://www.ncbi.nlm.nih.gov/pubmed/25977998,25977998,,
713,1999133,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9322,TRIP10,https://ctdbase.org/detail.go?type=gene&acc=9322,,,9322.0,TRIP10,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of TRIP10 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
714,1999134,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22059,TRP53,https://ctdbase.org/detail.go?type=gene&acc=22059,,,22059.0,Trp53,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [glycidamide results in increased expression of TRP53 mrna],,,PMID:32632975,https://www.ncbi.nlm.nih.gov/pubmed/32632975,32632975,,
715,1999135,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22059,TRP53,https://ctdbase.org/detail.go?type=gene&acc=22059,,,22059.0,Trp53,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of TRP53 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
716,1999136,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7224,TRPC5,https://ctdbase.org/detail.go?type=gene&acc=7224,,,7224.0,TRPC5,9606,Homo sapiens (human),Resveratrol promotes the reaction [ascorbic acid inhibits the reaction [gadolinium promotes the reaction [TRPC5 protein results in increased transport of calcium]]]|ascorbic acid inhibits the reaction [gadolinium promotes the reaction [TRPC5 protein results in increased transport of calcium]]|ascorbic acid inhibits the reaction [hydrogen peroxide promotes the reaction [TRPC5 protein results in increased transport of calcium]],,,PMID:21127073,https://www.ncbi.nlm.nih.gov/pubmed/21127073,21127073,,
717,1999137,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7442,TRPV1,https://ctdbase.org/detail.go?type=gene&acc=7442,,,7442.0,TRPV1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of TRPV1 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
718,1999268,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,55503,TRPV6,https://ctdbase.org/detail.go?type=gene&acc=55503,,,55503.0,TRPV6,13489,Dicentrarchus labrax (European seabass),Ascorbic acid results in decreased expression of TRPV6 mRNA,,,PMID:21281732,https://www.ncbi.nlm.nih.gov/pubmed/21281732,21281732,,
719,1999269,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7252,TSHB,https://ctdbase.org/detail.go?type=gene&acc=7252,,,7252.0,TSHB,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of TSHB protein],,,PMID:16298753,https://www.ncbi.nlm.nih.gov/pubmed/16298753,16298753,,
720,1999270,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,706,TSPO,https://ctdbase.org/detail.go?type=gene&acc=706,,,706.0,TSPO,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of TSPO mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
721,1999271,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7276,TTR,https://ctdbase.org/detail.go?type=gene&acc=7276,,,7276.0,TTR,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TTR mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
722,1999272,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10381,TUBB3,https://ctdbase.org/detail.go?type=gene&acc=10381,,,10381.0,TUBB3,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of TUBB3 protein,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
723,1999273,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22166,TXN1,https://ctdbase.org/detail.go?type=gene&acc=22166,,,22166.0,Txn1,10116,Rattus norvegicus (Norway rat),[alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [arsenite results in increased expression of TXN1 protein],,,PMID:21344382,https://www.ncbi.nlm.nih.gov/pubmed/21344382,21344382,,
724,1999274,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22166,TXN1,https://ctdbase.org/detail.go?type=gene&acc=22166,,,22166.0,Txn1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of TXN1 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
725,1999275,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,25828,TXN2,https://ctdbase.org/detail.go?type=gene&acc=25828,,,25828.0,TXN2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of TXN2 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
726,1999276,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628.0,TXNIP,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of TXNIP mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
727,1999277,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7296,TXNRD1,https://ctdbase.org/detail.go?type=gene&acc=7296,,,7296.0,TXNRD1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TXNRD1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
728,1999450,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10587,TXNRD2,https://ctdbase.org/detail.go?type=gene&acc=10587,,,10587.0,TXNRD2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of TXNRD2 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
729,1999451,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7297,TYK2,https://ctdbase.org/detail.go?type=gene&acc=7297,,,7297.0,TYK2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of TYK2 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
730,1999452,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7299,TYR,https://ctdbase.org/detail.go?type=gene&acc=7299,,,7299.0,TYR,9606,Homo sapiens (human),Glutathione inhibits the reaction [[TYR protein results in increased oxidation of caffeic acid phenethyl ester] which results in increased oxidation of ascorbic acid]|ethylenediamine inhibits the reaction [[TYR protein results in increased oxidation of caffeic acid phenethyl ester] which results in increased oxidation of ascorbic acid]|[tyr protein results in increased oxidation of caffeic acid phenethyl ester] which results in increased oxidation of ascorbic acid,,,PMID:20685355,https://www.ncbi.nlm.nih.gov/pubmed/20685355,20685355,,
731,1999453,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7319,UBE2A,https://ctdbase.org/detail.go?type=gene&acc=7319,,,7319.0,UBE2A,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of UBE2A mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
732,1999454,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54575,UGT1A10,https://ctdbase.org/detail.go?type=gene&acc=54575,,,54575.0,UGT1A10,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of UGT1A10 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
733,1999455,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22236,UGT1A2,https://ctdbase.org/detail.go?type=gene&acc=22236,,,22236.0,Ugt1a2,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of UGT1A2 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
734,1999456,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54578,UGT1A6,https://ctdbase.org/detail.go?type=gene&acc=54578,,,54578.0,UGT1A6,10116,Rattus norvegicus (Norway rat),UGT1A6 protein affects the reaction [methylcholanthrene results in increased abundance of ascorbic acid],,,PMID:8263600,https://www.ncbi.nlm.nih.gov/pubmed/8263600,8263600,,
735,1999457,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54600,UGT1A9,https://ctdbase.org/detail.go?type=gene&acc=54600,,,54600.0,UGT1A9,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of UGT1A9 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
736,1999458,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,79799,UGT2A3,https://ctdbase.org/detail.go?type=gene&acc=79799,,,79799.0,UGT2A3,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of UGT2A3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
737,1999617,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7366,UGT2B15,https://ctdbase.org/detail.go?type=gene&acc=7366,,,7366.0,UGT2B15,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of UGT2B15 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
738,1999618,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7367,UGT2B17,https://ctdbase.org/detail.go?type=gene&acc=7367,,,7367.0,UGT2B17,10116,Rattus norvegicus (Norway rat),UGT2B17 protein affects the reaction [phenobarbital results in increased abundance of ascorbic acid],,,PMID:8263600,https://www.ncbi.nlm.nih.gov/pubmed/8263600,8263600,,
739,1999619,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,29128,UHRF1,https://ctdbase.org/detail.go?type=gene&acc=29128,,,29128.0,UHRF1,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of UHRF1 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
740,1999620,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,115426,UHRF2,https://ctdbase.org/detail.go?type=gene&acc=115426,,,115426.0,UHRF2,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of UHRF2 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
741,1999621,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7374,UNG,https://ctdbase.org/detail.go?type=gene&acc=7374,,,7374.0,UNG,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of UNG mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
742,1999622,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7389,UROD,https://ctdbase.org/detail.go?type=gene&acc=7389,,,7389.0,UROD,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of UROD mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
743,1999623,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of VCAM1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
744,1999624,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of VCAM1 protein]",,,PMID:35349355,https://www.ncbi.nlm.nih.gov/pubmed/35349355,35349355,,
745,1999625,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of VCAM1 protein]|ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of VCAM1 mrna],,,PMID:25305479,https://www.ncbi.nlm.nih.gov/pubmed/25305479,25305479,,
746,1999626,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of VCAM1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
747,1999806,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7416,VDAC1,https://ctdbase.org/detail.go?type=gene&acc=7416,,,7416.0,VDAC1,9606,Homo sapiens (human),VDAC1 protein results in increased susceptibility to [arsenic trioxide co-treated with ascorbic acid co-treated with disulfiram],,,PMID:24126434,https://www.ncbi.nlm.nih.gov/pubmed/24126434,24126434,,
748,1999807,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,564511,VDRB,https://ctdbase.org/detail.go?type=gene&acc=564511,,,564511.0,vdrb,13489,Dicentrarchus labrax (European seabass),Ascorbic acid results in decreased expression of VDRB mRNA,,,PMID:21281732,https://www.ncbi.nlm.nih.gov/pubmed/21281732,21281732,,
749,1999808,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606,Homo sapiens (human),[ascorbic acid co-treated with quartz] results in increased expression of VEGFA mRNA,,,PMID:27381660,https://www.ncbi.nlm.nih.gov/pubmed/27381660,27381660,,
750,1999809,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased expression of VEGFA mRNA,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
751,1999810,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,51442,VGLL1,https://ctdbase.org/detail.go?type=gene&acc=51442,,,51442.0,VGLL1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of VGLL1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
752,1999811,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7428,VHL,https://ctdbase.org/detail.go?type=gene&acc=7428,,,7428.0,VHL,9606,Homo sapiens (human),Manganese chloride inhibits the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with ketoglutaric acids co-treated with ascorbic acid co-treated with ferrous chloride] promotes the reaction [VHL protein binds to HIF1A protein]]|[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with ketoglutaric acids co-treated with ascorbic acid co-treated with ferrous chloride] promotes the reaction [VHL protein binds to HIF1A protein],,,PMID:19263519,https://www.ncbi.nlm.nih.gov/pubmed/19263519,19263519,,
753,1999812,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431.0,VIM,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of VIM mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
754,1999813,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7432,VIP,https://ctdbase.org/detail.go?type=gene&acc=7432,,,7432.0,VIP,10116,Rattus norvegicus (Norway rat),Ascorbic acid affects the expression of VIP protein,,,PMID:22127604,https://www.ncbi.nlm.nih.gov/pubmed/22127604,22127604,,
755,1999814,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,55350,VNN3P,https://ctdbase.org/detail.go?type=gene&acc=55350,,,55350.0,VNN3P,9606,Homo sapiens (human),Ascorbic acid deficiency results in increased expression of VNN3P mrna|ascorbic acid affects the expression of VNN3P mRNA,,,PMID:19932582,https://www.ncbi.nlm.nih.gov/pubmed/19932582,19932582,,
756,1999815,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,27072,VPS41,https://ctdbase.org/detail.go?type=gene&acc=27072,,,27072.0,VPS41,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of VPS41 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
757,1999984,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7443,VRK1,https://ctdbase.org/detail.go?type=gene&acc=7443,,,7443.0,VRK1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of VRK1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
758,1999985,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7448,VTN,https://ctdbase.org/detail.go?type=gene&acc=7448,,,7448.0,VTN,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of VTN mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
759,1999986,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7448,VTN,https://ctdbase.org/detail.go?type=gene&acc=7448,,,7448.0,VTN,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of VTN mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
760,1999987,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7453,WARS1,https://ctdbase.org/detail.go?type=gene&acc=7453,,,7453.0,WARS1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of WARS1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
761,1999988,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10352,WARS2,https://ctdbase.org/detail.go?type=gene&acc=10352,,,10352.0,WARS2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of WARS2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
762,1999989,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7481,WNT11,https://ctdbase.org/detail.go?type=gene&acc=7481,,,7481.0,WNT11,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of WNT11 mrna|cadmium sulfate inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of WNT11 mrna],,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
763,1999990,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,89780,WNT3A,https://ctdbase.org/detail.go?type=gene&acc=89780,,,89780.0,WNT3A,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of KEAP1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPX2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGG mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of PLN mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HAVCR1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GATA6 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TF mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ZFAND2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ISL1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ESRG mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXB3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ASCL1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TFAP2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of CYP24A1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CEACAM6 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FLT1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SERPINA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of APOA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of RRAD mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of VCAM1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLM mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SRXN1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of H2BC14 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MPZL1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FOXG1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of UGT2A3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of POU5F1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TM4SF4 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTO1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX2 mrna|[[ascorbic acid co-treate,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
764,1999991,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,25937,WWTR1,https://ctdbase.org/detail.go?type=gene&acc=25937,,,25937.0,WWTR1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of WWTR1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
765,1999992,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7498,XDH,https://ctdbase.org/detail.go?type=gene&acc=7498,,,7498.0,XDH,9913,Bos taurus (cattle),Ascorbic acid results in decreased activity of XDH protein,,,PMID:35395231,https://www.ncbi.nlm.nih.gov/pubmed/35395231,35395231,,
766,1999993,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7498,XDH,https://ctdbase.org/detail.go?type=gene&acc=7498,,,7498.0,XDH,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased activity of XDH protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
767,2000171,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7512,XPNPEP2,https://ctdbase.org/detail.go?type=gene&acc=7512,,,7512.0,XPNPEP2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of XPNPEP2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
768,2000172,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7515,XRCC1,https://ctdbase.org/detail.go?type=gene&acc=7515,,,7515.0,XRCC1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [reactive oxygen species results in decreased expression of XRCC1 protein]|ascorbic acid inhibits the reaction [fenretinide results in decreased expression of XRCC1 protein],,,PMID:16124896,https://www.ncbi.nlm.nih.gov/pubmed/16124896,16124896,,
769,2000173,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7515,XRCC1,https://ctdbase.org/detail.go?type=gene&acc=7515,,,7515.0,XRCC1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [XRCC1 mutant form results in increased susceptibility to chromium hexavalent ion],,,PMID:22241526,https://www.ncbi.nlm.nih.gov/pubmed/22241526,22241526,,
770,2000174,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7531,YWHAE,https://ctdbase.org/detail.go?type=gene&acc=7531,,,7531.0,YWHAE,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of YWHAE protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
771,2000175,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,51201,ZDHHC2,https://ctdbase.org/detail.go?type=gene&acc=51201,,,51201.0,ZDHHC2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of ZDHHC2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
772,2000176,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,90637,ZFAND2A,https://ctdbase.org/detail.go?type=gene&acc=90637,,,90637.0,ZFAND2A,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ZFAND2A mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
773,2000177,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,7718,ZNF165,https://ctdbase.org/detail.go?type=gene&acc=7718,,,7718.0,ZNF165,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of ZNF165 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
774,2010921,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,DCN,https://www.dgidb.org/genes/hgnc:2705,,,1634.0,DCN,9606,Homo sapiens (human),,,,,,,,
775,2010922,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,CYP19A1,https://www.dgidb.org/genes/hgnc:2594,,,1588.0,CYP19A1,9606,Homo sapiens (human),,,,,,,,
776,2018661,54670067,Therapeutic Target Database (TTD),Ascorbic Acid,D07AHW,Vitamin C,https://idrblab.net/ttd/data/drug/details/D07AHW,T08378,Solute carrier family 23 member 2 (SLC23A2),https://idrblab.net/ttd/data/target/details/T08378,Q9UGH3,Solute carrier family 23 member 2,9962.0,SLC23A2,9606,Homo sapiens (human),Modulator,,,,,,,
777,2018662,54670067,Therapeutic Target Database (TTD),Ascorbic Acid,D07AHW,Vitamin C,https://idrblab.net/ttd/data/drug/details/D07AHW,T37382,Solute carrier family 23 member 1 (SLC23A1),https://idrblab.net/ttd/data/target/details/T37382,Q9UHI7,Solute carrier family 23 member 1,9963.0,SLC23A1,9606,Homo sapiens (human),Modulator,,,,,,,
778,2018663,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,LPO,https://www.dgidb.org/genes/hgnc:6678,,,4025.0,LPO,9606,Homo sapiens (human),,,,,,,,
779,2018664,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,G6PD,https://www.dgidb.org/genes/hgnc:4057,,,2539.0,G6PD,9606,Homo sapiens (human),,,,,,,,
780,2018665,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,AGTR1,https://www.dgidb.org/genes/hgnc:336,,,185.0,AGTR1,9606,Homo sapiens (human),,,,,,,,
781,2018666,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,ARSB,https://www.dgidb.org/genes/hgnc:714,,,411.0,ARSB,9606,Homo sapiens (human),,,,,,,,
782,2027273,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,SLC23A1,https://www.dgidb.org/genes/hgnc:10974,,,9963.0,SLC23A1,9606,Homo sapiens (human),,,,,,,,
783,2027274,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,SLC23A2,https://www.dgidb.org/genes/hgnc:10973,,,9962.0,SLC23A2,9606,Homo sapiens (human),,,,,,,,
784,2034105,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,COL18A1,https://www.dgidb.org/genes/hgnc:2195,,,80781.0,COL18A1,9606,Homo sapiens (human),,,,,,,,
785,2034106,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,HSPA4,https://www.dgidb.org/genes/hgnc:5237,,,3308.0,HSPA4,9606,Homo sapiens (human),,,,,,,,
786,2034538,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002192,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",https://www.drugbank.ca/bio_entities/BE0002192,O00469,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",5352.0,PLOD2,9606,Homo sapiens (human),Cofactor,,,PMID:9344473,https://www.ncbi.nlm.nih.gov/pubmed/9344473,9344473,,
787,2034539,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002117,"Phytanoyl-CoA dioxygenase, peroxisomal",https://www.drugbank.ca/bio_entities/BE0002117,O14832,"Phytanoyl-CoA dioxygenase, peroxisomal",5264.0,PHYH,9606,Homo sapiens (human),Cofactor,,,PMID:11555634,https://www.ncbi.nlm.nih.gov/pubmed/11555634,11555634,,
788,2034540,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002195,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",https://www.drugbank.ca/bio_entities/BE0002195,O60568,Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3,8985.0,PLOD3,9606,Homo sapiens (human),Cofactor,,,PMID:9344473,https://www.ncbi.nlm.nih.gov/pubmed/9344473,9344473,,
789,2034541,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002197,Gamma-butyrobetaine dioxygenase,https://www.drugbank.ca/bio_entities/BE0002197,O75936,Gamma-butyrobetaine dioxygenase,8424.0,BBOX1,9606,Homo sapiens (human),Cofactor,,,PMID:1962562|PMID:10709635|PMID:6432788,https://www.ncbi.nlm.nih.gov/pubmed/1962562|https://www.ncbi.nlm.nih.gov/pubmed/10709635|https://www.ncbi.nlm.nih.gov/pubmed/6432788,1962562|10709635|6432788,,
790,2034542,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0000138,Dopamine beta-hydroxylase,https://www.drugbank.ca/bio_entities/BE0000138,P09172,Dopamine beta-hydroxylase,1621.0,DBH,9606,Homo sapiens (human),Cofactor,,,PMID:9505234|PMID:3097015|PMID:10947967|PMID:1894598,https://www.ncbi.nlm.nih.gov/pubmed/9505234|https://www.ncbi.nlm.nih.gov/pubmed/3097015|https://www.ncbi.nlm.nih.gov/pubmed/10947967|https://www.ncbi.nlm.nih.gov/pubmed/1894598,9505234|3097015|10947967|1894598,,
791,2034721,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002200,Peptidyl-glycine alpha-amidating monooxygenase,https://www.drugbank.ca/bio_entities/BE0002200,P19021,Peptidyl-glycine alpha-amidating monooxygenase,5066.0,PAM,9606,Homo sapiens (human),Cofactor,,,PMID:17570561|PMID:16773376|PMID:9211255|PMID:17002377,https://www.ncbi.nlm.nih.gov/pubmed/17570561|https://www.ncbi.nlm.nih.gov/pubmed/16773376|https://www.ncbi.nlm.nih.gov/pubmed/9211255|https://www.ncbi.nlm.nih.gov/pubmed/17002377,17570561|16773376|9211255|17002377,,
792,2034722,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002202,Prolyl 3-hydroxylase 1,https://www.drugbank.ca/bio_entities/BE0002202,Q32P28,Prolyl 3-hydroxylase 1,64175.0,P3H1,9606,Homo sapiens (human),Cofactor,,,PMID:29289682,https://www.ncbi.nlm.nih.gov/pubmed/29289682,29289682,,
793,2034723,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002206,Prolyl 3-hydroxylase 2,https://www.drugbank.ca/bio_entities/BE0002206,Q8IVL5,Prolyl 3-hydroxylase 2,55214.0,P3H2,9606,Homo sapiens (human),Cofactor,,,PMID:29289682,https://www.ncbi.nlm.nih.gov/pubmed/29289682,29289682,,
794,2034724,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002208,Prolyl 3-hydroxylase 3,https://www.drugbank.ca/bio_entities/BE0002208,Q8IVL6,Prolyl 3-hydroxylase 3,10536.0,P3H3,9606,Homo sapiens (human),Cofactor,,,PMID:29289682,https://www.ncbi.nlm.nih.gov/pubmed/29289682,29289682,,
795,2034725,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0000060,Prolyl 4-hydroxylase subunit alpha-1,https://www.drugbank.ca/bio_entities/BE0000060,P13674,Prolyl 4-hydroxylase subunit alpha-1,5033.0,P4HA1,9606,Homo sapiens (human),Cofactor,,,PMID:29289682,https://www.ncbi.nlm.nih.gov/pubmed/29289682,29289682,,
796,2034726,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002210,Prolyl 3-hydroxylase OGFOD1,https://www.drugbank.ca/bio_entities/BE0002210,Q8N543,Prolyl 3-hydroxylase OGFOD1,55239.0,OGFOD1,9606,Homo sapiens (human),Cofactor,,,PMID:25540771,https://www.ncbi.nlm.nih.gov/pubmed/25540771,25540771,,
797,2034727,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002203,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2,https://www.drugbank.ca/bio_entities/BE0002203,Q6N063,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2,79676.0,OGFOD2,9606,Homo sapiens (human),Cofactor,,,PMID:25540771,https://www.ncbi.nlm.nih.gov/pubmed/25540771,25540771,,
798,2034728,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002205,DNA oxidative demethylase ALKBH2,https://www.drugbank.ca/bio_entities/BE0002205,Q6NS38,DNA oxidative demethylase ALKBH2,121642.0,ALKBH2,9606,Homo sapiens (human),Activator,,,PMID:12486230,https://www.ncbi.nlm.nih.gov/pubmed/12486230,12486230,,
799,2034729,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002213,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3,https://www.drugbank.ca/bio_entities/BE0002213,Q96Q83,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3,221120.0,ALKBH3,9606,Homo sapiens (human),Activator,,,PMID:12486230,https://www.ncbi.nlm.nih.gov/pubmed/12486230,12486230,,
800,2034730,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002215,Lysine-specific demethylase 5D,https://www.drugbank.ca/bio_entities/BE0002215,Q9BY66,Lysine-specific demethylase 5D,8284.0,KDM5D,9606,Homo sapiens (human),Cofactor,,,PMID:17320162,https://www.ncbi.nlm.nih.gov/pubmed/17320162,17320162,,
801,2034906,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0000087,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",https://www.drugbank.ca/bio_entities/BE0000087,Q02809,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",5351.0,PLOD1,9606,Homo sapiens (human),Cofactor,,,PMID:17100196|PMID:11752352|PMID:9344473,https://www.ncbi.nlm.nih.gov/pubmed/17100196|https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/9344473,17100196|11752352|9344473,,
802,2034907,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002221,"Trimethyllysine dioxygenase, mitochondrial",https://www.drugbank.ca/bio_entities/BE0002221,Q9NVH6,"Trimethyllysine dioxygenase, mitochondrial",55217.0,TMLHE,9606,Homo sapiens (human),Cofactor,,,PMID:17944936,https://www.ncbi.nlm.nih.gov/pubmed/17944936,17944936,,
803,2034908,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002223,Transmembrane prolyl 4-hydroxylase,https://www.drugbank.ca/bio_entities/BE0002223,Q9NXG6,Transmembrane prolyl 4-hydroxylase,54681.0,P4HTM,9606,Homo sapiens (human),Cofactor,,,PMID:27183028,https://www.ncbi.nlm.nih.gov/pubmed/27183028,27183028,,
804,2034909,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002217,Egl nine homolog 1,https://www.drugbank.ca/bio_entities/BE0002217,Q9GZT9,Egl nine homolog 1,54583.0,EGLN1,9606,Homo sapiens (human),Cofactor,,,PMID:29567393,https://www.ncbi.nlm.nih.gov/pubmed/29567393,29567393,,
805,2034910,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002211,Egl nine homolog 2,https://www.drugbank.ca/bio_entities/BE0002211,Q96KS0,Prolyl hydroxylase EGLN2,112398.0,EGLN2,9606,Homo sapiens (human),Cofactor,,,PMID:29567393|PMID:17627521|PMID:17627474,https://www.ncbi.nlm.nih.gov/pubmed/29567393|https://www.ncbi.nlm.nih.gov/pubmed/17627521|https://www.ncbi.nlm.nih.gov/pubmed/17627474,29567393|17627521|17627474,,
806,2034911,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0002219,Egl nine homolog 3,https://www.drugbank.ca/bio_entities/BE0002219,Q9H6Z9,Prolyl hydroxylase EGLN3,112399.0,EGLN3,9606,Homo sapiens (human),Cofactor,,,PMID:29567393,https://www.ncbi.nlm.nih.gov/pubmed/29567393,29567393,,
807,2034912,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0001979,"Thioredoxin reductase 1, cytoplasmic",https://www.drugbank.ca/bio_entities/BE0001979,Q16881,"Thioredoxin reductase 1, cytoplasmic",7296.0,TXNRD1,9606,Homo sapiens (human),Substrate,,,PMID:26779027,https://www.ncbi.nlm.nih.gov/pubmed/26779027,26779027,,
808,2034913,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0000168,Solute carrier family 23 member 1,https://www.drugbank.ca/bio_entities/BE0000168,Q9UHI7,Solute carrier family 23 member 1,9963.0,SLC23A1,9606,Homo sapiens (human),Substrate,,,PMID:17541511|PMID:17258485|PMID:17664139|PMID:17008880|PMID:16011461|PMID:17645691|PMID:10331392,https://www.ncbi.nlm.nih.gov/pubmed/17541511|https://www.ncbi.nlm.nih.gov/pubmed/17258485|https://www.ncbi.nlm.nih.gov/pubmed/17664139|https://www.ncbi.nlm.nih.gov/pubmed/17008880|https://www.ncbi.nlm.nih.gov/pubmed/16011461|https://www.ncbi.nlm.nih.gov/pubmed/17645691|https://www.ncbi.nlm.nih.gov/pubmed/10331392,17541511|17258485|17664139|17008880|16011461|17645691|10331392,,
809,2034914,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0009869,Solute carrier family 23 member 2,https://www.drugbank.ca/bio_entities/BE0009869,Q9UGH3,Solute carrier family 23 member 2,9962.0,SLC23A2,9606,Homo sapiens (human),Substrate,,,PMID:16011461,https://www.ncbi.nlm.nih.gov/pubmed/16011461,16011461,,
810,2034915,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0001057,"Solute carrier family 2, facilitated glucose transporter member 1",https://www.drugbank.ca/bio_entities/BE0001057,P11166,"Solute carrier family 2, facilitated glucose transporter member 1",6513.0,SLC2A1,9606,Homo sapiens (human),Substrate,,,PMID:16011461,https://www.ncbi.nlm.nih.gov/pubmed/16011461,16011461,,
811,2035061,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0004707,"Solute carrier family 2, facilitated glucose transporter member 3",https://www.drugbank.ca/bio_entities/BE0004707,P11169,"Solute carrier family 2, facilitated glucose transporter member 3",6515.0,SLC2A3,9606,Homo sapiens (human),Substrate,,,PMID:16011461,https://www.ncbi.nlm.nih.gov/pubmed/16011461,16011461,,
812,2035062,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0000893,"Solute carrier family 2, facilitated glucose transporter member 4",https://www.drugbank.ca/bio_entities/BE0000893,P14672,"Solute carrier family 2, facilitated glucose transporter member 4",6517.0,SLC2A4,9606,Homo sapiens (human),Substrate,,,PMID:16011461,https://www.ncbi.nlm.nih.gov/pubmed/16011461,16011461,,
813,2035063,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606,Homo sapiens (human),Binder,,,PMID:6735617|PMID:12090938,https://www.ncbi.nlm.nih.gov/pubmed/6735617|https://www.ncbi.nlm.nih.gov/pubmed/12090938,6735617|12090938,,
814,2035064,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0001361,Hyaluronate lyase,https://www.drugbank.ca/bio_entities/BE0001361,Q54873,Hyaluronate lyase,,,170187,Streptococcus pneumoniae TIGR4,Inhibitor,,,PMID:14567553|PMID:15322107|PMID:11278838,https://www.ncbi.nlm.nih.gov/pubmed/14567553|https://www.ncbi.nlm.nih.gov/pubmed/15322107|https://www.ncbi.nlm.nih.gov/pubmed/11278838,14567553|15322107|11278838,,
815,2035065,54670067,DrugBank,Ascorbic Acid,DB00126,Ascorbic acid,https://www.drugbank.ca/drugs/DB00126,BE0001225,Xylose isomerase,https://www.drugbank.ca/bio_entities/BE0001225,P24300,Xylose isomerase,,,1929,Streptomyces rubiginosus,Substrate,,,PMID:11278838,https://www.ncbi.nlm.nih.gov/pubmed/11278838,11278838,,
816,2048363,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,AQP1,https://www.dgidb.org/genes/hgnc:633,,,358.0,AQP1,9606,Homo sapiens (human),,,,,,,,
817,2052022,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,HSPB1,https://www.dgidb.org/genes/hgnc:5246,,,3315.0,HSPB1,9606,Homo sapiens (human),,,,,,,,
818,2063141,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,G6PD,https://www.dgidb.org/genes/hgnc:4057,,,2539.0,G6PD,9606,Homo sapiens (human),,,,,,,,
819,2063142,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,TXNRD1,https://www.dgidb.org/genes/hgnc:12437,,,7296.0,TXNRD1,9606,Homo sapiens (human),,,,,,,,
820,2063143,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,PLOD1,https://www.dgidb.org/genes/hgnc:9081,,,5351.0,PLOD1,9606,Homo sapiens (human),,,,,,,,
821,2096637,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,UGT1A9,https://www.dgidb.org/genes/hgnc:12541,,,54600.0,UGT1A9,9606,Homo sapiens (human),,,,,,,,
822,2096638,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,PLA2G2A,https://www.dgidb.org/genes/hgnc:9031,,,5320.0,PLA2G2A,9606,Homo sapiens (human),,,,,,,,
823,2099313,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9913,Bos taurus (cattle),Ascorbic acid inhibits the reaction [ANFT binds to ALB protein],,,PMID:2121382,https://www.ncbi.nlm.nih.gov/pubmed/2121382,2121382,,
824,2099314,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22859,ADGRL1,https://ctdbase.org/detail.go?type=gene&acc=22859,,,22859.0,ADGRL1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of ADGRL1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
825,2099315,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,16,AARS1,https://ctdbase.org/detail.go?type=gene&acc=16,,,16.0,AARS1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of AARS1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
826,2099316,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2,A2M,https://ctdbase.org/detail.go?type=gene&acc=2,,,2.0,A2M,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of A2M mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
827,2099317,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),[zinc co-treated with vitamin E co-treated with ascorbic acid] inhibits the reaction [sodium arsenite results in increased activity of ACHE protein],,,PMID:23619517,https://www.ncbi.nlm.nih.gov/pubmed/23619517,23619517,,
828,2099318,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2182,ACSL4,https://ctdbase.org/detail.go?type=gene&acc=2182,,,2182.0,ACSL4,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of ACSL4 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
829,2099319,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,51703,ACSL5,https://ctdbase.org/detail.go?type=gene&acc=51703,,,51703.0,ACSL5,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ACSL5 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
830,2099320,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of ACTA2 protein],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
831,2099443,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,9606,Homo sapiens (human),[ascorbic acid co-treated with TGFB1 protein] results in increased expression of ACTA2 protein|[ascorbic acid co-treated with TGFB1 protein] results in increased expression of ACTA2 mRNA,,,PMID:18607632,https://www.ncbi.nlm.nih.gov/pubmed/18607632,18607632,,
832,2099444,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [quartz results in increased expression of ACTA2 mrna],,,PMID:27381660,https://www.ncbi.nlm.nih.gov/pubmed/27381660,27381660,,
833,2099445,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,9606,Homo sapiens (human),[mercaptoethanol co-treated with ascorbic acid] results in increased expression of ACTA2 protein,,,PMID:17053324,https://www.ncbi.nlm.nih.gov/pubmed/17053324,17053324,,
834,2099446,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,9606,Homo sapiens (human),[LG 100268 co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna|diazepinylbenzoic acid inhibits the reaction [[LG 100268 co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of ABCA1 mrna|[rosiglitazone co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 protein|[bexarotene co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 protein|diazepinylbenzoic acid inhibits the reaction [[tributyltin co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna]|[tributyltin co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 protein|[tributyltin co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mrna|[diazepinylbenzoic acid co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in decreased expression of ABCA1 mrna|[t0901317 co-treated with [ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein]] results in increased expression of ABCA1 mRNA,,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
835,2099447,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of ABCA1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
836,2099448,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCB1 mrna]",,,PMID:22914566,https://www.ncbi.nlm.nih.gov/pubmed/22914566,22914566,,
837,2099449,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,18671,ABCB1A,https://ctdbase.org/detail.go?type=gene&acc=18671,,,18671.0,Abcb1a,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [abamectin results in increased expression of ABCB1A mrna]|[ascorbic acid co-treated with sesame oil] inhibits the reaction [abamectin results in increased expression of ABCB1A mrna],,,PMID:31739238,https://www.ncbi.nlm.nih.gov/pubmed/31739238,31739238,,
838,2099585,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ABCC1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
839,2099586,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC1 mrna]",,,PMID:22914566,https://www.ncbi.nlm.nih.gov/pubmed/22914566,22914566,,
840,2099587,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [3',4',7-trihydroxyisoflavone results in decreased expression of ABCC2 mrna]",,,PMID:22914566,https://www.ncbi.nlm.nih.gov/pubmed/22914566,22914566,,
841,2099588,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]]|ascorbic acid promotes the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]",,,PMID:19326901,https://www.ncbi.nlm.nih.gov/pubmed/19326901,19326901,,
842,2099589,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [fructose results in decreased expression of ABCC2 protein]|ascorbic acid inhibits the reaction [fructose results in decreased expression of ABCC2 mrna],,,PMID:31005848,https://www.ncbi.nlm.nih.gov/pubmed/31005848,31005848,,
843,2099590,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,176,ACAN,https://ctdbase.org/detail.go?type=gene&acc=176,,,176.0,ACAN,9606,Homo sapiens (human),[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ACAN mrna|resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ACAN mrna]]|il1b protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ACAN mrna],,,PMID:26526931,https://www.ncbi.nlm.nih.gov/pubmed/26526931,26526931,,
844,2099591,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [epigallocatechin gallate results in decreased activity of ACE protein],,,PMID:28544013,https://www.ncbi.nlm.nih.gov/pubmed/28544013,28544013,,
845,2099592,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,59272,ACE2,https://ctdbase.org/detail.go?type=gene&acc=59272,,,59272.0,ACE2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of ACE2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
846,2099593,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [glucose results in decreased activity of ACHE protein],,,PMID:26163454,https://www.ncbi.nlm.nih.gov/pubmed/26163454,26163454,,
847,2099746,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10090,Mus musculus (house mouse),Ascorbic acid results in decreased activity of ACHE protein,,,PMID:16822217,https://www.ncbi.nlm.nih.gov/pubmed/16822217,16822217,,
848,2099747,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10090,Mus musculus (house mouse),Hexachlorocyclohexane inhibits the reaction [[resveratrol co-treated with ascorbic acid co-treated with thioctic acid co-treated with vitamin E] results in increased activity of ACHE protein]|[resveratrol co-treated with ascorbic acid co-treated with thioctic acid co-treated with vitamin E] results in increased activity of ACHE protein,,,PMID:20663516,https://www.ncbi.nlm.nih.gov/pubmed/20663516,20663516,,
849,2099748,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased activity of ACHE protein],,,PMID:16248992,https://www.ncbi.nlm.nih.gov/pubmed/16248992,16248992,,
850,2099749,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [scopolamine results in decreased activity of ACHE protein],,,PMID:11814146,https://www.ncbi.nlm.nih.gov/pubmed/11814146,11814146,,
851,2099750,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium benzoate results in increased activity of ACHE protein],,,PMID:35187746,https://www.ncbi.nlm.nih.gov/pubmed/35187746,35187746,,
852,2099751,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased activity of ACHE protein,,,PMID:19703495,https://www.ncbi.nlm.nih.gov/pubmed/19703495,19703495,,
853,2099752,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),[dexamethasone co-treated with ascorbic acid] results in increased expression of ACHE mrna|[dexamethasone co-treated with ascorbic acid] results in increased expression of and results in increased activity of ACHE protein,,,PMID:27019979,https://www.ncbi.nlm.nih.gov/pubmed/27019979,27019979,,
854,2099753,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with ferrous sulfate] results in increased expression of ACTA2 protein,,,PMID:7593635,https://www.ncbi.nlm.nih.gov/pubmed/7593635,7593635,,
855,2099754,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,88,ACTN2,https://ctdbase.org/detail.go?type=gene&acc=88,,,88.0,ACTN2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ACTN2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
856,2099755,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,112,ADCY6,https://ctdbase.org/detail.go?type=gene&acc=112,,,112.0,ADCY6,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of ADCY6 mRNA,,,PMID:17303424,https://www.ncbi.nlm.nih.gov/pubmed/17303424,17303424,,
857,2099849,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,174,AFP,https://ctdbase.org/detail.go?type=gene&acc=174,,,174.0,AFP,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of AFP mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
858,2099850,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,174,AFP,https://ctdbase.org/detail.go?type=gene&acc=174,,,174.0,AFP,8022,Oncorhynchus mykiss (rainbow trout),[vitamin A co-treated with cholecalciferol co-treated with vitamin E co-treated with ascorbic acid] inhibits the reaction [[cyhalothrin co-treated with chlorantranilipole] results in increased expression of AFP protein],,,PMID:36813254,https://www.ncbi.nlm.nih.gov/pubmed/36813254,36813254,,
859,2099851,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,27161,AGO2,https://ctdbase.org/detail.go?type=gene&acc=27161,,,27161.0,AGO2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of AGO2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
860,2099852,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,9606,Homo sapiens (human),[ascorbic acid co-treated with copper sulfate] promotes the reaction [AGT protein modified form results in increased chemical synthesis of [pyruvamide binds to AGT protein modified form]]|losartan inhibits the reaction [[AGT protein modified form co-treated with ascorbic acid co-treated with copper sulfate] results in increased chemical synthesis of [4-hydroxy-2-nonenal binds to AGT protein modified form]]|losartan inhibits the reaction [[AGT protein modified form co-treated with ascorbic acid co-treated with copper sulfate] results in increased chemical synthesis of [pyruvamide binds to AGT protein modified form]]|[ascorbic acid co-treated with copper sulfate] promotes the reaction [AGT protein modified form results in increased chemical synthesis of [4-hydroxy-2-nonenal binds to AGT protein modified form]],,,PMID:31144504,https://www.ncbi.nlm.nih.gov/pubmed/31144504,31144504,,
861,2099853,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [linoleic acid hydroperoxide results in increased lipidation of AGT protein modified form],,,PMID:26111765,https://www.ncbi.nlm.nih.gov/pubmed/26111765,26111765,,
862,2099854,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [AGT protein modified form results in decreased hydroxylation of HIF1A protein]|ascorbic acid inhibits the reaction [AGT protein modified form results in increased expression of TIMP1 protein],,,PMID:20881940,https://www.ncbi.nlm.nih.gov/pubmed/20881940,20881940,,
863,2099855,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,205,AK4,https://ctdbase.org/detail.go?type=gene&acc=205,,,205.0,AK4,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of AK4 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
864,2099856,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10327,AKR1A1,https://ctdbase.org/detail.go?type=gene&acc=10327,,,10327.0,AKR1A1,10090,Mus musculus (house mouse),AKR1A1 gene mutant form results in decreased abundance of ascorbic acid|akr1a1 gene mutant form promotes the reaction [diethylnitrosamine results in decreased abundance of ascorbic acid]|[akr1a1 gene mutant form results in increased susceptibility to diethylnitrosamine] which results in decreased abundance of ascorbic acid,,,PMID:32805337,https://www.ncbi.nlm.nih.gov/pubmed/32805337,32805337,,
865,2099982,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,231,AKR1B1,https://ctdbase.org/detail.go?type=gene&acc=231,,,231.0,AKR1B1,9606,Homo sapiens (human),Ascorbic acid results in increased reduction of AKR1B1 protein modified form,,,PMID:19061876,https://www.ncbi.nlm.nih.gov/pubmed/19061876,19061876,,
866,2099983,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,57016,AKR1B10,https://ctdbase.org/detail.go?type=gene&acc=57016,,,57016.0,AKR1B10,9606,Homo sapiens (human),Ascorbic acid results in increased expression of AKR1B10 mRNA,,,PMID:26198647,https://www.ncbi.nlm.nih.gov/pubmed/26198647,26198647,,
867,2099984,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1646,AKR1C2,https://ctdbase.org/detail.go?type=gene&acc=1646,,,1646.0,AKR1C2,9606,Homo sapiens (human),Ascorbic acid results in increased expression of AKR1C2 mRNA,,,PMID:26198647,https://www.ncbi.nlm.nih.gov/pubmed/26198647,26198647,,
868,2099985,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in decreased phosphorylation of AKT1 protein],,,PMID:21911000,https://www.ncbi.nlm.nih.gov/pubmed/21911000,21911000,,
869,2099986,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased phosphorylation of AKT1 protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
870,2099987,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,208,AKT2,https://ctdbase.org/detail.go?type=gene&acc=208,,,208.0,AKT2,9606,Homo sapiens (human),Ascorbic acid affects the expression of AKT2 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
871,2099988,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,211,ALAS1,https://ctdbase.org/detail.go?type=gene&acc=211,,,211.0,ALAS1,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid] inhibits the reaction [griseofulvin results in increased activity of ALAS1 protein]|ascorbic acid inhibits the reaction [griseofulvin results in increased activity of ALAS1 protein]",,,PMID:24523661,https://www.ncbi.nlm.nih.gov/pubmed/24523661,24523661,,
872,2099989,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9913,Bos taurus (cattle),[docosahexaenoic acids co-treated with ferrous sulfate co-treated with ascorbic acid] affects the metabolism of ALB protein|[arachidonic acid co-treated with ferrous sulfate co-treated with ascorbic acid] affects the metabolism of ALB protein|[linoleic acid co-treated with ferrous sulfate co-treated with ascorbic acid] affects the metabolism of ALB protein,,,PMID:16582421,https://www.ncbi.nlm.nih.gov/pubmed/16582421,16582421,,
873,2099990,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9913,Bos taurus (cattle),Ascorbic acid results in increased glycation of ALB protein,,,PMID:26163454,https://www.ncbi.nlm.nih.gov/pubmed/26163454,26163454,,
874,2099991,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9913,Bos taurus (cattle),[copper co-treated with ascorbic acid co-treated with ALB protein] promotes the reaction [glyoxal binds to imidazolone],,,PMID:17390397,https://www.ncbi.nlm.nih.gov/pubmed/17390397,17390397,,
875,2100122,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ALB mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
876,2100123,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,217,ALDH2,https://ctdbase.org/detail.go?type=gene&acc=217,,,217.0,ALDH2,10090,Mus musculus (house mouse),ALDH2 protein affects the reaction [ascorbic acid deficiency results in decreased susceptibility to nitroglycerin],,,PMID:23194305,https://www.ncbi.nlm.nih.gov/pubmed/23194305,23194305,,
877,2100124,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,226,ALDOA,https://ctdbase.org/detail.go?type=gene&acc=226,,,226.0,ALDOA,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ALDOA mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
878,2100125,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,246,ALOX15,https://ctdbase.org/detail.go?type=gene&acc=246,,,246.0,ALOX15,9986,Oryctolagus cuniculus (rabbit),Ascorbic acid affects the activity of ALOX15 protein,,,PMID:10995031,https://www.ncbi.nlm.nih.gov/pubmed/10995031,10995031,,
879,2100126,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,246,ALOX15,https://ctdbase.org/detail.go?type=gene&acc=246,,,246.0,ALOX15,9986,Oryctolagus cuniculus (rabbit),Ascorbic acid inhibits the reaction [ALOX15 protein results in increased degradation of alpha-tocopherol]|ascorbic acid inhibits the reaction [ALOX15 protein results in increased abundance of cholesteryl ester hydroperoxide],,,PMID:9448720,https://www.ncbi.nlm.nih.gov/pubmed/9448720,9448720,,
880,2100127,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,248,ALPI,https://ctdbase.org/detail.go?type=gene&acc=248,,,248.0,ALPI,9913,Bos taurus (cattle),Ascorbic acid inhibits the reaction [reactive oxygen species results in decreased activity of ALPI protein]|ascorbic acid inhibits the reaction [perhydroxyl radical results in decreased activity of ALPI protein],,,PMID:17705259,https://www.ncbi.nlm.nih.gov/pubmed/17705259,17705259,,
881,2100128,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,248,ALPI,https://ctdbase.org/detail.go?type=gene&acc=248,,,248.0,ALPI,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of ALPI mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
882,2100129,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,249,ALPL,https://ctdbase.org/detail.go?type=gene&acc=249,,,249.0,ALPL,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of ALPL mrna|ezh2 protein inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of ALPL mrna],,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
883,2100130,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,249,ALPL,https://ctdbase.org/detail.go?type=gene&acc=249,,,249.0,ALPL,9606,Homo sapiens (human),Ascorbic acid results in increased expression of ALPL mRNA,,,PMID:28105418,https://www.ncbi.nlm.nih.gov/pubmed/28105418,28105418,,
884,2100264,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,249,ALPL,https://ctdbase.org/detail.go?type=gene&acc=249,,,249.0,ALPL,10090,Mus musculus (house mouse),"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of ALPL mrna]|[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of ALPL mRNA",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
885,2100265,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,249,ALPL,https://ctdbase.org/detail.go?type=gene&acc=249,,,249.0,ALPL,9823,Sus scrofa (pig),"2,2-bis(4-glycidyloxyphenyl)propane promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ALPL mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of ALPL mRNA",,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
886,2100266,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,269,AMHR2,https://ctdbase.org/detail.go?type=gene&acc=269,,,269.0,AMHR2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of AMHR2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
887,2100267,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,290,ANPEP,https://ctdbase.org/detail.go?type=gene&acc=290,,,290.0,ANPEP,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of ANPEP mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
888,2100268,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,301,ANXA1,https://ctdbase.org/detail.go?type=gene&acc=301,,,301.0,ANXA1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ANXA1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
889,2100269,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,301,ANXA1,https://ctdbase.org/detail.go?type=gene&acc=301,,,301.0,ANXA1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of ANXA1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
890,2100270,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,301,ANXA1,https://ctdbase.org/detail.go?type=gene&acc=301,,,301.0,ANXA1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of ANXA1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
891,2100271,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,308,ANXA5,https://ctdbase.org/detail.go?type=gene&acc=308,,,308.0,ANXA5,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of ANXA5 protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
892,2100272,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,308,ANXA5,https://ctdbase.org/detail.go?type=gene&acc=308,,,308.0,ANXA5,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of ANXA5 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
893,2100409,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,308,ANXA5,https://ctdbase.org/detail.go?type=gene&acc=308,,,308.0,ANXA5,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of ANXA5 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
894,2100410,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of APOA1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
895,2100411,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of APOA1 protein|ascorbic acid results in decreased expression of APOA1 mrna|ascorbic acid results in decreased activity of APOA1 promoter,,,PMID:16423621,https://www.ncbi.nlm.nih.gov/pubmed/16423621,16423621,,
896,2100412,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338.0,APOB,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [flavonoids inhibits the reaction [copper results in increased oxidation of APOB protein]]|ascorbic acid promotes the reaction [quercetin inhibits the reaction [copper results in increased oxidation of APOB protein]],,,PMID:17475462,https://www.ncbi.nlm.nih.gov/pubmed/17475462,17475462,,
897,2100413,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338.0,APOB,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of APOB mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
898,2100414,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of APOE mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
899,2100415,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,55937,APOM,https://ctdbase.org/detail.go?type=gene&acc=55937,,,55937.0,APOM,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of APOM mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
900,2100416,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606,Homo sapiens (human),APP protein inhibits the reaction [copper results in increased oxidation of ascorbic acid]|[app protein modified form binds to copper] which results in increased oxidation of ascorbic acid,,,PMID:24276282,https://www.ncbi.nlm.nih.gov/pubmed/24276282,24276282,,
901,2100417,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,571,BACH1,https://ctdbase.org/detail.go?type=gene&acc=571,,,571.0,BACH1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in decreased expression of BACH1 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
902,2100418,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,572,BAD,https://ctdbase.org/detail.go?type=gene&acc=572,,,572.0,BAD,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in increased expression of BAD protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
903,2100510,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,572,BAD,https://ctdbase.org/detail.go?type=gene&acc=572,,,572.0,BAD,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased phosphorylation of BAD protein]|ascorbic acid inhibits the reaction [potassium dichromate affects the localization of BAD protein]|ascorbic acid inhibits the reaction [potassium dichromate results in increased expression of BAD protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
904,2100511,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid co-treated with disulfiram] results in decreased expression of BAK1 protein,,,PMID:24126434,https://www.ncbi.nlm.nih.gov/pubmed/24126434,24126434,,
905,2100512,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,440,ASNS,https://ctdbase.org/detail.go?type=gene&acc=440,,,440.0,ASNS,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of ASNS mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
906,2100513,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,29028,ATAD2,https://ctdbase.org/detail.go?type=gene&acc=29028,,,29028.0,ATAD2,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of ATAD2 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
907,2100514,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606,Homo sapiens (human),[[[APP protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholines] which results in increased chemical synthesis of phosphatidylcholine hydroperoxide|[[[app protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal|[[app protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholine hydroperoxide|trientine inhibits the reaction [[[[APP protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal]|[[app protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholines|app protein modified form results in increased oxidation of ascorbic acid|deferoxamine inhibits the reaction [[[[APP protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal]|copper promotes the reaction [APP protein modified form results in increased oxidation of ascorbic acid]|[app protein modified form inhibits the reaction [[copper co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholine hydroperoxide]] which results in increased chemical synthesis of 4-hydroxy-2-nonenal|penicillamine inhibits the reaction [[[[APP protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholines] which results in increased chemical synthesis of phosphatidylcholine hydroperoxide]|app protein modified form inhibits the reaction [[copper co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholine hydroperoxide]|edetic acid inhibits the reaction [[[[APP protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholines] which results in increased chemical synthesis of phosphatidylcholine hydroperoxide]|trientine inhibits the reaction [[[[APP protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholines] which results in increased chemical synthesis of phosphatidylcholine hydroperoxide]|edetic acid inhibits the reaction [[[[APP protein modified form binds to copper] which co-treated with ascorbic acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal],,,PMID:17964426,https://www.ncbi.nlm.nih.gov/pubmed/17964426,17964426,,
908,2100515,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10116,Rattus norvegicus (Norway rat),APP protein modified form results in decreased abundance of ascorbic acid|resveratrol inhibits the reaction [APP protein modified form results in decreased abundance of ascorbic acid],,,PMID:25654502,https://www.ncbi.nlm.nih.gov/pubmed/25654502,25654502,,
909,2100608,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [APP protein modified form results in increased abundance of reactive oxygen species],,,PMID:15030205,https://www.ncbi.nlm.nih.gov/pubmed/15030205,15030205,,
910,2100609,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606,Homo sapiens (human),Ascorbic acid affects the reaction [[APP protein modified form binds to copper] which results in increased chemical synthesis of hydrogen peroxide],,,PMID:12192006,https://www.ncbi.nlm.nih.gov/pubmed/12192006,12192006,,
911,2100610,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606,Homo sapiens (human),Ascorbic acid results in increased reduction of [copper binds to APP protein modified form],,,PMID:17636872,https://www.ncbi.nlm.nih.gov/pubmed/17636872,17636872,,
912,2100611,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606,Homo sapiens (human),[[copper binds to APP protein modified form] which co-treated with oxygen] results in increased oxidation of ascorbic acid,,,PMID:20302320,https://www.ncbi.nlm.nih.gov/pubmed/20302320,20302320,,
913,2100612,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,360,AQP3,https://ctdbase.org/detail.go?type=gene&acc=360,,,360.0,AQP3,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of AQP3 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
914,2100613,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,396,ARHGDIA,https://ctdbase.org/detail.go?type=gene&acc=396,,,396.0,ARHGDIA,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of ARHGDIA mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
915,2100614,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,397,ARHGDIB,https://ctdbase.org/detail.go?type=gene&acc=397,,,397.0,ARHGDIB,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of ARHGDIB mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
916,2100615,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,397,ARHGDIB,https://ctdbase.org/detail.go?type=gene&acc=397,,,397.0,ARHGDIB,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of ARHGDIB protein,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
917,2100616,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10092,ARPC5,https://ctdbase.org/detail.go?type=gene&acc=10092,,,10092.0,ARPC5,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of ARPC5 protein|ascorbic acid results in increased expression of ARPC5 mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
918,2100617,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,429,ASCL1,https://ctdbase.org/detail.go?type=gene&acc=429,,,429.0,ASCL1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ASCL1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
919,2100764,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54454,ATAD2B,https://ctdbase.org/detail.go?type=gene&acc=54454,,,54454.0,ATAD2B,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of ATAD2B mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
920,2100765,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of ATF3 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
921,2100766,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,472,ATM,https://ctdbase.org/detail.go?type=gene&acc=472,,,472.0,ATM,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [potassium chromate(vi) results in increased expression of ATM protein modified form],,,PMID:25977998,https://www.ncbi.nlm.nih.gov/pubmed/25977998,25977998,,
922,2100767,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,472,ATM,https://ctdbase.org/detail.go?type=gene&acc=472,,,472.0,ATM,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of ATM mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
923,2100768,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,506,ATP5F1B,https://ctdbase.org/detail.go?type=gene&acc=506,,,506.0,ATP5F1B,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of ATP5F1B protein,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
924,2100769,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,523,ATP6V1A,https://ctdbase.org/detail.go?type=gene&acc=523,,,523.0,ATP6V1A,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of ATP6V1A mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
925,2100770,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9212,AURKB,https://ctdbase.org/detail.go?type=gene&acc=9212,,,9212.0,AURKB,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of AURKB mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
926,2100771,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,26053,AUTS2,https://ctdbase.org/detail.go?type=gene&acc=26053,,,26053.0,AUTS2,9606,Homo sapiens (human),Ascorbic acid results in increased expression of AUTS2 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
927,2100772,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,567,B2M,https://ctdbase.org/detail.go?type=gene&acc=567,,,567.0,B2M,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of B2M mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
928,2100773,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid co-treated with disulfiram] results in increased expression of BAX protein,,,PMID:24126434,https://www.ncbi.nlm.nih.gov/pubmed/24126434,24126434,,
929,2100935,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [deoxynivalenol results in increased expression of BAX protein],,,PMID:17166419,https://www.ncbi.nlm.nih.gov/pubmed/17166419,17166419,,
930,2100936,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [silicon dioxide results in increased expression of BAX mrna]|ascorbic acid inhibits the reaction [silicon dioxide results in increased expression of BAX protein],,,PMID:22245848,https://www.ncbi.nlm.nih.gov/pubmed/22245848,22245848,,
931,2100937,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in increased expression of BAX protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
932,2100938,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [glycidamide results in increased expression of BAX mrna],,,PMID:32632975,https://www.ncbi.nlm.nih.gov/pubmed/32632975,32632975,,
933,2100939,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9669,Mustela putorius furo (domestic ferret),[beta carotene co-treated with alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BAX protein],,,PMID:16401635,https://www.ncbi.nlm.nih.gov/pubmed/16401635,16401635,,
934,2100940,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [humic substances results in increased expression of BAX protein],,,PMID:18683188,https://www.ncbi.nlm.nih.gov/pubmed/18683188,18683188,,
935,2100941,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [lead acetate results in increased expression of BAX protein],,,PMID:17959157,https://www.ncbi.nlm.nih.gov/pubmed/17959157,17959157,,
936,2100942,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in increased expression of BAX protein]|ascorbic acid inhibits the reaction [potassium dichromate affects the localization of BAX protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
937,2100943,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [streptozocin results in increased expression of BAX protein],,,PMID:18758938,https://www.ncbi.nlm.nih.gov/pubmed/18758938,18758938,,
938,2100944,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,27113,BBC3,https://ctdbase.org/detail.go?type=gene&acc=27113,,,27113.0,BBC3,9606,Homo sapiens (human),Benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of BBC3 protein]|[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of BBC3 protein,,,PMID:20530418,https://www.ncbi.nlm.nih.gov/pubmed/20530418,20530418,,
939,2101068,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590.0,BCHE,10090,Mus musculus (house mouse),[resveratrol co-treated with ascorbic acid co-treated with thioctic acid co-treated with vitamin E] results in increased activity of BCHE protein|hexachlorocyclohexane inhibits the reaction [[resveratrol co-treated with ascorbic acid co-treated with thioctic acid co-treated with vitamin E] results in increased activity of BCHE protein],,,PMID:20663516,https://www.ncbi.nlm.nih.gov/pubmed/20663516,20663516,,
940,2101069,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid co-treated with disulfiram] results in decreased expression of BCL2 protein,,,PMID:24126434,https://www.ncbi.nlm.nih.gov/pubmed/24126434,24126434,,
941,2101070,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),[ascorbic acid co-treated with quartz] results in increased expression of BCL2 mRNA,,,PMID:27381660,https://www.ncbi.nlm.nih.gov/pubmed/27381660,27381660,,
942,2101071,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein],,,PMID:17166419,https://www.ncbi.nlm.nih.gov/pubmed/17166419,17166419,,
943,2101072,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [silicon dioxide results in decreased expression of BCL2 protein]|ascorbic acid inhibits the reaction [silicon dioxide results in decreased expression of BCL2 mrna],,,PMID:22245848,https://www.ncbi.nlm.nih.gov/pubmed/22245848,22245848,,
944,2101073,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of BCL2 mRNA,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
945,2101074,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),BCL2 protein results in increased abundance of ascorbic acid,,,PMID:15449323,https://www.ncbi.nlm.nih.gov/pubmed/15449323,15449323,,
946,2101075,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [glycidamide results in decreased expression of BCL2 mrna],,,PMID:32632975,https://www.ncbi.nlm.nih.gov/pubmed/32632975,32632975,,
947,2101076,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,8022,Oncorhynchus mykiss (rainbow trout),[vitamin A co-treated with cholecalciferol co-treated with vitamin E co-treated with ascorbic acid] inhibits the reaction [[cyhalothrin co-treated with chlorantranilipole] results in increased expression of BCL2 protein],,,PMID:36813254,https://www.ncbi.nlm.nih.gov/pubmed/36813254,36813254,,
948,2101077,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),[alpha-tocopherol co-treated with ascorbic acid] inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 mrna],,,PMID:29297235,https://www.ncbi.nlm.nih.gov/pubmed/29297235,29297235,,
949,2101201,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [humic substances results in decreased expression of BCL2 protein],,,PMID:18683188,https://www.ncbi.nlm.nih.gov/pubmed/18683188,18683188,,
950,2101202,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of BCL2 protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
951,2101203,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [streptozocin results in decreased expression of BCL2 protein],,,PMID:18758938,https://www.ncbi.nlm.nih.gov/pubmed/18758938,18758938,,
952,2101204,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),Ascorbic acid promotes the reaction [lead acetate results in increased expression of BCL2 protein],,,PMID:17959157,https://www.ncbi.nlm.nih.gov/pubmed/17959157,17959157,,
953,2101205,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of BCL2L1 protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
954,2101206,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [streptozocin results in decreased expression of BCL2L1 protein],,,PMID:18758938,https://www.ncbi.nlm.nih.gov/pubmed/18758938,18758938,,
955,2101207,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9823,Sus scrofa (pig),[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of BCL2L1 mRNA,,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
956,2101208,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,79370,BCL2L14,https://ctdbase.org/detail.go?type=gene&acc=79370,,,79370.0,BCL2L14,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of BCL2L14 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
957,2101209,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,599,BCL2L2,https://ctdbase.org/detail.go?type=gene&acc=599,,,599.0,BCL2L2,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of BCL2L2 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
958,2101210,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,53630,BCO1,https://ctdbase.org/detail.go?type=gene&acc=53630,,,53630.0,BCO1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [oxidants inhibits the reaction [BCO1 protein results in increased oxidation of beta carotene]],,,PMID:9526112,https://www.ncbi.nlm.nih.gov/pubmed/9526112,9526112,,
959,2101344,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of S100B mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SYN mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of FZD10 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of S100B protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of DLG4 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of E2F2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SYN protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of RBFOX3 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of MAP2 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of TUBB3 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GABRA2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN2B mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of CNTN1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIA2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SCN2A mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN2A mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of TERT mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of FOXM1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GFAP mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SLC17A7 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of RBFOX3 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SLC17A6 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of GLI1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of HOXB1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of HES3 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of INHBE mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of LEF1 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
960,2101345,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of BDNF mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
961,2101346,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,9606,Homo sapiens (human),Tributyltin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|bexarotene inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA,,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
962,2101402,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,9606,Homo sapiens (human),[ascorbic acid co-treated with dexamethasone] results in increased expression of BGLAP mRNA,,,PMID:12510807,https://www.ncbi.nlm.nih.gov/pubmed/12510807,12510807,,
963,2101403,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,9606,Homo sapiens (human),[cholecalciferol co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] results in increased expression of BGLAP protein,,,PMID:17692823,https://www.ncbi.nlm.nih.gov/pubmed/17692823,17692823,,
964,2101404,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,10090,Mus musculus (house mouse),4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of BGLAP protein]|4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of BGLAP mrna]|[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of BGLAP protein|[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of BGLAP mRNA,,,PMID:31935364,https://www.ncbi.nlm.nih.gov/pubmed/31935364,31935364,,
965,2101405,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,10090,Mus musculus (house mouse),"Tretinoin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|triphenyltin hydroxide inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|allethrins inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|d,d-T80-prallethrin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna|quinoxyfen inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]|pioglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of BGLAP mrna]",,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
966,2101406,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP protein|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP protein]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mrna]|[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BGLAP mRNA",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
967,2101407,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,10116,Rattus norvegicus (Norway rat),Hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of BGLAP mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of BGLAP mrna|quercetin affects the reaction [hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of BGLAP mrna]],,,PMID:27028516,https://www.ncbi.nlm.nih.gov/pubmed/27028516,27028516,,
968,2101517,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,9606,Homo sapiens (human),[ascorbic acid co-treated with IL11 protein] results in increased expression of BGLAP mRNA,,,PMID:17956465,https://www.ncbi.nlm.nih.gov/pubmed/17956465,17956465,,
969,2101518,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,9606,Homo sapiens (human),Ascorbic acid results in increased expression of BGLAP mRNA,,,PMID:17274723,https://www.ncbi.nlm.nih.gov/pubmed/17274723,17274723,,
970,2101519,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,12095,BGLAP3,https://ctdbase.org/detail.go?type=gene&acc=12095,,,12095.0,Bglap3,9606,Homo sapiens (human),[ascorbic acid co-treated with copper] affects the cleavage of BGLAP3 protein|bglap3 protein binds to ascorbic acid,,,PMID:11396734,https://www.ncbi.nlm.nih.gov/pubmed/11396734,11396734,,
971,2101520,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,637,BID,https://ctdbase.org/detail.go?type=gene&acc=637,,,637.0,BID,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] affects the expression of BID protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
972,2101521,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,330,BIRC3,https://ctdbase.org/detail.go?type=gene&acc=330,,,330.0,BIRC3,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of BIRC3 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
973,2101522,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of BIRC5 mRNA,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
974,2101523,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,649,BMP1,https://ctdbase.org/detail.go?type=gene&acc=649,,,649.0,BMP1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP1 mRNA,,,PMID:15994055,https://www.ncbi.nlm.nih.gov/pubmed/15994055,15994055,,
975,2101524,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,650,BMP2,https://ctdbase.org/detail.go?type=gene&acc=650,,,650.0,BMP2,10090,Mus musculus (house mouse),"[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mrna]|n-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein]|[ascorbic acid co-treated with dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mRNA",,,PMID:26492236,https://www.ncbi.nlm.nih.gov/pubmed/26492236,26492236,,
976,2101525,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,650,BMP2,https://ctdbase.org/detail.go?type=gene&acc=650,,,650.0,BMP2,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mRNA,,,PMID:15994055,https://www.ncbi.nlm.nih.gov/pubmed/15994055,15994055,,
977,2101526,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,650,BMP2,https://ctdbase.org/detail.go?type=gene&acc=650,,,650.0,BMP2,10116,Rattus norvegicus (Norway rat),Ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein]]|nog protein inhibits the reaction [ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein]]]|dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein]|[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 protein,,,PMID:27387537,https://www.ncbi.nlm.nih.gov/pubmed/27387537,27387537,,
978,2101682,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,651,BMP3,https://ctdbase.org/detail.go?type=gene&acc=651,,,651.0,BMP3,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP3 mRNA,,,PMID:15994055,https://www.ncbi.nlm.nih.gov/pubmed/15994055,15994055,,
979,2101683,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,652,BMP4,https://ctdbase.org/detail.go?type=gene&acc=652,,,652.0,BMP4,13489,Dicentrarchus labrax (European seabass),Ascorbic acid affects the expression of BMP4 mRNA,,,PMID:21281732,https://www.ncbi.nlm.nih.gov/pubmed/21281732,21281732,,
980,2101684,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,652,BMP4,https://ctdbase.org/detail.go?type=gene&acc=652,,,652.0,BMP4,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of KEAP1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPX2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGG mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of PLN mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HAVCR1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GATA6 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TF mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ZFAND2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ISL1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ESRG mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXB3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ASCL1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TFAP2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of CYP24A1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CEACAM6 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FLT1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SERPINA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of APOA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of RRAD mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of VCAM1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLM mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SRXN1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of H2BC14 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MPZL1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FOXG1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of UGT2A3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of POU5F1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TM4SF4 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTO1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX2 mrna|[[ascorbic acid co-treate,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
981,2101685,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,653,BMP5,https://ctdbase.org/detail.go?type=gene&acc=653,,,653.0,BMP5,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of BMP5 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
982,2101686,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,655,BMP7,https://ctdbase.org/detail.go?type=gene&acc=655,,,655.0,BMP7,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMP7 mRNA,,,PMID:15994055,https://www.ncbi.nlm.nih.gov/pubmed/15994055,15994055,,
983,2101687,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,657,BMPR1A,https://ctdbase.org/detail.go?type=gene&acc=657,,,657.0,BMPR1A,10116,Rattus norvegicus (Norway rat),Ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMPR1A protein]]|nog protein inhibits the reaction [ginsenoside rg3 inhibits the reaction [dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMPR1A protein]]]|[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMPR1A protein|dexamethasone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of BMPR1A protein],,,PMID:27387537,https://www.ncbi.nlm.nih.gov/pubmed/27387537,27387537,,
984,2101688,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,658,BMPR1B,https://ctdbase.org/detail.go?type=gene&acc=658,,,658.0,BMPR1B,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of BMPR1B mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
985,2101689,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,699,BUB1,https://ctdbase.org/detail.go?type=gene&acc=699,,,699.0,BUB1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of BUB1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
986,2101690,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,28970,C11ORF54,https://ctdbase.org/detail.go?type=gene&acc=28970,,,28970.0,C11orf54,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of C11ORF54 mrna|ascorbic acid results in decreased expression of C11ORF54 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
987,2101804,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,718,C3,https://ctdbase.org/detail.go?type=gene&acc=718,,,718.0,C3,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of C3 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
988,2101805,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,727,C5,https://ctdbase.org/detail.go?type=gene&acc=727,,,727.0,C5,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [asbestos, serpentine results in increased cleavage of C5 protein]|ascorbic acid inhibits the reaction [asbestos, crocidolite results in increased cleavage of C5 protein]",,,PMID:10777245,https://www.ncbi.nlm.nih.gov/pubmed/10777245,10777245,,
989,2101806,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,768,CA9,https://ctdbase.org/detail.go?type=gene&acc=768,,,768.0,CA9,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nickel sulfate results in increased expression of CA9 protein],,,PMID:16288478,https://www.ncbi.nlm.nih.gov/pubmed/16288478,16288478,,
990,2101807,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8912,CACNA1H,https://ctdbase.org/detail.go?type=gene&acc=8912,,,8912.0,CACNA1H,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [vincristine results in increased expression of CACNA1H protein]|ascorbic acid inhibits the reaction [vincristine results in increased expression of CACNA1H mrna]|ascorbic acid results in decreased activity of CACNA1H protein,,,PMID:34286406,https://www.ncbi.nlm.nih.gov/pubmed/34286406,34286406,,
991,2101808,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,794,CALB2,https://ctdbase.org/detail.go?type=gene&acc=794,,,794.0,CALB2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of CALB2 protein],,,PMID:31708536,https://www.ncbi.nlm.nih.gov/pubmed/31708536,31708536,,
992,2101809,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,12349,CAR2,https://ctdbase.org/detail.go?type=gene&acc=12349,,,12349.0,Car2,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of CAR2 mrna|[ascorbic acid co-treated with TNFSF11 protein] results in decreased expression of CAR2 mRNA,,,PMID:15730627,https://www.ncbi.nlm.nih.gov/pubmed/15730627,15730627,,
993,2101810,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,12349,CAR2,https://ctdbase.org/detail.go?type=gene&acc=12349,,,12349.0,Car2,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 mrna]|ascorbic acid inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 protein],,,PMID:15952411,https://www.ncbi.nlm.nih.gov/pubmed/15952411,15952411,,
994,2101811,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,835,CASP2,https://ctdbase.org/detail.go?type=gene&acc=835,,,835.0,CASP2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [norepinephrine results in increased activity of CASP2 protein],,,PMID:15158148,https://www.ncbi.nlm.nih.gov/pubmed/15158148,15158148,,
995,2101812,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10140,Cavia (guinea pigs),[ascorbic acid co-treated with ethanol] results in decreased activity of CASP3 protein,,,PMID:22149461,https://www.ncbi.nlm.nih.gov/pubmed/22149461,22149461,,
996,2101813,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),CAT protein inhibits the reaction [[ascorbic acid co-treated with eosine I bluish] results in increased activity of CASP3 protein]|[ascorbic acid co-treated with eosine I bluish] results in increased activity of CASP3 protein,,,PMID:24488945,https://www.ncbi.nlm.nih.gov/pubmed/24488945,24488945,,
997,2101939,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),[hyaluronic acid co-treated with chondroitin sulfates] inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CASP3 mrna]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CASP3 mrna|[ascorbic acid co-treated with ferrous sulfate] results in increased activity of CASP3 protein|[hyaluronic acid co-treated with chondroitin sulfates] inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of CASP3 protein],,,PMID:17879260,https://www.ncbi.nlm.nih.gov/pubmed/17879260,17879260,,
998,2101940,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[chromium hexavalent ion co-treated with rotenone] results in increased activity of CASP3 protein]|ascorbic acid inhibits the reaction [[chromium hexavalent ion co-treated with antimycin A] results in increased activity of CASP3 protein]|ascorbic acid inhibits the reaction [rotenone results in increased activity of CASP3 protein]|ascorbic acid inhibits the reaction [chromium hexavalent ion results in increased activity of CASP3 protein]|ascorbic acid inhibits the reaction [antimycin A results in increased activity of CASP3 protein],,,PMID:24732427,https://www.ncbi.nlm.nih.gov/pubmed/24732427,24732427,,
999,2101941,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [deoxynivalenol results in increased expression of CASP3 protein],,,PMID:17166419,https://www.ncbi.nlm.nih.gov/pubmed/17166419,17166419,,
1000,2101942,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased activity of CASP3 protein],,,PMID:16124896|PMID:16407847,https://www.ncbi.nlm.nih.gov/pubmed/16124896|https://www.ncbi.nlm.nih.gov/pubmed/16407847,16124896|16407847,,
1001,2101943,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [triethylene glycol dimethacrylate results in increased activity of CASP3 protein]|ascorbic acid inhibits the reaction [hydroxyethyl methacrylate results in increased activity of CASP3 protein],,,PMID:33248029,https://www.ncbi.nlm.nih.gov/pubmed/33248029,33248029,,
1002,2101944,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [oleanolic acid results in increased cleavage of CASP3 protein],,,PMID:22678527,https://www.ncbi.nlm.nih.gov/pubmed/22678527,22678527,,
1003,2101945,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [paraquat results in increased activity of CASP3 protein],,,PMID:33592258,https://www.ncbi.nlm.nih.gov/pubmed/33592258,33592258,,
1004,2101946,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [reactive oxygen species results in increased activity of CASP3 protein],,,PMID:16124896,https://www.ncbi.nlm.nih.gov/pubmed/16124896,16124896,,
1005,2101947,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [silicon dioxide results in increased activity of CASP3 protein]|ascorbic acid inhibits the reaction [silicon dioxide results in decreased expression of CASP3 mrna],,,PMID:22245848,https://www.ncbi.nlm.nih.gov/pubmed/22245848,22245848,,
1006,2102055,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP3 protein],,,PMID:23711929,https://www.ncbi.nlm.nih.gov/pubmed/23711929,23711929,,
1007,2102056,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [arsenic trioxide results in increased activity of CASP3 protein],,,PMID:12750841,https://www.ncbi.nlm.nih.gov/pubmed/12750841,12750841,,
1008,2102057,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of CASP3 protein],,,PMID:16867262,https://www.ncbi.nlm.nih.gov/pubmed/16867262,16867262,,
1009,2102058,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [chromium hexavalent ion results in increased cleavage of CASP3 protein],,,PMID:17301063,https://www.ncbi.nlm.nih.gov/pubmed/17301063,17301063,,
1010,2102059,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid results in decreased activity of CASP3 protein,,,PMID:17618090,https://www.ncbi.nlm.nih.gov/pubmed/17618090,17618090,,
1011,2102060,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),Ascorbic acid results in increased expression of CASP3 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
1012,2102061,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased expression of CASP3 protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
1013,2102062,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [glycidamide results in increased expression of CASP3 mrna],,,PMID:32632975,https://www.ncbi.nlm.nih.gov/pubmed/32632975,32632975,,
1014,2102063,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with sesame oil] inhibits the reaction [abamectin results in increased expression of CASP3 protein]|ascorbic acid inhibits the reaction [abamectin results in increased expression of CASP3 protein],,,PMID:31739238,https://www.ncbi.nlm.nih.gov/pubmed/31739238,31739238,,
1015,2102064,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [arsenic results in increased activity of CASP3 protein],,,PMID:24295472,https://www.ncbi.nlm.nih.gov/pubmed/24295472,24295472,,
1016,2102199,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [arsenic trioxide results in increased activity of CASP3 protein],,,PMID:20356860,https://www.ncbi.nlm.nih.gov/pubmed/20356860,20356860,,
1017,2102200,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [norepinephrine results in increased activity of CASP3 protein],,,PMID:15158148,https://www.ncbi.nlm.nih.gov/pubmed/15158148,15158148,,
1018,2102201,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in increased cleavage of CASP3 protein],,,PMID:21262251,https://www.ncbi.nlm.nih.gov/pubmed/21262251,21262251,,
1019,2102202,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium benzoate results in increased expression of CASP3 protein],,,PMID:35187746,https://www.ncbi.nlm.nih.gov/pubmed/35187746,35187746,,
1020,2102203,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein],,,PMID:21873648,https://www.ncbi.nlm.nih.gov/pubmed/21873648,21873648,,
1021,2102204,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [streptozocin results in increased activity of CASP3 protein],,,PMID:18758938,https://www.ncbi.nlm.nih.gov/pubmed/18758938,18758938,,
1022,2102205,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),[vitamin E co-treated with ascorbic acid] inhibits the reaction [dichlorvos results in increased activity of CASP3 protein],,,PMID:16973328,https://www.ncbi.nlm.nih.gov/pubmed/16973328,16973328,,
1023,2102206,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9823,Sus scrofa (pig),[troglitazone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of CASP3 mRNA,,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
1024,2102207,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,837,CASP4,https://ctdbase.org/detail.go?type=gene&acc=837,,,837.0,CASP4,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[kojic acid co-treated with diethylnitrosamine] results in increased expression of CASP4 mrna],,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
1025,2102208,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,839,CASP6,https://ctdbase.org/detail.go?type=gene&acc=839,,,839.0,CASP6,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [norepinephrine results in increased activity of CASP6 protein],,,PMID:15158148,https://www.ncbi.nlm.nih.gov/pubmed/15158148,15158148,,
1026,2102343,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,840,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840.0,CASP7,9606,Homo sapiens (human),[hyaluronic acid co-treated with chondroitin sulfates] inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of CASP7 protein]|[hyaluronic acid co-treated with chondroitin sulfates] inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CASP7 mrna]|[ascorbic acid co-treated with ferrous sulfate] results in increased activity of CASP7 protein|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CASP7 mRNA,,,PMID:17879260,https://www.ncbi.nlm.nih.gov/pubmed/17879260,17879260,,
1027,2102344,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,840,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840.0,CASP7,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [chromium hexavalent ion results in increased cleavage of CASP7 protein],,,PMID:17301063,https://www.ncbi.nlm.nih.gov/pubmed/17301063,17301063,,
1028,2102345,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein],,,PMID:23711929,https://www.ncbi.nlm.nih.gov/pubmed/23711929,23711929,,
1029,2102346,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606,Homo sapiens (human),Ascorbic acid results in increased expression of CASP8 mRNA,,,PMID:30597948,https://www.ncbi.nlm.nih.gov/pubmed/30597948,30597948,,
1030,2102347,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with INS1 protein] results in increased expression of CASP8 mRNA,,,PMID:20400526,https://www.ncbi.nlm.nih.gov/pubmed/20400526,20400526,,
1031,2102348,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with kojic acid co-treated with diethylnitrosamine] results in decreased expression of CASP8 mRNA,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
1032,2102349,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP9 protein],,,PMID:23711929,https://www.ncbi.nlm.nih.gov/pubmed/23711929,23711929,,
1033,2102350,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [norepinephrine results in increased activity of CASP9 protein],,,PMID:15158148,https://www.ncbi.nlm.nih.gov/pubmed/15158148,15158148,,
1034,2102351,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,10116,Rattus norvegicus (Norway rat),[vitamin E co-treated with ascorbic acid] inhibits the reaction [dichlorvos results in increased activity of CASP9 protein],,,PMID:16973328,https://www.ncbi.nlm.nih.gov/pubmed/16973328,16973328,,
1035,2102352,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,831,CAST,https://ctdbase.org/detail.go?type=gene&acc=831,,,831.0,CAST,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CAST mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1036,2102485,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9925,Capra hircus (goat),Ascorbic acid inhibits the reaction [cypermethrin results in decreased activity of CAT protein],,,PMID:29975445,https://www.ncbi.nlm.nih.gov/pubmed/29975445,29975445,,
1037,2102486,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10029,Cricetulus griseus (Chinese hamster),"Ascorbic acid inhibits the reaction [3,5-dimethylaminophenol results in decreased activity of CAT protein]",,,PMID:25178734,https://www.ncbi.nlm.nih.gov/pubmed/25178734,25178734,,
1038,2102487,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),Ascorbic acid affects the expression of CAT protein,,,PMID:10772068,https://www.ncbi.nlm.nih.gov/pubmed/10772068,10772068,,
1039,2102488,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),"[ascorbic acid co-treated with vitamin E] inhibits the reaction [air pollutants, occupational affects the expression of CAT protein]",,,PMID:20535553,https://www.ncbi.nlm.nih.gov/pubmed/20535553,20535553,,
1040,2102489,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),[ascorbic acid co-treated with vitamin E] inhibits the reaction [malathion results in increased activity of CAT protein]|ascorbic acid inhibits the reaction [malathion results in increased activity of CAT protein],,,PMID:18655177,https://www.ncbi.nlm.nih.gov/pubmed/18655177,18655177,,
1041,2102490,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),[ascorbic acid co-treated with vitamin E] results in increased expression of CAT mRNA,,,PMID:22207723,https://www.ncbi.nlm.nih.gov/pubmed/22207723,22207723,,
1042,2102491,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [dimethoate results in increased activity of CAT protein],,,PMID:20077558,https://www.ncbi.nlm.nih.gov/pubmed/20077558,20077558,,
1043,2102492,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [triethylene glycol dimethacrylate results in increased degradation of CAT mrna]|ascorbic acid inhibits the reaction [hydroxyethyl methacrylate results in increased degradation of CAT mrna],,,PMID:33248029,https://www.ncbi.nlm.nih.gov/pubmed/33248029,33248029,,
1044,2102493,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),Ascorbic acid results in increased activity of CAT protein|ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of CAT mrna]|ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased activity of CAT protein],,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
1045,2102494,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),Ascorbic acid results in increased expression of CAT mRNA,,,PMID:31576639|PMID:32913121|PMID:33248029,https://www.ncbi.nlm.nih.gov/pubmed/31576639|https://www.ncbi.nlm.nih.gov/pubmed/32913121|https://www.ncbi.nlm.nih.gov/pubmed/33248029,31576639|32913121|33248029,,
1046,2102658,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),CAT protein inhibits the reaction [[ascorbic acid co-treated with eosine I bluish] results in increased phosphorylation of MAPK8 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with eosine I bluish] results in increased phosphorylation of MAPK9 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with eosine I bluish] results in increased activity of CASP3 protein],,,PMID:24488945,https://www.ncbi.nlm.nih.gov/pubmed/24488945,24488945,,
1047,2102659,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),CAT protein inhibits the reaction [copper promotes the reaction [ascorbic acid results in decreased activity of PON1 protein]],,,PMID:15104111,https://www.ncbi.nlm.nih.gov/pubmed/15104111,15104111,,
1048,2102660,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),CAT protein results in decreased susceptibility to [arsenic trioxide co-treated with ascorbic acid],,,PMID:20171736,https://www.ncbi.nlm.nih.gov/pubmed/20171736,20171736,,
1049,2102661,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),CAT protein results in decreased susceptibility to ascorbic acid,,,PMID:14698046,https://www.ncbi.nlm.nih.gov/pubmed/14698046,14698046,,
1050,2102662,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),CAT results in decreased susceptibility to [vitamin K 3 co-treated with ascorbic acid],,,PMID:21689642,https://www.ncbi.nlm.nih.gov/pubmed/21689642,21689642,,
1051,2102663,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased activity of CAT protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
1052,2102664,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),[ascorbic acid co-treated with CAT protein] inhibits the reaction [zinc deficiency results in increased expression of IREB2 protein]|[ascorbic acid co-treated with CAT protein] inhibits the reaction [zinc deficiency results in increased expression of TFRC protein],,,PMID:18073202,https://www.ncbi.nlm.nih.gov/pubmed/18073202,18073202,,
1053,2102665,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [arsenic trioxide results in decreased activity of CAT protein],,,PMID:18715643,https://www.ncbi.nlm.nih.gov/pubmed/18715643,18715643,,
1054,2102666,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [cadmium chloride results in decreased activity of CAT protein],,,PMID:18548748,https://www.ncbi.nlm.nih.gov/pubmed/18548748,18548748,,
1055,2102667,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [fipronil results in decreased activity of CAT protein],,,PMID:25721553,https://www.ncbi.nlm.nih.gov/pubmed/25721553,25721553,,
1056,2102802,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),Ascorbic acid results in increased activity of CAT protein,,,PMID:29572072,https://www.ncbi.nlm.nih.gov/pubmed/29572072,29572072,,
1057,2102803,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of CAT mRNA,,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
1058,2102804,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cyclosporine results in decreased activity of CAT protein],,,PMID:19391111,https://www.ncbi.nlm.nih.gov/pubmed/19391111,19391111,,
1059,2102805,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [food additives affects the activity of CAT protein],,,PMID:16758767,https://www.ncbi.nlm.nih.gov/pubmed/16758767,16758767,,
1060,2102806,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),CAT protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR4 mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CD44 mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of NOS2 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of IL1B mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR4 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR2 mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of MMP13 mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of IL1B protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TNF protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of MMP13 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of NOS2 mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TLR2 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of TNF mrna]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CD44 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased activity of [NFKB1 protein binds to RELA protein]]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased degradation of hyaluronic acid],,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
1061,2102807,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090,Mus musculus (house mouse),CAT protein inhibits the reaction [ascorbic acid promotes the reaction [quartz results in increased secretion of TNF protein]],,,PMID:19298665,https://www.ncbi.nlm.nih.gov/pubmed/19298665,19298665,,
1062,2102808,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with beta carotene co-treated with alpha-tocopherol co-treated with sodium selenite] inhibits the reaction [galactosamine results in increased activity of CAT protein],,,PMID:31022331,https://www.ncbi.nlm.nih.gov/pubmed/31022331,31022331,,
1063,2102962,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with lead] results in increased expression of CAT protein,,,PMID:22056337,https://www.ncbi.nlm.nih.gov/pubmed/22056337,22056337,,
1064,2102963,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [abamectin results in increased activity of CAT protein]|[ascorbic acid co-treated with sesame oil] inhibits the reaction [abamectin results in increased activity of CAT protein],,,PMID:31739238,https://www.ncbi.nlm.nih.gov/pubmed/31739238,31739238,,
1065,2102964,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with sodium arsenite] results in increased activity of CAT protein,,,PMID:12540038,https://www.ncbi.nlm.nih.gov/pubmed/12540038,12540038,,
1066,2102965,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [arsenic results in decreased activity of CAT protein],,,PMID:24295472,https://www.ncbi.nlm.nih.gov/pubmed/24295472,24295472,,
1067,2102966,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [barium chloride results in decreased activity of CAT protein]|[[sodium selenite results in increased abundance of selenium] which co-treated with ascorbic acid] inhibits the reaction [barium chloride results in decreased activity of CAT protein],,,PMID:27941167,https://www.ncbi.nlm.nih.gov/pubmed/27941167,27941167,,
1068,2102967,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [bisphenol A results in decreased activity of CAT protein],,,PMID:12767684,https://www.ncbi.nlm.nih.gov/pubmed/12767684,12767684,,
1069,2102968,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cadmium results in decreased activity of CAT protein],,,PMID:22008531,https://www.ncbi.nlm.nih.gov/pubmed/22008531,22008531,,
1070,2102969,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [carbon tetrachloride results in decreased activity of CAT protein],,,PMID:30676168,https://www.ncbi.nlm.nih.gov/pubmed/30676168,30676168,,
1071,2102970,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased activity of CAT protein],,,PMID:16248992|PMID:16298753,https://www.ncbi.nlm.nih.gov/pubmed/16248992|https://www.ncbi.nlm.nih.gov/pubmed/16298753,16248992|16298753,,
1072,2102971,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased activity of CAT protein],,,PMID:17822687,https://www.ncbi.nlm.nih.gov/pubmed/17822687,17822687,,
1073,2103093,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cisplatin results in decreased activity of CAT protein],,,PMID:21310208,https://www.ncbi.nlm.nih.gov/pubmed/21310208,21310208,,
1074,2103094,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [indomethacin results in increased activity of CAT protein],,,PMID:18726076,https://www.ncbi.nlm.nih.gov/pubmed/18726076,18726076,,
1075,2103095,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased activity of CAT protein],,,PMID:17822687|PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/17822687|https://www.ncbi.nlm.nih.gov/pubmed/23470461,17822687|23470461,,
1076,2103096,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of CAT mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
1077,2103097,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased activity of CAT protein],,,PMID:20028703|PMID:20122981|PMID:23194016,https://www.ncbi.nlm.nih.gov/pubmed/20028703|https://www.ncbi.nlm.nih.gov/pubmed/20122981|https://www.ncbi.nlm.nih.gov/pubmed/23194016,20028703|20122981|23194016,,
1078,2103098,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased expression of CAT protein],,,PMID:19429265,https://www.ncbi.nlm.nih.gov/pubmed/19429265,19429265,,
1079,2103099,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium arsenite results in increased activity of CAT protein],,,PMID:20876158,https://www.ncbi.nlm.nih.gov/pubmed/20876158,20876158,,
1080,2103100,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium benzoate results in decreased activity of CAT protein],,,PMID:35187746,https://www.ncbi.nlm.nih.gov/pubmed/35187746,35187746,,
1081,2103101,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium fluoride results in decreased activity of CAT protein],,,PMID:34089294,https://www.ncbi.nlm.nih.gov/pubmed/34089294,34089294,,
1082,2103102,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased activity of CAT protein,,,PMID:31005848,https://www.ncbi.nlm.nih.gov/pubmed/31005848,31005848,,
1083,2103252,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased activity of CAT protein,,,PMID:18096215|PMID:22008531,https://www.ncbi.nlm.nih.gov/pubmed/18096215|https://www.ncbi.nlm.nih.gov/pubmed/22008531,18096215|22008531,,
1084,2103253,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CAT protein,,,PMID:17512118,https://www.ncbi.nlm.nih.gov/pubmed/17512118,17512118,,
1085,2103254,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116,Rattus norvegicus (Norway rat),[zinc co-treated with vitamin E co-treated with ascorbic acid co-treated with sodium arsenite] results in increased activity of CAT protein,,,PMID:23619517,https://www.ncbi.nlm.nih.gov/pubmed/23619517,23619517,,
1086,2103255,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [1-hydroxyethyl radical results in decreased activity of CAT protein],,,PMID:10600175,https://www.ncbi.nlm.nih.gov/pubmed/10600175,10600175,,
1087,2103256,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,857,CAV1,https://ctdbase.org/detail.go?type=gene&acc=857,,,857.0,CAV1,9606,Homo sapiens (human),"Ascorbic acid inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased phosphorylation of CAV1 protein]",,,PMID:35349355,https://www.ncbi.nlm.nih.gov/pubmed/35349355,35349355,,
1088,2103257,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,875,CBS,https://ctdbase.org/detail.go?type=gene&acc=875,,,875.0,CBS,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of CBS mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
1089,2103258,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606,Homo sapiens (human),Ascorbic acid deficiency affects the expression of CCL2 mrna|ascorbic acid affects the expression of CCL2 mRNA,,,PMID:19932582,https://www.ncbi.nlm.nih.gov/pubmed/19932582,19932582,,
1090,2103259,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of CCL2 mRNA,,,PMID:21796779,https://www.ncbi.nlm.nih.gov/pubmed/21796779,21796779,,
1091,2103260,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,18829,CCL21A,https://ctdbase.org/detail.go?type=gene&acc=18829,,,18829.0,Ccl21a,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CCL21A mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1092,2103261,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6348,CCL3,https://ctdbase.org/detail.go?type=gene&acc=6348,,,6348.0,CCL3,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CCL3 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1093,2103402,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8900,CCNA1,https://ctdbase.org/detail.go?type=gene&acc=8900,,,8900.0,CCNA1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CCNA1 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
1094,2103403,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CCNB1 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
1095,2103404,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,892,CCNC,https://ctdbase.org/detail.go?type=gene&acc=892,,,892.0,CCNC,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CCNC mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1096,2103405,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of CCND1 mRNA,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
1097,2103406,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [phenylhydrazine results in decreased expression of CCND1 mrna],,,PMID:30140404,https://www.ncbi.nlm.nih.gov/pubmed/30140404,30140404,,
1098,2103407,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CCND1 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1099,2103408,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CCND1 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
1100,2103409,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,894,CCND2,https://ctdbase.org/detail.go?type=gene&acc=894,,,894.0,CCND2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of CCND2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1101,2103410,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,894,CCND2,https://ctdbase.org/detail.go?type=gene&acc=894,,,894.0,CCND2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CCND2 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
1102,2103411,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,896,CCND3,https://ctdbase.org/detail.go?type=gene&acc=896,,,896.0,CCND3,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [juglone results in decreased expression of CCND3 protein],,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
1103,2103537,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,896,CCND3,https://ctdbase.org/detail.go?type=gene&acc=896,,,896.0,CCND3,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CCND3 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
1104,2103538,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9134,CCNE2,https://ctdbase.org/detail.go?type=gene&acc=9134,,,9134.0,CCNE2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CCNE2 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
1105,2103539,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,900,CCNG1,https://ctdbase.org/detail.go?type=gene&acc=900,,,900.0,CCNG1,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CCNG1 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1106,2103540,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,900,CCNG1,https://ctdbase.org/detail.go?type=gene&acc=900,,,900.0,CCNG1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with kojic acid co-treated with diethylnitrosamine] results in increased expression of CCNG1 mRNA,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
1107,2103541,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,929,CD14,https://ctdbase.org/detail.go?type=gene&acc=929,,,929.0,CD14,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of CD14 mrna],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
1108,2103542,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,100133941,CD24,https://ctdbase.org/detail.go?type=gene&acc=100133941,,,100133941.0,CD24,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of CD24 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1109,2103543,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,947,CD34,https://ctdbase.org/detail.go?type=gene&acc=947,,,947.0,CD34,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of CD34 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1110,2103544,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,958,CD40,https://ctdbase.org/detail.go?type=gene&acc=958,,,958.0,CD40,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of CD40 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1111,2103545,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),Ascorbic acid results in decreased activity of CYP1A1 protein,,,PMID:17512695,https://www.ncbi.nlm.nih.gov/pubmed/17512695,17512695,,
1112,2103546,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of CYP1A1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1113,2103692,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,960,CD44,https://ctdbase.org/detail.go?type=gene&acc=960,,,960.0,CD44,10090,Mus musculus (house mouse),"CAT protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CD44 mrna]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CD44 protein|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CD44 mrna]|[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CD44 mrna|mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CD44 protein]|cat protein inhibits the reaction [[ascorbic acid co-treated with ferrous sulfate] results in increased expression of CD44 protein]",,,PMID:23692848,https://www.ncbi.nlm.nih.gov/pubmed/23692848,23692848,,
1114,2103693,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,962,CD48,https://ctdbase.org/detail.go?type=gene&acc=962,,,962.0,CD48,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CD48 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1115,2103694,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,969,CD69,https://ctdbase.org/detail.go?type=gene&acc=969,,,969.0,CD69,10090,Mus musculus (house mouse),Ascorbic acid deficiency results in decreased expression of CD69 protein,,,PMID:22306178,https://www.ncbi.nlm.nih.gov/pubmed/22306178,22306178,,
1116,2103695,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3732,CD82,https://ctdbase.org/detail.go?type=gene&acc=3732,,,3732.0,CD82,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CD82 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1117,2103696,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,991,CDC20,https://ctdbase.org/detail.go?type=gene&acc=991,,,991.0,CDC20,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of CDC20 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1118,2103697,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,990,CDC6,https://ctdbase.org/detail.go?type=gene&acc=990,,,990.0,CDC6,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of CDC6 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1119,2103698,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,8022,Oncorhynchus mykiss (rainbow trout),[vitamin A co-treated with cholecalciferol co-treated with vitamin E co-treated with ascorbic acid] inhibits the reaction [[cyhalothrin co-treated with chlorantranilipole] results in decreased expression of CDH1 protein],,,PMID:36813254,https://www.ncbi.nlm.nih.gov/pubmed/36813254,36813254,,
1120,2103699,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1008,CDH10,https://ctdbase.org/detail.go?type=gene&acc=1008,,,1008.0,CDH10,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CDH10 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1121,2103700,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1012,CDH13,https://ctdbase.org/detail.go?type=gene&acc=1012,,,1012.0,CDH13,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of CDH13 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1122,2103761,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,E2F1,https://www.dgidb.org/genes/hgnc:3113,,,1869.0,E2F1,9606,Homo sapiens (human),,,,,,,,
1123,2103762,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,CDK4,https://www.dgidb.org/genes/hgnc:1773,,,1019.0,CDK4,9606,Homo sapiens (human),,,,,,,,
1124,2103763,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,CHUK,https://www.dgidb.org/genes/hgnc:1974,,,1147.0,CHUK,9606,Homo sapiens (human),,,,,,,,
1125,2103764,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,GJA1,https://www.dgidb.org/genes/hgnc:4274,,,2697.0,GJA1,9606,Homo sapiens (human),,,,,,,,
1126,2103837,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1000,CDH2,https://ctdbase.org/detail.go?type=gene&acc=1000,,,1000.0,CDH2,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CDH2 protein],,,PMID:29940330,https://www.ncbi.nlm.nih.gov/pubmed/29940330,29940330,,
1127,2103838,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,64405,CDH22,https://ctdbase.org/detail.go?type=gene&acc=64405,,,64405.0,CDH22,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CDH22 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1128,2103839,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CDK1 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
1129,2103840,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,728642,CDK11A,https://ctdbase.org/detail.go?type=gene&acc=728642,,,728642.0,CDK11A,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of CDK11A mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1130,2103841,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CDK2 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
1131,2103842,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased expression of CDK4 protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
1132,2103843,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CDK4 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
1133,2103844,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1021,CDK6,https://ctdbase.org/detail.go?type=gene&acc=1021,,,1021.0,CDK6,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CDK6 protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
1134,2103845,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606,Homo sapiens (human),[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of CDKN1A mrna|nutlin 3 inhibits the reaction [[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of CDKN1A mrna],,,PMID:20530418,https://www.ncbi.nlm.nih.gov/pubmed/20530418,20530418,,
1135,2103846,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein],,,PMID:20067818,https://www.ncbi.nlm.nih.gov/pubmed/20067818,20067818,,
1136,2103960,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CDKN1A mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1137,2103961,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10116,Rattus norvegicus (Norway rat),[INS1 protein co-treated with ascorbic acid] results in increased expression of CDKN1A mrna|ascorbic acid results in increased expression of CDKN1A mRNA,,,PMID:20400526,https://www.ncbi.nlm.nih.gov/pubmed/20400526,20400526,,
1138,2103962,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with kojic acid co-treated with diethylnitrosamine] results in decreased expression of CDKN1B mRNA,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
1139,2103963,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1029,CDKN2A,https://ctdbase.org/detail.go?type=gene&acc=1029,,,1029.0,CDKN2A,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in increased expression of CDKN2A protein],,,PMID:21621607,https://www.ncbi.nlm.nih.gov/pubmed/21621607,21621607,,
1140,2103964,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4680,CEACAM6,https://ctdbase.org/detail.go?type=gene&acc=4680,,,4680.0,CEACAM6,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CEACAM6 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1141,2103965,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1050,CEBPA,https://ctdbase.org/detail.go?type=gene&acc=1050,,,1050.0,CEBPA,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of CEBPA mRNA,,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
1142,2103966,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1050,CEBPA,https://ctdbase.org/detail.go?type=gene&acc=1050,,,1050.0,CEBPA,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of CEBPA protein,,,PMID:14505802,https://www.ncbi.nlm.nih.gov/pubmed/14505802,14505802,,
1143,2103967,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1050,CEBPA,https://ctdbase.org/detail.go?type=gene&acc=1050,,,1050.0,CEBPA,9823,Sus scrofa (pig),[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of CEBPA mrna|troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of CEBPA mrna],,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
1144,2103968,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1051,CEBPB,https://ctdbase.org/detail.go?type=gene&acc=1051,,,1051.0,CEBPB,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CEBPB mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1145,2104093,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,629,CFB,https://ctdbase.org/detail.go?type=gene&acc=629,,,629.0,CFB,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of CFB mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1146,2104094,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1080,CFTR,https://ctdbase.org/detail.go?type=gene&acc=1080,,,1080.0,CFTR,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [vehicle emissions results in decreased activity of CFTR protein],,,PMID:34601066,https://www.ncbi.nlm.nih.gov/pubmed/34601066,34601066,,
1147,2104095,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1080,CFTR,https://ctdbase.org/detail.go?type=gene&acc=1080,,,1080.0,CFTR,9606,Homo sapiens (human),Ascorbic acid promotes the reaction [CFTR protein results in increased secretion of chlorides],,,PMID:14993613,https://www.ncbi.nlm.nih.gov/pubmed/14993613,14993613,,
1148,2104096,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1080,CFTR,https://ctdbase.org/detail.go?type=gene&acc=1080,,,1080.0,CFTR,9606,Homo sapiens (human),Ascorbic acid results in increased activity of CFTR protein,,,PMID:14993613|PMID:32374624,https://www.ncbi.nlm.nih.gov/pubmed/14993613|https://www.ncbi.nlm.nih.gov/pubmed/32374624,14993613|32374624,,
1149,2104097,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1080,CFTR,https://ctdbase.org/detail.go?type=gene&acc=1080,,,1080.0,CFTR,9606,Homo sapiens (human),[bicarbonates co-treated with glutathione co-treated with ascorbic acid] results in increased activity of CFTR protein,,,PMID:32374624,https://www.ncbi.nlm.nih.gov/pubmed/32374624,32374624,,
1150,2104098,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8208,CHAF1B,https://ctdbase.org/detail.go?type=gene&acc=8208,,,8208.0,CHAF1B,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of CHAF1B mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
1151,2104099,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2058,EPRS1,https://ctdbase.org/detail.go?type=gene&acc=2058,,,2058.0,EPRS1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of EPRS1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
1152,2104100,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1103,CHAT,https://ctdbase.org/detail.go?type=gene&acc=1103,,,1103.0,CHAT,10116,Rattus norvegicus (Norway rat),Tobacco smoke pollution inhibits the reaction [[ascorbic acid co-treated with alpha-tocopherol co-treated with acetylcysteine] results in increased expression of CHAT protein]|[ascorbic acid co-treated with alpha-tocopherol co-treated with acetylcysteine] results in increased expression of CHAT protein,,,PMID:25891525,https://www.ncbi.nlm.nih.gov/pubmed/25891525,25891525,,
1153,2104101,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11200,CHEK2,https://ctdbase.org/detail.go?type=gene&acc=11200,,,11200.0,CHEK2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of CHEK2 protein],,,PMID:31388677,https://www.ncbi.nlm.nih.gov/pubmed/31388677,31388677,,
1154,2104102,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11200,CHEK2,https://ctdbase.org/detail.go?type=gene&acc=11200,,,11200.0,CHEK2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [potassium chromate(vi) results in increased expression of CHEK2 protein modified form]|ascorbic acid inhibits the reaction [potassium chromate(vi) results in increased phosphorylation of CHEK2 protein],,,PMID:25977998,https://www.ncbi.nlm.nih.gov/pubmed/25977998,25977998,,
1155,2104265,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11200,CHEK2,https://ctdbase.org/detail.go?type=gene&acc=11200,,,11200.0,CHEK2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[kojic acid co-treated with diethylnitrosamine] results in increased expression of CHEK2 mrna],,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
1156,2104266,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,63924,CIDEC,https://ctdbase.org/detail.go?type=gene&acc=63924,,,63924.0,CIDEC,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CIDEC mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1157,2104267,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11113,CIT,https://ctdbase.org/detail.go?type=gene&acc=11113,,,11113.0,CIT,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of CIT mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1158,2104268,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4435,CITED1,https://ctdbase.org/detail.go?type=gene&acc=4435,,,4435.0,CITED1,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of CITED1 mrna|cadmium sulfate inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of CITED1 mrna],,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
1159,2104269,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9076,CLDN1,https://ctdbase.org/detail.go?type=gene&acc=9076,,,9076.0,CLDN1,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in decreased expression of CLDN1 mrna],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
1160,2104270,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1191,CLU,https://ctdbase.org/detail.go?type=gene&acc=1191,,,1191.0,CLU,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CLU mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1161,2104271,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,80790,CMIP,https://ctdbase.org/detail.go?type=gene&acc=80790,,,80790.0,CMIP,9606,Homo sapiens (human),Ascorbic acid results in increased expression of CMIP mrna|[arsenic trioxide co-treated with ascorbic acid] results in increased expression of CMIP mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1162,2104272,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1264,CNN1,https://ctdbase.org/detail.go?type=gene&acc=1264,,,1264.0,CNN1,9606,Homo sapiens (human),[ascorbic acid co-treated with TGFB1 protein] results in increased expression of CNN1 protein|[ascorbic acid co-treated with TGFB1 protein] results in increased expression of CNN1 mRNA,,,PMID:18607632,https://www.ncbi.nlm.nih.gov/pubmed/18607632,18607632,,
1163,2104273,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1264,CNN1,https://ctdbase.org/detail.go?type=gene&acc=1264,,,1264.0,CNN1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CNN1 protein,,,PMID:14639096,https://www.ncbi.nlm.nih.gov/pubmed/14639096,14639096,,
1164,2104274,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of CNR1 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
1165,2104426,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1269,CNR2,https://ctdbase.org/detail.go?type=gene&acc=1269,,,1269.0,CNR2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of CNR2 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
1166,2104427,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1270,CNTF,https://ctdbase.org/detail.go?type=gene&acc=1270,,,1270.0,CNTF,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [mercuric chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT1 protein]]|ascorbic acid inhibits the reaction [mercuric chloride inhibits the reaction [CNTF protein results in increased phosphorylation of STAT3 protein]],,,PMID:16896058,https://www.ncbi.nlm.nih.gov/pubmed/16896058,16896058,,
1167,2104428,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1272,CNTN1,https://ctdbase.org/detail.go?type=gene&acc=1272,,,1272.0,CNTN1,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of CNTN1 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1168,2104429,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8506,CNTNAP1,https://ctdbase.org/detail.go?type=gene&acc=8506,,,8506.0,CNTNAP1,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in increased expression of CNTNAP1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1169,2104430,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1300,COL10A1,https://ctdbase.org/detail.go?type=gene&acc=1300,,,1300.0,COL10A1,10090,Mus musculus (house mouse),U 0126 inhibits the reaction [ascorbic acid results in increased expression of COL10A1 mrna]|ascorbic acid results in increased expression of COL10A1 mRNA,,,PMID:20530736,https://www.ncbi.nlm.nih.gov/pubmed/20530736,20530736,,
1170,2104431,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1301,COL11A1,https://ctdbase.org/detail.go?type=gene&acc=1301,,,1301.0,COL11A1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of COL11A1 mRNA,,,PMID:17518733,https://www.ncbi.nlm.nih.gov/pubmed/17518733,17518733,,
1171,2104432,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10140,Cavia (guinea pigs),[ascorbic acid co-treated with ethanol] results in decreased expression of COL1A1 mRNA,,,PMID:22149461,https://www.ncbi.nlm.nih.gov/pubmed/22149461,22149461,,
1172,2104433,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10141,Cavia porcellus (domestic guinea pig),Ascorbic acid inhibits the reaction [ethanol results in increased expression of COL1A1 protein],,,PMID:24239723,https://www.ncbi.nlm.nih.gov/pubmed/24239723,24239723,,
1173,2104434,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of COL1A1 mRNA,,,PMID:12510807|PMID:28105418,https://www.ncbi.nlm.nih.gov/pubmed/12510807|https://www.ncbi.nlm.nih.gov/pubmed/28105418,12510807|28105418,,
1174,2104435,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10090,Mus musculus (house mouse),[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of COL1A1 mrna|4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[[dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbic acid] co-treated with fasudil] results in increased expression of COL1A1 mrna],,,PMID:31935364,https://www.ncbi.nlm.nih.gov/pubmed/31935364,31935364,,
1175,2104560,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of COL1A1 mRNA,,,PMID:14566779,https://www.ncbi.nlm.nih.gov/pubmed/14566779,14566779,,
1176,2104561,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,9823,Sus scrofa (pig),"2,2-bis(4-glycidyloxyphenyl)propane promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL1A1 mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL1A1 mRNA",,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
1177,2104562,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1278,COL1A2,https://ctdbase.org/detail.go?type=gene&acc=1278,,,1278.0,COL1A2,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in increased expression of COL1A2 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1178,2104563,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1278,COL1A2,https://ctdbase.org/detail.go?type=gene&acc=1278,,,1278.0,COL1A2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of COL1A2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1179,2104564,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1280,COL2A1,https://ctdbase.org/detail.go?type=gene&acc=1280,,,1280.0,COL2A1,9606,Homo sapiens (human),IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL2A1 mrna]|[tgfb3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL2A1 mrna|resveratrol inhibits the reaction [IL1B protein inhibits the reaction [[TGFB3 protein co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of COL2A1 mrna]],,,PMID:26526931,https://www.ncbi.nlm.nih.gov/pubmed/26526931,26526931,,
1180,2104565,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1280,COL2A1,https://ctdbase.org/detail.go?type=gene&acc=1280,,,1280.0,COL2A1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of COL2A1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1181,2104566,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1281,COL3A1,https://ctdbase.org/detail.go?type=gene&acc=1281,,,1281.0,COL3A1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of COL3A1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1182,2104567,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1356,CP,https://ctdbase.org/detail.go?type=gene&acc=1356,,,1356.0,CP,9606,Homo sapiens (human),CP mRNA affects the reaction [[ascorbic acid co-treated with zinc] results in increased degradation of heparitin sulfate]|copper affects the reaction [CP mRNA affects the reaction [[ascorbic acid co-treated with zinc] results in increased degradation of heparitin sulfate]],,,PMID:14707133,https://www.ncbi.nlm.nih.gov/pubmed/14707133,14707133,,
1183,2104568,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1380,CR2,https://ctdbase.org/detail.go?type=gene&acc=1380,,,1380.0,CR2,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of CR2 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1184,2104697,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1397,CRIP2,https://ctdbase.org/detail.go?type=gene&acc=1397,,,1397.0,CRIP2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CRIP2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1185,2104698,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2670,GFAP,https://ctdbase.org/detail.go?type=gene&acc=2670,,,2670.0,GFAP,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of GFAP protein,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1186,2104699,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1401,CRP,https://ctdbase.org/detail.go?type=gene&acc=1401,,,1401.0,CRP,9606,Homo sapiens (human),[vitamin E co-treated with ascorbic acid co-treated with folic acid co-treated with riboflavin co-treated with vitamin B 6 co-treated with vitamin B 12] results in decreased expression of CRP protein|[vitamin E co-treated with ascorbic acid] results in decreased expression of CRP protein,,,PMID:16517955,https://www.ncbi.nlm.nih.gov/pubmed/16517955,16517955,,
1187,2104700,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1410,CRYAB,https://ctdbase.org/detail.go?type=gene&acc=1410,,,1410.0,CRYAB,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CRYAB mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1188,2104701,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1410,CRYAB,https://ctdbase.org/detail.go?type=gene&acc=1410,,,1410.0,CRYAB,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CRYAB mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1189,2104702,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1431,CS,https://ctdbase.org/detail.go?type=gene&acc=1431,,,1431.0,CS,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein],,,PMID:27385396,https://www.ncbi.nlm.nih.gov/pubmed/27385396,27385396,,
1190,2104703,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10675,CSPG5,https://ctdbase.org/detail.go?type=gene&acc=10675,,,10675.0,CSPG5,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of CSPG5 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1191,2104704,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1465,CSRP1,https://ctdbase.org/detail.go?type=gene&acc=1465,,,1465.0,CSRP1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CSRP1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1192,2104705,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1474,CST6,https://ctdbase.org/detail.go?type=gene&acc=1474,,,1474.0,CST6,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of CST6 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1193,2104706,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in increased expression of and affects the localization of CTNNB1 protein]|[ascorbic acid co-treated with vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CTNNB1 protein],,,PMID:29940330,https://www.ncbi.nlm.nih.gov/pubmed/29940330,29940330,,
1194,2104840,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9823,Sus scrofa (pig),"[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of CTNNB1 mrna|troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of CTNNB1 mrna]|2,2-bis(4-glycidyloxyphenyl)propane promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of CTNNB1 mrna]",,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
1195,2104841,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,56474,CTPS2,https://ctdbase.org/detail.go?type=gene&acc=56474,,,56474.0,CTPS2,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of CTPS2 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1196,2104842,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1509,CTSD,https://ctdbase.org/detail.go?type=gene&acc=1509,,,1509.0,CTSD,10116,Rattus norvegicus (Norway rat),[ferulic acid co-treated with ascorbic acid] inhibits the reaction [isoproterenol results in increased activity of CTSD protein],,,PMID:17045618,https://www.ncbi.nlm.nih.gov/pubmed/17045618,17045618,,
1197,2104843,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1513,CTSK,https://ctdbase.org/detail.go?type=gene&acc=1513,,,1513.0,CTSK,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of CTSK mRNA,,,PMID:15730627,https://www.ncbi.nlm.nih.gov/pubmed/15730627,15730627,,
1198,2104844,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1519,CTSO,https://ctdbase.org/detail.go?type=gene&acc=1519,,,1519.0,CTSO,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of CTSO mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1199,2104845,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2919,CXCL1,https://ctdbase.org/detail.go?type=gene&acc=2919,,,2919.0,CXCL1,10116,Rattus norvegicus (Norway rat),Ascorbic acid deficiency results in increased expression of CXCL1 mrna|ascorbic acid deficiency results in increased expression of CXCL1 protein,,,PMID:16637227,https://www.ncbi.nlm.nih.gov/pubmed/16637227,16637227,,
1200,2104846,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3627,CXCL10,https://ctdbase.org/detail.go?type=gene&acc=3627,,,3627.0,CXCL10,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of CXCL10 mrna|ascorbic acid deficiency results in increased expression of CXCL10 mRNA,,,PMID:19932582,https://www.ncbi.nlm.nih.gov/pubmed/19932582,19932582,,
1201,2104847,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,6372,CXCL6,https://ctdbase.org/detail.go?type=gene&acc=6372,,,6372.0,CXCL6,9606,Homo sapiens (human),Ascorbic acid deficiency results in increased expression of CXCL6 mrna|ascorbic acid results in decreased expression of CXCL6 mRNA,,,PMID:19932582,https://www.ncbi.nlm.nih.gov/pubmed/19932582,19932582,,
1202,2104848,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),Ascorbic acid deficiency affects the expression of CXCL8 mrna|ascorbic acid affects the expression of CXCL8 mRNA,,,PMID:19932582,https://www.ncbi.nlm.nih.gov/pubmed/19932582,19932582,,
1203,2104849,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),Ascorbic acid affects the reaction [homocysteine results in increased secretion of CXCL8 protein]|ascorbic acid affects the reaction [homocysteine thiolactone results in increased secretion of CXCL8 protein],,,PMID:16715183,https://www.ncbi.nlm.nih.gov/pubmed/16715183,16715183,,
1204,2104971,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),[ascorbic acid co-treated with alpha-tocopherol co-treated with ferulic acid] inhibits the reaction [[ozone co-treated with oxygen] results in increased expression of CXCL8 mrna],,,PMID:26270818,https://www.ncbi.nlm.nih.gov/pubmed/26270818,26270818,,
1205,2104972,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606,Homo sapiens (human),[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]|[ascorbic acid co-treated with lycopene co-treated with alpha-tocopherol] inhibits the reaction [TNF protein results in increased expression of CXCL8 mrna]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of CXCL8 mrna]|ascorbic acid inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein],,,PMID:25551565,https://www.ncbi.nlm.nih.gov/pubmed/25551565,25551565,,
1206,2104973,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4283,CXCL9,https://ctdbase.org/detail.go?type=gene&acc=4283,,,4283.0,CXCL9,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of CXCL9 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1207,2104974,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,643,CXCR5,https://ctdbase.org/detail.go?type=gene&acc=643,,,643.0,CXCR5,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of CXCR5 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1208,2104975,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1528,CYB5A,https://ctdbase.org/detail.go?type=gene&acc=1528,,,1528.0,CYB5A,10140,Cavia (guinea pigs),[ascorbic acid deficiency co-treated with buthionine sulfoximine] results in decreased expression of CYB5A mrna|[ascorbic acid deficiency co-treated with buthionine sulfoximine] results in decreased expression of CYB5A protein,,,PMID:20221587,https://www.ncbi.nlm.nih.gov/pubmed/20221587,20221587,,
1209,2104976,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1535,CYBA,https://ctdbase.org/detail.go?type=gene&acc=1535,,,1535.0,CYBA,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of CYBA protein]|ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of CYBA mrna],,,PMID:25305479,https://www.ncbi.nlm.nih.gov/pubmed/25305479,25305479,,
1210,2104977,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1536,CYBB,https://ctdbase.org/detail.go?type=gene&acc=1536,,,1536.0,CYBB,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of CYBB protein,,,PMID:21570463,https://www.ncbi.nlm.nih.gov/pubmed/21570463,21570463,,
1211,2104978,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,79901,CYBRD1,https://ctdbase.org/detail.go?type=gene&acc=79901,,,79901.0,CYBRD1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of CYBRD1 protein|ascorbic acid results in decreased expression of CYBRD1 protein,,,PMID:18815723,https://www.ncbi.nlm.nih.gov/pubmed/18815723,18815723,,
1212,2104979,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [TNFSF10 protein affects the localization of CYCS protein],,,PMID:23711929,https://www.ncbi.nlm.nih.gov/pubmed/23711929,23711929,,
1213,2105090,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of CYP11A1 mRNA,,,PMID:17901237,https://www.ncbi.nlm.nih.gov/pubmed/17901237,17901237,,
1214,2105091,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cadmium results in decreased expression of CYP11A1 mrna],,,PMID:15223132,https://www.ncbi.nlm.nih.gov/pubmed/15223132,15223132,,
1215,2105092,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased activity of CYP11A1 protein],,,PMID:16298753,https://www.ncbi.nlm.nih.gov/pubmed/16298753,16298753,,
1216,2105093,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of CYP11A1 mrna],,,PMID:17280759,https://www.ncbi.nlm.nih.gov/pubmed/17280759,17280759,,
1217,2105094,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of CYP19A1 mRNA,,,PMID:17901237,https://www.ncbi.nlm.nih.gov/pubmed/17901237,17901237,,
1218,2105095,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of CYP19A1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1219,2105096,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]|ascorbic acid inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A1 mrna]|ascorbic acid inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein],,,PMID:19268519,https://www.ncbi.nlm.nih.gov/pubmed/19268519,19268519,,
1220,2105097,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090,Mus musculus (house mouse),Ascorbic acid affects the reaction [beta-naphthoflavone results in increased expression of CYP1A1 mrna]|ascorbic acid affects the reaction [andrographolide affects the reaction [beta-naphthoflavone results in increased expression of CYP1A1 mrna]],,,PMID:21094198,https://www.ncbi.nlm.nih.gov/pubmed/21094198,21094198,,
1221,2105098,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in increased expression of CYP1A1 mrna]|ascorbic acid inhibits the reaction [sodium arsenite results in increased expression of CYP1A1 mrna],,,PMID:16517059,https://www.ncbi.nlm.nih.gov/pubmed/16517059,16517059,,
1222,2105099,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,10116,Rattus norvegicus (Norway rat),Ascorbic acid deficiency results in increased expression of CYP1A2 mrna|ascorbic acid deficiency results in increased expression of CYP1A2 protein,,,PMID:8269614,https://www.ncbi.nlm.nih.gov/pubmed/8269614,8269614,,
1223,2105197,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1591,CYP24A1,https://ctdbase.org/detail.go?type=gene&acc=1591,,,1591.0,CYP24A1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of CYP24A1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1224,2105198,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,56603,CYP26B1,https://ctdbase.org/detail.go?type=gene&acc=56603,,,56603.0,CYP26B1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CYP26B1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1225,2105199,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,13087,CYP2A5,https://ctdbase.org/detail.go?type=gene&acc=13087,,,13087.0,Cyp2a5,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [ethanol results in increased expression of and results in increased activity of CYP2A5 protein],,,PMID:22552773,https://www.ncbi.nlm.nih.gov/pubmed/22552773,22552773,,
1226,2105200,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,13087,CYP2A5,https://ctdbase.org/detail.go?type=gene&acc=13087,,,13087.0,Cyp2a5,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CYP2A5 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1227,2105201,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1548,CYP2A6,https://ctdbase.org/detail.go?type=gene&acc=1548,,,1548.0,CYP2A6,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [ethanol results in increased expression of CYP2A6 protein]|ascorbic acid inhibits the reaction [ethanol results in increased expression of CYP2A6 mrna],,,PMID:22530035,https://www.ncbi.nlm.nih.gov/pubmed/22530035,22530035,,
1228,2105202,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1548,CYP2A6,https://ctdbase.org/detail.go?type=gene&acc=1548,,,1548.0,CYP2A6,9606,Homo sapiens (human),Ascorbic acid results in decreased activity of CYP2A6 protein,,,PMID:17512695,https://www.ncbi.nlm.nih.gov/pubmed/17512695,17512695,,
1229,2105203,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,13088,CYP2B10,https://ctdbase.org/detail.go?type=gene&acc=13088,,,13088.0,Cyp2b10,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CYP2B10 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1230,2105204,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,361523,CYP2B2,https://ctdbase.org/detail.go?type=gene&acc=361523,,,361523.0,Cyp2b2,10116,Rattus norvegicus (Norway rat),Ascorbic acid deficiency results in decreased expression of CYP2B2 protein,,,PMID:8269614,https://www.ncbi.nlm.nih.gov/pubmed/8269614,8269614,,
1231,2105205,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1556,CYP2B7P,https://ctdbase.org/detail.go?type=gene&acc=1556,,,1556.0,CYP2B7P,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of CYP2B7P mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1232,2105325,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,13094,CYP2B9,https://ctdbase.org/detail.go?type=gene&acc=13094,,,13094.0,Cyp2b9,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CYP2B9 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1233,2105326,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,10140,Cavia (guinea pigs),[ascorbic acid co-treated with ethanol] results in decreased expression of CYP2E1 mRNA,,,PMID:22149461,https://www.ncbi.nlm.nih.gov/pubmed/22149461,22149461,,
1234,2105327,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,9606,Homo sapiens (human),Ascorbic acid results in decreased activity of CYP2E1 protein,,,PMID:17512695,https://www.ncbi.nlm.nih.gov/pubmed/17512695,17512695,,
1235,2105328,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [abamectin results in increased expression of CYP2E1 protein]|[ascorbic acid co-treated with sesame oil] inhibits the reaction [abamectin results in increased expression of CYP2E1 protein],,,PMID:31739238,https://www.ncbi.nlm.nih.gov/pubmed/31739238,31739238,,
1236,2105329,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased expression of CYP2E1 protein]|ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased expression of CYP2E1 mrna],,,PMID:31585129,https://www.ncbi.nlm.nih.gov/pubmed/31585129,31585129,,
1237,2105330,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1577,CYP3A5,https://ctdbase.org/detail.go?type=gene&acc=1577,,,1577.0,CYP3A5,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CYP3A5 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1238,2105331,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,13117,CYP4A10,https://ctdbase.org/detail.go?type=gene&acc=13117,,,13117.0,Cyp4a10,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CYP4A10 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1239,2105332,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with ascorbic acid] results in increased expression of CYP7A1 mrna|[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of CYP7A1 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1240,2105333,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1601,DAB2,https://ctdbase.org/detail.go?type=gene&acc=1601,,,1601.0,DAB2,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of DAB2 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1241,2105504,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1610,DAO,https://ctdbase.org/detail.go?type=gene&acc=1610,,,1610.0,DAO,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [diquat results in increased activity of DAO protein],,,PMID:33475796,https://www.ncbi.nlm.nih.gov/pubmed/33475796,33475796,,
1242,2105505,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1630,DCC,https://ctdbase.org/detail.go?type=gene&acc=1630,,,1630.0,DCC,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DCC mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1243,2105506,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9201,DCLK1,https://ctdbase.org/detail.go?type=gene&acc=9201,,,9201.0,DCLK1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of DCLK1 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1244,2105507,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1634,DCN,https://ctdbase.org/detail.go?type=gene&acc=1634,,,1634.0,DCN,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DCN mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1245,2105508,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1641,DCX,https://ctdbase.org/detail.go?type=gene&acc=1641,,,1641.0,DCX,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of DCX mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1246,2105509,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with kojic acid co-treated with diethylnitrosamine] results in decreased expression of DDIT3 mRNA,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
1247,2105510,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,10170,DHRS9,https://ctdbase.org/detail.go?type=gene&acc=10170,,,10170.0,DHRS9,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DHRS9 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1248,2105511,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,22943,DKK1,https://ctdbase.org/detail.go?type=gene&acc=22943,,,22943.0,DKK1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of DKK1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
1249,2105512,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,27123,DKK2,https://ctdbase.org/detail.go?type=gene&acc=27123,,,27123.0,DKK2,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [benzo(a)pyrene results in increased methylation of DKK2 promoter]|ascorbic acid inhibits the reaction [benzo(a)pyrene results in decreased expression of DKK2 mrna],,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1250,2105661,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1738,DLD,https://ctdbase.org/detail.go?type=gene&acc=1738,,,1738.0,DLD,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [cadmium chloride results in decreased activity of and results in increased phosphorylation of DLD protein],,,PMID:29158198,https://www.ncbi.nlm.nih.gov/pubmed/29158198,29158198,,
1251,2105662,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1742,DLG4,https://ctdbase.org/detail.go?type=gene&acc=1742,,,1742.0,DLG4,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of DLG4 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1252,2105663,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1742,DLG4,https://ctdbase.org/detail.go?type=gene&acc=1742,,,1742.0,DLG4,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [corticosterone results in decreased expression of DLG4 protein],,,PMID:33872575,https://www.ncbi.nlm.nih.gov/pubmed/33872575,33872575,,
1253,2105664,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9787,DLGAP5,https://ctdbase.org/detail.go?type=gene&acc=9787,,,9787.0,DLGAP5,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of DLGAP5 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1254,2105665,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1758,DMP1,https://ctdbase.org/detail.go?type=gene&acc=1758,,,1758.0,DMP1,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of DMP1 mrna|rosiglitazone inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of DMP1 mrna]|bexarotene inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of DMP1 mrna]|tributyltin inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of DMP1 mrna],,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
1255,2105666,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3337,DNAJB1,https://ctdbase.org/detail.go?type=gene&acc=3337,,,3337.0,DNAJB1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DNAJB1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1256,2105667,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54431,DNAJC10,https://ctdbase.org/detail.go?type=gene&acc=54431,,,54431.0,DNAJC10,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [fenretinide results in increased expression of DNAJC10 mrna],,,PMID:17353921,https://www.ncbi.nlm.nih.gov/pubmed/17353921,17353921,,
1257,2105668,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1773,DNASE1,https://ctdbase.org/detail.go?type=gene&acc=1773,,,1773.0,DNASE1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of DNASE1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1258,2105669,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8193,DPF1,https://ctdbase.org/detail.go?type=gene&acc=8193,,,8193.0,DPF1,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of DPF1 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
1259,2105807,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1803,DPP4,https://ctdbase.org/detail.go?type=gene&acc=1803,,,1803.0,DPP4,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of DPP4 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1260,2105808,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,151871,DPPA2,https://ctdbase.org/detail.go?type=gene&acc=151871,,,151871.0,DPPA2,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of DPPA2 mRNA,,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
1261,2105809,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,434423,DPPA5A,https://ctdbase.org/detail.go?type=gene&acc=434423,,,434423.0,Dppa5a,10090,Mus musculus (house mouse),Ascorbic acid results in decreased expression of DPPA5A mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1262,2105810,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1848,DUSP6,https://ctdbase.org/detail.go?type=gene&acc=1848,,,1848.0,DUSP6,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of DUSP6 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1263,2105811,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1870,E2F2,https://ctdbase.org/detail.go?type=gene&acc=1870,,,1870.0,E2F2,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of E2F2 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1264,2105812,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,253738,EBF3,https://ctdbase.org/detail.go?type=gene&acc=253738,,,253738.0,EBF3,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EBF3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1265,2105813,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,641700,ECSCR,https://ctdbase.org/detail.go?type=gene&acc=641700,,,641700.0,ECSCR,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ECSCR mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1266,2105814,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906.0,EDN1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of EDN1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1267,2105815,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1908,EDN3,https://ctdbase.org/detail.go?type=gene&acc=1908,,,1908.0,EDN3,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of EDN3 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1268,2105816,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1910,EDNRB,https://ctdbase.org/detail.go?type=gene&acc=1910,,,1910.0,EDNRB,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of EDNRB mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1269,2105955,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of EGFR mRNA,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
1270,2105956,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54583,EGLN1,https://ctdbase.org/detail.go?type=gene&acc=54583,,,54583.0,EGLN1,10090,Mus musculus (house mouse),EGLN1 mRNA affects the reaction [ascorbic acid results in increased expression of SP7 protein],,,PMID:21467157,https://www.ncbi.nlm.nih.gov/pubmed/21467157,21467157,,
1271,2105957,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,112399,EGLN3,https://ctdbase.org/detail.go?type=gene&acc=112399,,,112399.0,EGLN3,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EGLN3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1272,2105958,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,112399,EGLN3,https://ctdbase.org/detail.go?type=gene&acc=112399,,,112399.0,EGLN3,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of EGLN3 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1273,2105959,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8894,EIF2S2,https://ctdbase.org/detail.go?type=gene&acc=8894,,,8894.0,EIF2S2,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of EIF2S2 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
1274,2105960,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8661,EIF3A,https://ctdbase.org/detail.go?type=gene&acc=8661,,,8661.0,EIF3A,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of EIF3A mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
1275,2105961,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8663,EIF3C,https://ctdbase.org/detail.go?type=gene&acc=8663,,,8663.0,EIF3C,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of EIF3C mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
1276,2105962,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8668,EIF3I,https://ctdbase.org/detail.go?type=gene&acc=8668,,,8668.0,EIF3I,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of EIF3I mRNA,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
1277,2105963,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1973,EIF4A1,https://ctdbase.org/detail.go?type=gene&acc=1973,,,1973.0,EIF4A1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of EIF4A1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
1278,2105964,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,286512,EIF4A2P4,https://ctdbase.org/detail.go?type=gene&acc=286512,,,286512.0,EIF4A2P4,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of EIF4A2P4 mrna|ascorbic acid results in decreased expression of EIF4A2P4 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1279,2106063,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1995,ELAVL3,https://ctdbase.org/detail.go?type=gene&acc=1995,,,1995.0,ELAVL3,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ELAVL3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1280,2106064,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1996,ELAVL4,https://ctdbase.org/detail.go?type=gene&acc=1996,,,1996.0,ELAVL4,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ELAVL4 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1281,2106065,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,54859,ELP6,https://ctdbase.org/detail.go?type=gene&acc=54859,,,54859.0,ELP6,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of ELP6 mrna|ascorbic acid results in decreased expression of ELP6 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1282,2106066,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2012,EMP1,https://ctdbase.org/detail.go?type=gene&acc=2012,,,2012.0,EMP1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of EMP1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1283,2106067,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2014,EMP3,https://ctdbase.org/detail.go?type=gene&acc=2014,,,2014.0,EMP3,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of EMP3 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1284,2106068,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2018,EMX2,https://ctdbase.org/detail.go?type=gene&acc=2018,,,2018.0,EMX2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of EMX2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1285,2106069,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2019,EN1,https://ctdbase.org/detail.go?type=gene&acc=2019,,,2019.0,EN1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [benzo(a)pyrene results in decreased expression of EN1 mrna]|ascorbic acid inhibits the reaction [benzo(a)pyrene results in increased methylation of EN1 promoter],,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1286,2106070,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2034,EPAS1,https://ctdbase.org/detail.go?type=gene&acc=2034,,,2034.0,EPAS1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [nickel sulfate results in increased expression of EPAS1 protein],,,PMID:16288478,https://www.ncbi.nlm.nih.gov/pubmed/16288478,16288478,,
1287,2106071,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2052,EPHX1,https://ctdbase.org/detail.go?type=gene&acc=2052,,,2052.0,EPHX1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of EPHX1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1288,2106203,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2053,EPHX2,https://ctdbase.org/detail.go?type=gene&acc=2053,,,2053.0,EPHX2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of EPHX2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1289,2106204,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2068,ERCC2,https://ctdbase.org/detail.go?type=gene&acc=2068,,,2068.0,ERCC2,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of ERCC2 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1290,2106205,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2072,ERCC4,https://ctdbase.org/detail.go?type=gene&acc=2072,,,2072.0,ERCC4,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of ERCC4 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1291,2106206,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2073,ERCC5,https://ctdbase.org/detail.go?type=gene&acc=2073,,,2073.0,ERCC5,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of ERCC5 mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1292,2106207,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of ESR1 mrna],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
1293,2106208,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of ESR2 mrna],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
1294,2106209,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,790952,ESRG,https://ctdbase.org/detail.go?type=gene&acc=790952,,,790952.0,ESRG,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ESRG mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1295,2106210,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2145,EZH1,https://ctdbase.org/detail.go?type=gene&acc=2145,,,2145.0,EZH1,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of EZH1 mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
1296,2106211,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2146,EZH2,https://ctdbase.org/detail.go?type=gene&acc=2146,,,2146.0,EZH2,9606,Homo sapiens (human),EZH2 protein inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of TNFRSF11B mrna]|ezh2 protein inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of RUNX2 mrna]|ezh2 protein inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of SATB2 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of EZH2 protein|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of EZH2 mrna|ezh2 protein inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of ALPL mrna],,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
1297,2106356,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2152,F3,https://ctdbase.org/detail.go?type=gene&acc=2152,,,2152.0,F3,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [norepinephrine results in increased expression of F3 mrna],,,PMID:23114885,https://www.ncbi.nlm.nih.gov/pubmed/23114885,23114885,,
1298,2106357,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FABP1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1299,2106358,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA,,,PMID:25932594,https://www.ncbi.nlm.nih.gov/pubmed/25932594,25932594,,
1300,2106359,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mrna|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS1 protein co-treated with firemaster 550] results in increased expression of FABP4 mRNA,,,PMID:25062436,https://www.ncbi.nlm.nih.gov/pubmed/25062436,25062436,,
1301,2106360,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090,Mus musculus (house mouse),"Pioglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|tetrabromobisphenol A promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|rosiglitazone promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna|triphenyltin hydroxide promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]|d,d-T80-prallethrin promotes the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna]",,,PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/32473317,32473317,,
1302,2106361,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,9823,Sus scrofa (pig),"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of FABP4 mrna]|troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of FABP4 mrna]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] results in increased expression of FABP4 mRNA",,,PMID:30481989,https://www.ncbi.nlm.nih.gov/pubmed/30481989,30481989,,
1303,2106362,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2172,FABP6,https://ctdbase.org/detail.go?type=gene&acc=2172,,,2172.0,FABP6,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of FABP6 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1304,2106363,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2184,FAH,https://ctdbase.org/detail.go?type=gene&acc=2184,,,2184.0,FAH,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FAH mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1305,2106500,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,55120,FANCL,https://ctdbase.org/detail.go?type=gene&acc=55120,,,55120.0,FANCL,9606,Homo sapiens (human),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in decreased expression of FANCL mRNA,,,PMID:26424790,https://www.ncbi.nlm.nih.gov/pubmed/26424790,26424790,,
1306,2106501,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2195,FAT1,https://ctdbase.org/detail.go?type=gene&acc=2195,,,2195.0,FAT1,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in increased expression of FAT1 mrna|ascorbic acid results in increased expression of FAT1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1307,2106502,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2192,FBLN1,https://ctdbase.org/detail.go?type=gene&acc=2192,,,2192.0,FBLN1,9606,Homo sapiens (human),[arsenic trioxide co-treated with ascorbic acid] results in increased expression of FBLN1 mrna|ascorbic acid results in increased expression of FBLN1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1308,2106503,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2203,FBP1,https://ctdbase.org/detail.go?type=gene&acc=2203,,,2203.0,FBP1,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of FBP1 protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
1309,2106504,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,114907,FBXO32,https://ctdbase.org/detail.go?type=gene&acc=114907,,,114907.0,FBXO32,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FBXO32 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1310,2106505,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2232,FDXR,https://ctdbase.org/detail.go?type=gene&acc=2232,,,2232.0,FDXR,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of FDXR mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1311,2106506,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2244,FGB,https://ctdbase.org/detail.go?type=gene&acc=2244,,,2244.0,FGB,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGB mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1312,2106507,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2246,FGF1,https://ctdbase.org/detail.go?type=gene&acc=2246,,,2246.0,FGF1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of KEAP1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPX2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGG mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of PLN mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HAVCR1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GATA6 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TF mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ZFAND2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ISL1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ESRG mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXB3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ASCL1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TFAP2A mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of CYP24A1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of CEACAM6 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FLT1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of SERPINA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of APOA1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of RRAD mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of VCAM1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLM mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SRXN1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of H2BC14 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MPZL1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FOXG1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of UGT2A3 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of POU5F1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TM4SF4 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTO1 mrna|[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of SOX2 mrna|[[ascorbic acid co-treate,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1313,2106508,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2247,FGF2,https://ctdbase.org/detail.go?type=gene&acc=2247,,,2247.0,FGF2,9031,Gallus gallus (chicken),Ascorbic acid promotes the reaction [alliin results in decreased activity of FGF2 protein],,,PMID:16351512,https://www.ncbi.nlm.nih.gov/pubmed/16351512,16351512,,
1314,2106509,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2252,FGF7,https://ctdbase.org/detail.go?type=gene&acc=2252,,,2252.0,FGF7,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGF7 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1315,2106659,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2266,FGG,https://ctdbase.org/detail.go?type=gene&acc=2266,,,2266.0,FGG,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FGG mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1316,2106660,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,23767,FLRT3,https://ctdbase.org/detail.go?type=gene&acc=23767,,,23767.0,FLRT3,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of FLRT3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1317,2106661,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2817,GPC1,https://ctdbase.org/detail.go?type=gene&acc=2817,,,2817.0,GPC1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of GPC1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1318,2106662,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2321,FLT1,https://ctdbase.org/detail.go?type=gene&acc=2321,,,2321.0,FLT1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FLT1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1319,2106663,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2321,FLT1,https://ctdbase.org/detail.go?type=gene&acc=2321,,,2321.0,FLT1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of FLT1 mRNA,,,PMID:21919647,https://www.ncbi.nlm.nih.gov/pubmed/21919647,21919647,,
1320,2106664,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2326,FMO1,https://ctdbase.org/detail.go?type=gene&acc=2326,,,2326.0,FMO1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of FMO1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1321,2106665,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2330,FMO5,https://ctdbase.org/detail.go?type=gene&acc=2330,,,2330.0,FMO5,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of FMO5 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1322,2106666,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2332,FMR1,https://ctdbase.org/detail.go?type=gene&acc=2332,,,2332.0,FMR1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein],,,PMID:27385396,https://www.ncbi.nlm.nih.gov/pubmed/27385396,27385396,,
1323,2106667,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,9606,Homo sapiens (human),[ascorbic acid co-treated with quartz] results in increased expression of FN1 mRNA,,,PMID:27381660,https://www.ncbi.nlm.nih.gov/pubmed/27381660,27381660,,
1324,2106668,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of FN1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1325,2106822,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,79672,FN3KRP,https://ctdbase.org/detail.go?type=gene&acc=79672,,,79672.0,FN3KRP,9606,Homo sapiens (human),Ascorbic acid results in increased expression of FN3KRP mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1326,2106823,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of FOS mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1327,2106824,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,3170,FOXA2,https://ctdbase.org/detail.go?type=gene&acc=3170,,,3170.0,FOXA2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [nitrofen results in decreased expression of FOXA2 protein],,,PMID:16863852,https://www.ncbi.nlm.nih.gov/pubmed/16863852,16863852,,
1328,2106825,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,27022,FOXD3,https://ctdbase.org/detail.go?type=gene&acc=27022,,,27022.0,FOXD3,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FOXD3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1329,2106826,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2290,FOXG1,https://ctdbase.org/detail.go?type=gene&acc=2290,,,2290.0,FOXG1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of FOXG1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1330,2106827,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2302,FOXJ1,https://ctdbase.org/detail.go?type=gene&acc=2302,,,2302.0,FOXJ1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of FOXJ1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1331,2106828,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2302,FOXJ1,https://ctdbase.org/detail.go?type=gene&acc=2302,,,2302.0,FOXJ1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of FOXJ1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1332,2106829,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2305,FOXM1,https://ctdbase.org/detail.go?type=gene&acc=2305,,,2305.0,FOXM1,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of FOXM1 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1333,2106830,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309.0,FOXO3,9606,Homo sapiens (human),Ascorbic acid results in increased expression of FOXO3 mrna|foxo3 protein affects the reaction [ascorbic acid results in decreased expression of PCSK9 protein]|ascorbic acid affects the localization of FOXO3 protein|foxo3 protein affects the reaction [ascorbic acid results in increased expression of LDLR protein]|ascorbic acid results in increased expression of and results in decreased phosphorylation of FOXO3 protein,,,PMID:32913121,https://www.ncbi.nlm.nih.gov/pubmed/32913121,32913121,,
1334,2106973,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased expression of FSHB protein],,,PMID:16248992|PMID:17280759,https://www.ncbi.nlm.nih.gov/pubmed/16248992|https://www.ncbi.nlm.nih.gov/pubmed/17280759,16248992|17280759,,
1335,2106974,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in increased expression of FSHB protein],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
1336,2106975,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in increased expression of FSHB protein],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
1337,2106976,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2492,FSHR,https://ctdbase.org/detail.go?type=gene&acc=2492,,,2492.0,FSHR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of FSHR mrna],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
1338,2106977,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2492,FSHR,https://ctdbase.org/detail.go?type=gene&acc=2492,,,2492.0,FSHR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of FSHR mrna]|ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of FSHR protein],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
1339,2106978,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2495,FTH1,https://ctdbase.org/detail.go?type=gene&acc=2495,,,2495.0,FTH1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of FTH1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1340,2106979,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2512,FTL,https://ctdbase.org/detail.go?type=gene&acc=2512,,,2512.0,FTL,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of FTL protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
1341,2106980,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2534,FYN,https://ctdbase.org/detail.go?type=gene&acc=2534,,,2534.0,FYN,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [bis(2-hydroxy-2-ethylbutanoato)oxochromate(v) results in increased phosphorylation of FYN protein]|ascorbic acid inhibits the reaction [potassium dichromate results in increased phosphorylation of FYN protein],,,PMID:14572611,https://www.ncbi.nlm.nih.gov/pubmed/14572611,14572611,,
1342,2106981,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11211,FZD10,https://ctdbase.org/detail.go?type=gene&acc=11211,,,11211.0,FZD10,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of FZD10 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1343,2106982,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2535,FZD2,https://ctdbase.org/detail.go?type=gene&acc=2535,,,2535.0,FZD2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of FZD2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1344,2107194,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,50486,G0S2,https://ctdbase.org/detail.go?type=gene&acc=50486,,,50486.0,G0S2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of G0S2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1345,2107195,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539.0,G6PD,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [cadmium chloride results in decreased activity of G6PD protein],,,PMID:18548748,https://www.ncbi.nlm.nih.gov/pubmed/18548748,18548748,,
1346,2107196,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11337,GABARAP,https://ctdbase.org/detail.go?type=gene&acc=11337,,,11337.0,GABARAP,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of GABARAP mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1347,2107197,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2555,GABRA2,https://ctdbase.org/detail.go?type=gene&acc=2555,,,2555.0,GABRA2,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GABRA2 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1348,2107198,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GADD45A mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1349,2107199,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,4616,GADD45B,https://ctdbase.org/detail.go?type=gene&acc=4616,,,4616.0,GADD45B,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with kojic acid co-treated with diethylnitrosamine] results in decreased expression of GADD45B mRNA,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
1350,2107200,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2580,GAK,https://ctdbase.org/detail.go?type=gene&acc=2580,,,2580.0,GAK,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in decreased expression of GAK mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1351,2107201,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,51083,GAL,https://ctdbase.org/detail.go?type=gene&acc=51083,,,51083.0,GAL,10116,Rattus norvegicus (Norway rat),[ferulic acid co-treated with ascorbic acid] inhibits the reaction [isoproterenol results in increased activity of GAL protein],,,PMID:17045618,https://www.ncbi.nlm.nih.gov/pubmed/17045618,17045618,,
1352,2107202,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2592,GALT,https://ctdbase.org/detail.go?type=gene&acc=2592,,,2592.0,GALT,7227,Drosophila melanogaster (fruit fly),Ascorbic acid inhibits the reaction [GALT gene mutant form results in increased susceptibility to galactose],,,PMID:22773758,https://www.ncbi.nlm.nih.gov/pubmed/22773758,22773758,,
1353,2107203,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2593,GAMT,https://ctdbase.org/detail.go?type=gene&acc=2593,,,2593.0,GAMT,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of GAMT protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
1354,2107329,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2597,GAPDH,https://ctdbase.org/detail.go?type=gene&acc=2597,,,2597.0,GAPDH,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of GAPDH protein,,,PMID:22139585,https://www.ncbi.nlm.nih.gov/pubmed/22139585,22139585,,
1355,2107330,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2597,GAPDH,https://ctdbase.org/detail.go?type=gene&acc=2597,,,2597.0,GAPDH,9986,Oryctolagus cuniculus (rabbit),"Ascorbic acid affects the reaction [3,4-dihydroxyphenylacetaldehyde binds to and affects the metabolism of GAPDH protein]",,,PMID:19537779,https://www.ncbi.nlm.nih.gov/pubmed/19537779,19537779,,
1356,2107331,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2617,GARS1,https://ctdbase.org/detail.go?type=gene&acc=2617,,,2617.0,GARS1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of GARS1 mRNA,,,PMID:19197388,https://www.ncbi.nlm.nih.gov/pubmed/19197388,19197388,,
1357,2107332,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,8522,GAS7,https://ctdbase.org/detail.go?type=gene&acc=8522,,,8522.0,GAS7,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of GAS7 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1358,2107333,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2623,GATA1,https://ctdbase.org/detail.go?type=gene&acc=2623,,,2623.0,GATA1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of GATA1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1359,2107334,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2626,GATA4,https://ctdbase.org/detail.go?type=gene&acc=2626,,,2626.0,GATA4,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of GATA4 mRNA,,,PMID:12668514,https://www.ncbi.nlm.nih.gov/pubmed/12668514,12668514,,
1360,2107335,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2627,GATA6,https://ctdbase.org/detail.go?type=gene&acc=2627,,,2627.0,GATA6,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GATA6 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1361,2107336,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2634,GBP2,https://ctdbase.org/detail.go?type=gene&acc=2634,,,2634.0,GBP2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of GBP2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1362,2107337,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2643,GCH1,https://ctdbase.org/detail.go?type=gene&acc=2643,,,2643.0,GCH1,9913,Bos taurus (cattle),Ascorbic acid inhibits the reaction [[4-hydroxy-2-nonenal results in decreased activity of GCH1 protein] which results in decreased chemical synthesis of sapropterin]|ascorbic acid inhibits the reaction [4-hydroxy-2-nonenal results in increased degradation of GCH1 protein],,,PMID:17872449,https://www.ncbi.nlm.nih.gov/pubmed/17872449,17872449,,
1363,2107338,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased expression of GCLC protein]|ascorbic acid inhibits the reaction [ethylene chlorohydrin results in increased expression of GCLC mrna],,,PMID:31585129,https://www.ncbi.nlm.nih.gov/pubmed/31585129,31585129,,
1364,2107473,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,10116,Rattus norvegicus (Norway rat),Quercetin affects the reaction [hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of GCLC mrna]]|[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of GCLC mrna|hydrogen peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with ascorbic acid co-treated with dexamethasone] affects the expression of GCLC mrna],,,PMID:27028516,https://www.ncbi.nlm.nih.gov/pubmed/27028516,27028516,,
1365,2107474,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLM mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1366,2107475,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2662,GDF10,https://ctdbase.org/detail.go?type=gene&acc=2662,,,2662.0,GDF10,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with beta-glycerophosphoric acid] results in increased expression of GDF10 mRNA,,,PMID:15994055,https://www.ncbi.nlm.nih.gov/pubmed/15994055,15994055,,
1367,2107476,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2745,GLRX,https://ctdbase.org/detail.go?type=gene&acc=2745,,,2745.0,GLRX,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of GLRX mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
1368,2107477,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2744,GLS,https://ctdbase.org/detail.go?type=gene&acc=2744,,,2744.0,GLS,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of GLS mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1369,2107478,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2785,GNG3,https://ctdbase.org/detail.go?type=gene&acc=2785,,,2785.0,GNG3,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of GNG3 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1370,2107479,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2786,GNG4,https://ctdbase.org/detail.go?type=gene&acc=2786,,,2786.0,GNG4,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of GNG4 mRNA,,,PMID:15305145,https://www.ncbi.nlm.nih.gov/pubmed/15305145,15305145,,
1371,2107480,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2805,GOT1,https://ctdbase.org/detail.go?type=gene&acc=2805,,,2805.0,GOT1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [carbon tetrachloride results in increased expression of GOT1 protein],,,PMID:30676168,https://www.ncbi.nlm.nih.gov/pubmed/30676168,30676168,,
1372,2107481,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,84803,GPAT3,https://ctdbase.org/detail.go?type=gene&acc=84803,,,84803.0,GPAT3,9606,Homo sapiens (human),Ascorbic acid results in increased expression of GPAT3 mRNA,,,PMID:26198647,https://www.ncbi.nlm.nih.gov/pubmed/26198647,26198647,,
1373,2107482,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2817,GPC1,https://ctdbase.org/detail.go?type=gene&acc=2817,,,2817.0,GPC1,10090,Mus musculus (house mouse),Zinc promotes the reaction [[ascorbic acid co-treated with nitric oxide] results in increased degradation of GPC1 protein modified form]|[ascorbic acid co-treated with nitric oxide] results in increased degradation of GPC1 protein modified form,,,PMID:15677459,https://www.ncbi.nlm.nih.gov/pubmed/15677459,15677459,,
1374,2107611,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2817,GPC1,https://ctdbase.org/detail.go?type=gene&acc=2817,,,2817.0,GPC1,10090,Mus musculus (house mouse),Ascorbic acid results in increased degradation of GPC1 protein,,,PMID:21642435,https://www.ncbi.nlm.nih.gov/pubmed/21642435,21642435,,
1375,2107612,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2719,GPC3,https://ctdbase.org/detail.go?type=gene&acc=2719,,,2719.0,GPC3,10090,Mus musculus (house mouse),[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of GPC3 mrna|cadmium sulfate inhibits the reaction [[ascorbic acid co-treated with beta-glycerophosphoric acid co-treated with dexamethasone] results in increased expression of GPC3 mrna],,,PMID:28189605,https://www.ncbi.nlm.nih.gov/pubmed/28189605,28189605,,
1376,2107613,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2819,GPD1,https://ctdbase.org/detail.go?type=gene&acc=2819,,,2819.0,GPD1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with INS1 protein] results in decreased expression of GPD1 mRNA,,,PMID:20400526,https://www.ncbi.nlm.nih.gov/pubmed/20400526,20400526,,
1377,2107614,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2668,GDNF,https://ctdbase.org/detail.go?type=gene&acc=2668,,,2668.0,GDNF,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of S100B mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SYN mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of FZD10 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of S100B protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of DLG4 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of E2F2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SYN protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of RBFOX3 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of MAP2 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of TUBB3 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GABRA2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN2B mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of CNTN1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIA2 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SCN2A mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN2A mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of TERT mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of FOXM1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GFAP mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SLC17A7 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of RBFOX3 protein|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of SLC17A6 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of GLI1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of HOXB1 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of HES3 mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of INHBE mrna|[bdnf protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of LEF1 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1378,2107698,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2670,GFAP,https://ctdbase.org/detail.go?type=gene&acc=2670,,,2670.0,GFAP,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GFAP mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1379,2107699,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2670,GFAP,https://ctdbase.org/detail.go?type=gene&acc=2670,,,2670.0,GFAP,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [vincristine results in increased expression of GFAP protein],,,PMID:34286406,https://www.ncbi.nlm.nih.gov/pubmed/34286406,34286406,,
1380,2107700,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2674,GFRA1,https://ctdbase.org/detail.go?type=gene&acc=2674,,,2674.0,GFRA1,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of GFRA1 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1381,2107701,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2678,GGT1,https://ctdbase.org/detail.go?type=gene&acc=2678,,,2678.0,GGT1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased activity of GGT1 protein],,,PMID:16298753,https://www.ncbi.nlm.nih.gov/pubmed/16298753,16298753,,
1382,2107702,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2688,GH1,https://ctdbase.org/detail.go?type=gene&acc=2688,,,2688.0,GH1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of GH1 protein],,,PMID:18602937,https://www.ncbi.nlm.nih.gov/pubmed/18602937,18602937,,
1383,2107703,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2697,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697.0,GJA1,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [vincristine results in increased expression of GJA1 protein]|ascorbic acid inhibits the reaction [vincristine results in increased expression of GJA1 mrna],,,PMID:34286406,https://www.ncbi.nlm.nih.gov/pubmed/34286406,34286406,,
1384,2107704,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2697,GJA1,https://ctdbase.org/detail.go?type=gene&acc=2697,,,2697.0,GJA1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GJA1 protein]|[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in decreased expression of GJA1 protein],,,PMID:29940330,https://www.ncbi.nlm.nih.gov/pubmed/29940330,29940330,,
1385,2107705,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2717,GLA,https://ctdbase.org/detail.go?type=gene&acc=2717,,,2717.0,GLA,13489,Dicentrarchus labrax (European seabass),Ascorbic acid results in decreased expression of GLA mRNA,,,PMID:21281732,https://www.ncbi.nlm.nih.gov/pubmed/21281732,21281732,,
1386,2107706,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2735,GLI1,https://ctdbase.org/detail.go?type=gene&acc=2735,,,2735.0,GLI1,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in decreased expression of GLI1 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1387,2107707,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2739,GLO1,https://ctdbase.org/detail.go?type=gene&acc=2739,,,2739.0,GLO1,10090,Mus musculus (house mouse),Ascorbic acid affects the expression of GLO1 protein,,,PMID:19224539,https://www.ncbi.nlm.nih.gov/pubmed/19224539,19224539,,
1388,2107810,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,11321,GPN1,https://ctdbase.org/detail.go?type=gene&acc=11321,,,11321.0,GPN1,9606,Homo sapiens (human),Ascorbic acid results in decreased expression of GPN1 mrna|[arsenic trioxide co-treated with ascorbic acid] results in decreased expression of GPN1 mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1389,2107811,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,1880,GPR183,https://ctdbase.org/detail.go?type=gene&acc=1880,,,1880.0,GPR183,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPR183 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1390,2107812,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9290,GPR55,https://ctdbase.org/detail.go?type=gene&acc=9290,,,9290.0,GPR55,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased expression of GPR55 protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
1391,2107813,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [diquat results in increased expression of GPT protein],,,PMID:33475796,https://www.ncbi.nlm.nih.gov/pubmed/33475796,33475796,,
1392,2107814,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,8022,Oncorhynchus mykiss (rainbow trout),[vitamin A co-treated with cholecalciferol co-treated with vitamin E co-treated with ascorbic acid] inhibits the reaction [[cyhalothrin co-treated with chlorantranilipole] results in increased activity of GPT protein],,,PMID:36813254,https://www.ncbi.nlm.nih.gov/pubmed/36813254,36813254,,
1393,2107815,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [carbon tetrachloride results in increased expression of GPT protein],,,PMID:30676168,https://www.ncbi.nlm.nih.gov/pubmed/30676168,30676168,,
1394,2107816,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cyclosporine results in increased activity of GPT protein],,,PMID:19391111,https://www.ncbi.nlm.nih.gov/pubmed/19391111,19391111,,
1395,2107817,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [food additives results in increased activity of GPT protein],,,PMID:16758767,https://www.ncbi.nlm.nih.gov/pubmed/16758767,16758767,,
1396,2107818,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10029,Cricetulus griseus (Chinese hamster),"Ascorbic acid inhibits the reaction [3,5-dimethylaminophenol results in decreased activity of GPX1 protein]|ascorbic acid results in increased activity of GPX1 protein",,,PMID:25178734,https://www.ncbi.nlm.nih.gov/pubmed/25178734,25178734,,
1397,2107819,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,9606,Homo sapiens (human),[ascorbic acid co-treated with vitamin E] results in increased expression of GPX1 mRNA,,,PMID:22207723,https://www.ncbi.nlm.nih.gov/pubmed/22207723,22207723,,
1398,2107943,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,9606,Homo sapiens (human),[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of GPX1 mrna|nutlin 3 inhibits the reaction [[ascorbic acid co-treated with zinc acetate co-treated with motexafin gadolinium] results in decreased expression of GPX1 mrna],,,PMID:20530418,https://www.ncbi.nlm.nih.gov/pubmed/20530418,20530418,,
1399,2107944,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of GPX1 mrna],,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
1400,2107945,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,9606,Homo sapiens (human),Ascorbic acid results in increased expression of GPX1 mRNA,,,PMID:31576639,https://www.ncbi.nlm.nih.gov/pubmed/31576639,31576639,,
1401,2107946,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,9606,Homo sapiens (human),[vitamin A co-treated with ascorbic acid co-treated with vitamin E] results in increased expression of GPX1 protein,,,PMID:17179735,https://www.ncbi.nlm.nih.gov/pubmed/17179735,17179735,,
1402,2107947,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116,Rattus norvegicus (Norway rat),[ascorbic acid co-treated with vitamin E] inhibits the reaction [diethylhexyl phthalate results in increased expression of GPX1 protein],,,PMID:29663635,https://www.ncbi.nlm.nih.gov/pubmed/29663635,29663635,,
1403,2107948,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [carbon tetrachloride results in decreased activity of GPX1 protein],,,PMID:30676168,https://www.ncbi.nlm.nih.gov/pubmed/30676168,30676168,,
1404,2107949,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased activity of GPX1 protein],,,PMID:16248992|PMID:16298753,https://www.ncbi.nlm.nih.gov/pubmed/16248992|https://www.ncbi.nlm.nih.gov/pubmed/16298753,16248992|16298753,,
1405,2107950,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of GPX1 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1406,2107951,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2877,GPX2,https://ctdbase.org/detail.go?type=gene&acc=2877,,,2877.0,GPX2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPX2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1407,2107952,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2877,GPX2,https://ctdbase.org/detail.go?type=gene&acc=2877,,,2877.0,GPX2,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in increased expression of GPX2 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1408,2108073,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2877,GPX2,https://ctdbase.org/detail.go?type=gene&acc=2877,,,2877.0,GPX2,9606,Homo sapiens (human),[tretinoin co-treated with ascorbic acid] results in increased expression of GPX2 mRNA,,,PMID:16443354,https://www.ncbi.nlm.nih.gov/pubmed/16443354,16443354,,
1409,2108074,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2879,GPX4,https://ctdbase.org/detail.go?type=gene&acc=2879,,,2879.0,GPX4,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of GPX4 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1410,2108075,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2890,GRIA1,https://ctdbase.org/detail.go?type=gene&acc=2890,,,2890.0,GRIA1,10090,Mus musculus (house mouse),Ascorbic acid results in increased expression of GRIA1 protein,,,PMID:33872575,https://www.ncbi.nlm.nih.gov/pubmed/33872575,33872575,,
1411,2108076,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2891,GRIA2,https://ctdbase.org/detail.go?type=gene&acc=2891,,,2891.0,GRIA2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1412,2108077,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2891,GRIA2,https://ctdbase.org/detail.go?type=gene&acc=2891,,,2891.0,GRIA2,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIA2 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1413,2108078,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2892,GRIA3,https://ctdbase.org/detail.go?type=gene&acc=2892,,,2892.0,GRIA3,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GRIA3 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1414,2108079,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2902,GRIN1,https://ctdbase.org/detail.go?type=gene&acc=2902,,,2902.0,GRIN1,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN1 mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1415,2108080,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2903,GRIN2A,https://ctdbase.org/detail.go?type=gene&acc=2903,,,2903.0,GRIN2A,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN2A mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1416,2108081,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,9606,Homo sapiens (human),[BDNF protein co-treated with GDNF protein co-treated with cyclic AMP co-treated with TGFB3 protein co-treated with ascorbic acid] results in increased expression of GRIN2B mRNA,,,PMID:33713149,https://www.ncbi.nlm.nih.gov/pubmed/33713149,33713149,,
1417,2108196,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2896,GRN,https://ctdbase.org/detail.go?type=gene&acc=2896,,,2896.0,GRN,9606,Homo sapiens (human),Ascorbic acid results in increased expression of GRN mrna|[arsenic trioxide co-treated with ascorbic acid] results in increased expression of GRN mRNA,,,PMID:25555879,https://www.ncbi.nlm.nih.gov/pubmed/25555879,25555879,,
1418,2108197,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [excitatory amino acid agonists results in increased phosphorylation of GSK3B protein],,,PMID:24675465,https://www.ncbi.nlm.nih.gov/pubmed/24675465,24675465,,
1419,2108198,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in decreased expression of GSK3B mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1420,2108199,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9922,Capra,Ascorbic acid inhibits the reaction [methoxychlor results in decreased activity of GSR protein],,,PMID:11753474,https://www.ncbi.nlm.nih.gov/pubmed/11753474,11753474,,
1421,2108200,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10029,Cricetulus griseus (Chinese hamster),"Ascorbic acid inhibits the reaction [3,5-dimethylaminophenol results in decreased activity of GSR protein]",,,PMID:25178734,https://www.ncbi.nlm.nih.gov/pubmed/25178734,25178734,,
1422,2108201,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606,Homo sapiens (human),[ascorbic acid co-treated with GSR protein] affects the metabolism of glucose,,,PMID:1901343,https://www.ncbi.nlm.nih.gov/pubmed/1901343,1901343,,
1423,2108202,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [hydrogen peroxide results in increased activity of GSR protein],,,PMID:28285367,https://www.ncbi.nlm.nih.gov/pubmed/28285367,28285367,,
1424,2108203,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606,Homo sapiens (human),[juglone co-treated with ascorbic acid] results in decreased activity of GSR protein,,,PMID:29992683,https://www.ncbi.nlm.nih.gov/pubmed/29992683,29992683,,
1425,2108204,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [arsenic trioxide results in decreased activity of GSR protein],,,PMID:18715643,https://www.ncbi.nlm.nih.gov/pubmed/18715643,18715643,,
1426,2108205,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10090,Mus musculus (house mouse),Ascorbic acid inhibits the reaction [cadmium chloride results in decreased activity of GSR protein],,,PMID:18548748,https://www.ncbi.nlm.nih.gov/pubmed/18548748,18548748,,
1427,2108312,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with kojic acid co-treated with ascorbic acid] results in increased expression of GSR mRNA,,,PMID:17917374,https://www.ncbi.nlm.nih.gov/pubmed/17917374,17917374,,
1428,2108313,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [bisphenol A results in decreased activity of GSR protein],,,PMID:12767684,https://www.ncbi.nlm.nih.gov/pubmed/12767684,12767684,,
1429,2108314,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased activity of GSR protein],,,PMID:16248992|PMID:16298753,https://www.ncbi.nlm.nih.gov/pubmed/16248992|https://www.ncbi.nlm.nih.gov/pubmed/16298753,16248992|16298753,,
1430,2108315,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [cyclosporine results in decreased activity of GSR protein],,,PMID:19391111,https://www.ncbi.nlm.nih.gov/pubmed/19391111,19391111,,
1431,2108316,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased activity of GSR protein],,,PMID:32407874,https://www.ncbi.nlm.nih.gov/pubmed/32407874,32407874,,
1432,2108317,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of GSR mrna]|ascorbic acid inhibits the reaction [potassium dichromate results in decreased activity of GSR protein],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
1433,2108318,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased activity of GSR protein],,,PMID:23194016,https://www.ncbi.nlm.nih.gov/pubmed/23194016,23194016,,
1434,2108319,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased expression of GSR protein],,,PMID:19429265,https://www.ncbi.nlm.nih.gov/pubmed/19429265,19429265,,
1435,2108320,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2938,GSTA1,https://ctdbase.org/detail.go?type=gene&acc=2938,,,2938.0,GSTA1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1436,2108321,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2938,GSTA1,https://ctdbase.org/detail.go?type=gene&acc=2938,,,2938.0,GSTA1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of GSTA1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1437,2108448,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2938,GSTA1,https://ctdbase.org/detail.go?type=gene&acc=2938,,,2938.0,GSTA1,10090,Mus musculus (house mouse),Ascorbic acid promotes the reaction [sodium arsenite results in increased expression of GSTA1 mrna],,,PMID:16517059,https://www.ncbi.nlm.nih.gov/pubmed/16517059,16517059,,
1438,2108449,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTA2 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1439,2108450,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2941,GSTA4,https://ctdbase.org/detail.go?type=gene&acc=2941,,,2941.0,GSTA4,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of GSTA4 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
1440,2108451,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,9606,Homo sapiens (human),GSTM1 affects the susceptibility to ascorbic acid deficiency,,,PMID:19710200,https://www.ncbi.nlm.nih.gov/pubmed/19710200,19710200,,
1441,2108452,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,9606,Homo sapiens (human),"GSTM1 gene polymorphism affects the susceptibility to [ascorbic acid co-treated with tocotrienol, alpha]",,,PMID:15668500,https://www.ncbi.nlm.nih.gov/pubmed/15668500,15668500,,
1442,2108453,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of GSTM1 mrna]|ascorbic acid inhibits the reaction [chromium hexavalent ion results in decreased expression of GSTM1 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
1443,2108454,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [potassium dichromate results in decreased expression of GSTM2 mrna],,,PMID:23470461,https://www.ncbi.nlm.nih.gov/pubmed/23470461,23470461,,
1444,2108455,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10116,Rattus norvegicus (Norway rat),Ascorbic acid results in increased expression of GSTM2 mRNA,,,PMID:15372504,https://www.ncbi.nlm.nih.gov/pubmed/15372504,15372504,,
1445,2108456,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9446,GSTO1,https://ctdbase.org/detail.go?type=gene&acc=9446,,,9446.0,GSTO1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GSTO1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1446,2108457,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,9446,GSTO1,https://ctdbase.org/detail.go?type=gene&acc=9446,,,9446.0,GSTO1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [[lead acetate results in increased abundance of lead] which results in decreased expression of GSTO1 mrna]|ascorbic acid results in increased expression of GSTO1 mRNA,,,PMID:31610155,https://www.ncbi.nlm.nih.gov/pubmed/31610155,31610155,,
1447,2108570,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,9606,Homo sapiens (human),[[ascorbic acid co-treated with chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of GSTP1 mRNA,,,PMID:34480604,https://www.ncbi.nlm.nih.gov/pubmed/34480604,34480604,,
1448,2108571,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,9606,Homo sapiens (human),Ascorbic acid inhibits the reaction [sodium arsenite results in decreased expression of GSTP1 protein]|ascorbic acid inhibits the reaction [sodium arsenite results in increased methylation of GSTP1 promoter],,,PMID:33388378,https://www.ncbi.nlm.nih.gov/pubmed/33388378,33388378,,
1449,2108572,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2952,GSTT1,https://ctdbase.org/detail.go?type=gene&acc=2952,,,2952.0,GSTT1,9606,Homo sapiens (human),GSTT1 affects the susceptibility to ascorbic acid deficiency,,,PMID:19710200,https://www.ncbi.nlm.nih.gov/pubmed/19710200,19710200,,
1450,2108573,54670067,Comparative Toxicogenomics Database (CTD),Ascorbic Acid,D001205,Ascorbic Acid,https://ctdbase.org/detail.go?type=chem&acc=D001205,2965,GTF2H1,https://ctdbase.org/detail.go?type=gene&acc=2965,,,2965.0,GTF2H1,9606,Homo sapiens (human),[quercetin co-treated with ascorbic acid] results in decreased expression of GTF2H1 mRNA,,,PMID:17639512,https://www.ncbi.nlm.nih.gov/pubmed/17639512,17639512,,
1451,2142333,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,PRL,https://www.dgidb.org/genes/hgnc:9445,,,5617.0,PRL,9606,Homo sapiens (human),,,,,,,,
1452,2142334,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,NFE2L2,https://www.dgidb.org/genes/hgnc:7782,,,4780.0,NFE2L2,9606,Homo sapiens (human),,,,,,,,
1453,2142335,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,GFAP,https://www.dgidb.org/genes/hgnc:4235,,,2670.0,GFAP,9606,Homo sapiens (human),,,,,,,,
1454,2142336,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,GFAP,https://www.dgidb.org/genes/hgnc:4235,,,2670.0,GFAP,9606,Homo sapiens (human),,,,,,,,
1455,2156112,54670067,IUPHAR/BPS Guide to PHARMACOLOGY,Ascorbic Acid,4532,[14C]ascorbic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4532,1041,Sodium-dependent vitamin C transporter 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1041,Q9UHI7,Solute carrier family 23 member 1,9963.0,SLC23A1,9606,Homo sapiens (human),Binding,,4.19,PMID:11895172,https://www.ncbi.nlm.nih.gov/pubmed/11895172,11895172,,
1456,2156113,54670067,IUPHAR/BPS Guide to PHARMACOLOGY,Ascorbic Acid,4532,[14C]ascorbic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4532,1042,Sodium-dependent vitamin C transporter 2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1042,Q9UGH3,Solute carrier family 23 member 2,9962.0,SLC23A2,9606,Homo sapiens (human),,,4.19,,,,,
1457,2156114,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,SP7,https://www.dgidb.org/genes/hgnc:17321,,,121340.0,SP7,9606,Homo sapiens (human),,,,,,,,
1458,2156115,54670067,Drug Gene Interaction database (DGIdb),Ascorbic Acid,,ASCORBIC ACID,https://www.dgidb.org/drugs/rxcui:1151,,DDIT3,https://www.dgidb.org/genes/hgnc:2726,,,1649.0,DDIT3,9606,Homo sapiens (human),,,,,,,,
